pmcid,table_id,table_label,table_caption,table_foot,n_header_rows,table_data_file
4444480,T1,Table 1,Subject baseline characteristics,"Baseline characteristics of the group that converted to Alzheimer's disease (MCIc) and the group that did not convert to Alzheimer's disease (MCInc) at a two-year follow-up. Values are mean (SD). All neuropsychological test scores are raw values. Group comparisons by *t-test and †Fisher exact test, two-tailed. MCI, Mild Cognitive impairment; MCIc, MCI group converted to Alzheimer's disease; MCInc, MCI group not converted to Alzheimer's disease; BDS-ADL, Blessed Dementia Scale-Activities of Daily living.",1,articles/50e/pmcid_4444480/tables/table_000.csv
4444480,T2,Table 2,Brain regions showing significantly lower glucose metabolism and gray matter in AD-converted MCI compared to non-converted MCI,"*Brain regions were transformed to Talairach atlas from MNI coordinates. AD, Alzheimer's disease; MNI, Montreal Neurological Institute; FDG-PET, fluorodeoxyglucose-positron emission tomography.",2,articles/50e/pmcid_4444480/tables/table_001.csv
4444480,T3,Table 3,Logistic regression analyses designed to select appropriate models for Alzheimer's disease prediction in MCI,"*All models contain age and years of education as covariates. AD, Alzheimer's disease; MCI, mild cognitive impairment; -2LL,-2 log likelihood; df, degree of freedom; edu, year of education; MMSE, mini-mental state examination; Model N, model using MMSE; Model P, model using PET; Model M, model using MRI; model NP, combination of model N and P; model NM, combination of model N and M; model PM, combination of model P and M; model NPM, combination of model N, P, and M.",1,articles/50e/pmcid_4444480/tables/table_002.csv
4444480,T4,Table 4,Final logistic regression model (model NP)* for Alzheimer's disease prediction in mild cognitive impairment,"*Chi-square, 34.416; df, 4; P<0.001. Model NP, combination of MMSE and PET.",1,articles/50e/pmcid_4444480/tables/table_003.csv
5461938,T1,Table 1,Baseline characteristics of the study population,Other missing data not previously reported; former smoker =3; peripheral vascular disease =1.,1,articles/d23/pmcid_5461938/tables/table_000.csv
5461938,T2,Table 2,Mean scores for key individual variables using all available data,,1,articles/d23/pmcid_5461938/tables/table_001.csv
5461938,T3,Table 3,Results from linear regression ‘Simple model’ analyses,All numbers are standardized β-values (P-values). Significant relationships are shown in bold while the most strongly associated MR variable per outcome per category is underlined.,1,articles/d23/pmcid_5461938/tables/table_002.csv
5461938,T4,Table 4,Results from linear regression ‘Complex model’ analyses,"All numbers are standardized β-values (P-values) (95% standardized β confidence interval (CI)), with overall model significance being given on the bottom row. Models are separated into those which test NAWM and WM metrics horizontally. Significant associations are shown in bold.",1,articles/d23/pmcid_5461938/tables/table_003.csv
8258736,Tab1,Table 1,(A) Structural gray matter studies (structural MRI). (B) Structural white matter studies (DMRI/DTI). (C) Structural longitudinal/cohort studies (MRI or CT).,"(A) C concordant, dlPFC dorsal lateral prefrontal cortex, GM gray matter, GMV gray matter volume, HC healthy control, IFG_tri inferior frontal gyrus triangular part, L loneliness, ME multiple episodes of depression, MTG middle temporal gyrus, MRI magnetic resonance imaging, NS not stated, pSTS posterior superior temporal sulcus, R robust, rGMV regional gray matter volume, ROI region of interest, S susceptible, SE single episode of depression, SI social isolation, tGMV total gray matter volume, TIV total intracranial volume, UCLA-LS University of California Los Angeles loneliness scale, vmPFC ventromedial prefrontal cortex.(B) AI anterior insula, dmPFC dorsal medial prefrontal cortex, DMRI diffusion MRI, DTI diffusion tensor imaging, IFG inferior front gyrus, IPL inferior parietal lobule, M/M Met/Met genotype, NR not stated, pSTS posterior superior temporal sulcus, pTPJ posterior temporoparietal junction, rlPFC rostro lateral prefrontal cortex, ROIs regions of interest, rWMD regional white matter density, SLF superior longitudinal fasciculus, TPJ temporoparietal junction, UCLA-LS University of California Los Angeles Loneliness Scale, VAN ventral attentional network, V/M Val/Met genotype, V/V Val/Val genotype.(C) AI anterior insula, BMI body mass index, BP blood pressure, C non-empty nest elderly control group, CE couples empty-nest group, CT Computerized tomography, DM diabetes mellitus, HC healthy controls, HTN hypertension, MRI magnetic resonance imaging, PFC prefrontal cortex, pTBI penetrating traumatic brain injuries, SE single empty-nest group, UCLA-LS University of California Los Angeles Loneliness Scale, WMH white matter hyperintensities.",1,articles/d4a/pmcid_8258736/tables/table_000.csv
8258736,Tab2,Table 2,(A) Task-based fMRI Studies. (B) Resting state fMRI.,"(A) aAlso featured in the structural MRI work; C concordant, DLPFC dorsal lateral prefrontal cortex, DMN default mode network, dmPFC dorsal medial prefrontal cortex, fMRI functional magnetic resonance imaging, GMV gray matter volume, L loneliness, LLD late-life depression, MDD major depressive disorder, mPFC medial prefrontal cortex, NS not stated, NC non-psychiatric control group, O old, R robust, ROI region of interest, S susceptible, SFG superior frontal gyrus, SI social isolation, SMA supplementary motor area, SZ individuals with schizophrenia, UCLA-LS University of California Los Angeles Loneliness Scale, VS ventral striatum, vmPFC ventromedial prefrontal cortex, Y young.(B) ACC anterior cingulate cortex, ALFF amplitude of low-frequency fluctuations, DMN default mode network, dlPFC dorsal lateral prefrontal cortex, FC functional connectivity, fMRI functional magnetic resonance imaging, ITG inferior temporal gyrus, mPFC medial prefrontal cortex, NIH National Institutes of Health, NS not stated, UCLA-LS University of California Los Angeles Loneliness Scale.",1,articles/d4a/pmcid_8258736/tables/table_001.csv
8258736,Tab3,Table 3,Other studies.,"AD Alzheimer’s Disease, CENA Chicago Electrical Neuroimaging Analytics, CG control group, dlPFC dorsal lateral prefrontal cortex, EEG electroencephalogram, ERP event-related potential, HC healthy control, HL high loneliness, LL low loneliness, NG nostalgic group, NS not stated, PET positron emission tomography, SHI severe hearing impairment, SPECT single-photon emission computed tomography, RNA ribonucleic acid, UCLA-LS University of California Los Angeles Loneliness Scale.",1,articles/d4a/pmcid_8258736/tables/table_002.csv
3669206,pone-0064925-t001,Table 1,Demographic data and MMSE of the subjects.,"1not significantly different between groups, χ2 (1) = 1.5, p = 0.22.2significantly different between groups, t (278) = 3.92, p<0.001.3significantly different between groups, Mann-Whitney U = 263, p<0.001.4significantly different between groups, t (271) = −6.7, p<0.001.Abbreviations: SD, standard deviation; MMSE, mini-mental state examination; AD, Alzheimer’s disease.",1,articles/0c3/pmcid_3669206/tables/table_000.csv
3669206,pone-0064925-t002,Table 2,Scan parameters for DTI and number of subjects per scanner.,"Abbreviations: TR, repetition time; TE, echo time; iPAT, integrated parallel imaging techniques; AD, Alzheimer’s disease.",1,articles/0c3/pmcid_3669206/tables/table_001.csv
3669206,pone-0064925-t003,Table 3,SVM classification results for the original and PCA variance reduced data (pooled cross-validation).,"For each modality the average number of informative voxels is provided and in parentheses the proportion compared to the respective tissue masks is presented. In the last column the removed variance proportion is given.Abbreviations: FA, fractional anisotropy; MD, mean diffusivity; WMD, white matter density; GMD, gray matter density.",1,articles/0c3/pmcid_3669206/tables/table_002.csv
3669206,pone-0064925-t004,Table 4,Cross-validation results using the data of each scanner as fold.,"For each modality the average number of informative voxels is provided and in parentheses the proportion compared to the respective tissue masks is presented.Abbreviations: FA, fractional anisotropy; MD, mean diffusivity; WMD, white matter density; GMD, gray matter density; ML, machine learning; SVM, Support Vector Machine; NB, Naïve Bayes.",1,articles/0c3/pmcid_3669206/tables/table_003.csv
3669206,pone-0064925-t005,Table 5,NB classification results for the original and PCA variance reduced data (pooled cross-validation).,"Abbreviations: FA, fractional anisotropy; MD, mean diffusivity; WMD, white matter density; GMD, gray matter density.",1,articles/0c3/pmcid_3669206/tables/table_004.csv
3669206,pone-0064925-t006,Table 6,Anatomic areas of the twenty most informative voxels derived from the averaged SVM sensitivity maps for FA.,"These points were restricted to be at least 10.5 mm distant from each other. The coordinates given are in MNI space. For easier interpretation, we first applied the natural logarithm to the sensitivity values and then rescaled them to be between zero and one.Abbreviations: WM, white matter; L, left hemisphere; R, right hemisphere.",2,articles/0c3/pmcid_3669206/tables/table_005.csv
3669206,pone-0064925-t007,Table 7,Anatomic areas of the twenty most informative voxels derived from the averaged SVM sensitivity maps for MD.,"These points were restricted to be at least 10.5 mm distant from each other. The coordinates given are in MNI space. For easier interpretation, we first applied the natural logarithm to the sensitivity values and then rescaled them to be between zero and one.Abbreviations: WM, white matter; L, left hemisphere; R, right hemisphere.",2,articles/0c3/pmcid_3669206/tables/table_006.csv
3669206,pone-0064925-t008,Table 8,Anatomic areas of the twenty most informative voxels derived from the averaged SVM sensitivity maps for WMD.,"These points were restricted to be at least 10.5 mm distant from each other. The coordinates given are in MNI space. For easier interpretation, we first applied the natural logarithm to the sensitivity values and then rescaled them to be between zero and one.Abbreviations: WM, white matter; L, left hemisphere; R, right hemisphere.",2,articles/0c3/pmcid_3669206/tables/table_007.csv
3669206,pone-0064925-t009,Table 9,Anatomic areas of the twenty most informative voxels derived from the averaged SVM sensitivity maps for GMD.,"These points were restricted to be at least 10.5 mm distant from each other. The coordinates given are in MNI space. For easier interpretation, we first applied the natural logarithm to the sensitivity values and then rescaled them to be between zero and one.Abbreviations: L, left hemisphere; R, right hemisphere.",2,articles/0c3/pmcid_3669206/tables/table_008.csv
7683078,jad-78-jad200423-t001,Table 1,Characteristics of the intervention and control groups in the DTI population,"Values are means (SD) unless otherwise specified; BMI, body mass index; MRI, magnetic resonance imaging; NTB, neuropsychological test battery.",2,articles/caf/pmcid_7683078/tables/table_000.csv
7683078,jad-78-jad200423-t002,Table 2,"Primary and secondary cognitive end points from baseline to 2-years, DTI population","Mixed-model repeated-measures analyses were used to assess between-group differences (group×time interaction) in the changes from baseline to 24 months based. Scores on the NTB total score and memory, executive functioning and processing speed domain scores are estimated mean values (standard errors) of z scores of the cognitive tests included in each cognitive outcome with higher scores indicating better performance. A positive value of the estimate of the between-group differences indicates the effect is in favor of the intervention group.",2,articles/caf/pmcid_7683078/tables/table_001.csv
4418835,pone.0126310.t001,Table 1,Demographic information and neuropsychological test scores.,"Data are presented as mean ± std. p-value indicates the significance of the difference among the three study cohorts (one-way ANOVA). Abbreviations: CDR, Clinical Dementia Rating; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; CDT, Clock Drawing Task; ADL, Activity of Daily Living Scale; HAMD, Hamilton Depression Scale; HIS, Hachinski Ischemic Score.",1,articles/161/pmcid_4418835/tables/table_000.csv
4418835,pone.0126310.t002,Table 2,"VMHC differences between AD, MCI and CN.","ANOVA, uncorrected, p < 0.01, extent threshold = 97. Coordinates are given in the left-posterior-inferior system. For the symmetric results, only the left side structures are listed. Abbreviations: MNI, Montreal Neurological Institute space; x, y, z, coordinates of cluster locations in the MNI space; OFC, orbitofrontal cortex; ACC, anterior cingulate cortex; NAcc, nucleus accumbens; POC, primary olfactory cortex; SMC, sensorimotor cortex; OcG, occipital gyrus.",2,articles/161/pmcid_4418835/tables/table_001.csv
4418835,pone.0126310.t003,Table 3,"Correlation between diffusion parameters, volume of the genu of corpus callosum, VMHC, and MMSE scores of all the subjects.","The values in the table are the correlation coefficients and corresponding p-values (partial correlation with age effect corrected).*, p ≤ 0.05;**, p ≤ 0.01;***, p ≤ 0.001.Abbreviations: FA, fractional anisotropy; MD, mean diffusivity (×10–3 mm2/s); λ‖, axial diffusivity (×10–3 mm2/s); λ┴, radial diffusion (×10–3 mm2/s); VMHC, voxel mirror homotopic connectivity; OFC, orbitofrontal cortex; ACC, anterior cingulate cortex; NAcc, nucleus accumbens; SMC, sensorimotor cortex; OcG, occipital gyrus.",1,articles/161/pmcid_4418835/tables/table_002.csv
5428287,Tab1,Table 1,Group difference in age for the minimum/maximum DTI-derived measures based on analysis of the Poisson model and TBSS.,These data were tested as significant group difference with independent t-test using FDR correction with q value 0.05. SD: standard derivation. FA: fractional anisotropy; MD: mean diffusivity; Da: axial diffusivity; Dr: Radial diffusivity.,2,articles/8f5/pmcid_5428287/tables/table_000.csv
5428287,Tab2,Table 2,Group difference in the minimum/maximum DTI-derived measures based on analysis of the Poisson model and TBSS.,These data were tested as significant group difference with independent t-test using FDR correction with q value 0.05 (*). SD: standard derivation. FA: fractional anisotropy; MD: mean diffusivity; Da: axial diffusivity; Dr: Radial diffusivity.,2,articles/8f5/pmcid_5428287/tables/table_001.csv
5428287,Tab3,Table 3,FA group difference at ages from 6 to 24 months.,The data were tested with a two-way ANOVA and post-hoc analysis with significant level of p < 0.05 (*). SD: standard derivation. FA: fractional anisotropy.,2,articles/8f5/pmcid_5428287/tables/table_002.csv
5428287,Tab4,Table 4,FA group difference at ages from 30 to 48 months.,The data were tested with a two-way ANOVA and post-hoc analysis with significant level of p < 0.05 (*). SD: standard derivation. FA: fractional anisotropy.,2,articles/8f5/pmcid_5428287/tables/table_003.csv
10481508,Tab1,Table 1,"CSF parameters of PMS patients. Data including white cell count/µl, total protein in mg/dl, lactate in mmol/l, intrathecal IgG synthesis, oligoclonal bands, tau protein in pg/ml (reference range < 400 pg/mL), amyloid-ß in pg/ml (reference range > 600 pg/mL), CXCL13 in pg/ml, pNF-H in pg/ml, amyloid-ß 42/40, p-Tau 181 in pg/ml","Abbreviations: OCB = oligoclonal bands, Aß = amyloid-ß, CXCL13 = C-X-C motif chemokine 13, pNF-H = neurofilament heavy chain",1,articles/19c/pmcid_10481508/tables/table_000.csv
10481508,Tab2,Table 2,Association clusters of proteins amyloid-β and tau and FA,,1,articles/19c/pmcid_10481508/tables/table_001.csv
10481508,Tab4,Table 4,"clinical data of PMS patients including age, genetic findings, and stage of development","Abbreviations: ASD = autism spectrum disorder, ASHD = attention deficit hyperactivity disease, * = this patient is PMS-SHANK3 unrelated",1,articles/19c/pmcid_10481508/tables/table_003.csv
4240303,awu298-T1,Table 1,Demographics of the healthy control and sporadic CJD cohorta,"aSee text for demographics on controls subjects.bAll but one subject with sporadic CJD ruled out for genetic prion disease by PRNP analysis; this subject was not path-proven, but had no family history of neuropsychiatric disorder and presented clinically like sporadic CJD.cOne subject with codon 129 data, but no prion typing on western blot available, was called MM 1 based on the histopathology autopsy findings. Percentages might not add exactly due to rounding.— = not relevant; N/A = data not available; M = methionine; V = valine. ± refers to standard deviation (SD). Previously published and used with permission (Caverzasi et al., 2014).",1,articles/798/pmcid_4240303/tables/table_000.csv
4240303,awu298-T2,Table 2,Cross-sectional analysis of DTI metrics in the subcortical white matter volumes of interest in patients with sporadic CJD compared with control subjects after multi-comparison correction (FDR),"Mean diffusivity, axial and radial diffusivity values are reported in mm2/s × 10−3 at a lobar level as average ± SD for both control and sporadic CJD groups. The significance is reported as ***P < 0.001, **P < 0.01, *P < 0.05, (*) trend with P < 0.1, with sporadic CJD DTI metrics reduced versus controls. NS = non-significant; MD = mean diffusivity; FA = fractional anisotropy; AD = axial diffusivity; RD = radial diffusivity. No DTI metrics were increased in any volumes of interest in sporadic CJD.",2,articles/798/pmcid_4240303/tables/table_001.csv
4240303,awu298-T3,Table 3,White matter histopathology ratings in three brain regions in six subjects with sporadic CJD with available pathology,"Subjects are listed based on the time interval between MRI and death. PrPSc deposition, gliosis and vacuolation are reported as % of area involved. For gliosis and PrPSc deposition a rate of involvement was performed (0 = none; 1 = mild; 2 = moderate; 3 = severe). Scores in between two ordinals were graded with ‘0.5’; PrPSc deposition was also described as fine or course. Subjects 5 was the single case considered to have PrPSc in the white matter.* Subject 12, as parietal tissue was not available for all immunohistochemistry, superior temporal was used instead.# Second time point MRI.",2,articles/798/pmcid_4240303/tables/table_002.csv
11656998,TAB1,Table 1,"Mean and standard deviation for the volume, FA, and MD of the 10 white matter tracts examined in men aged 18-50 years.Non-parametric tests (Kruskal-Wallis test) and chi-square tests were used for group comparisons. The 10 white matter tracts are IFOF, SFOF, ILF, SLF, cingulum, CST, forceps major, forceps minor, uncinate fasciculus, and ATR.FA: fractional anisotropy; MD: mean diffusivity; IFOF: inferior fronto-occipital fasciculus; SFOF: superior fronto-occipital fasciculus; ILF: inferior longitudinal fasciculus; SLF: superior longitudinal fasciculus; CST: corticospinal tract; ATR: anterior thalamic radiation.***P values of volume and MD of IFOF are significant.",,1,articles/2e3/pmcid_11656998/tables/table_000.csv
5346640,T1,Table 1,Demographic and test data for cognitively normal controls and all patients with lacunar infarction,"Abbreviation: CN, cognitively normal controls; LI, lacunar infarction ; LI-Non MCI, lacunar infarction patient with non mild cognitive impairment; LI-MCI, lacunar infarction patient with mild cognitive impairment; LDL, low-density lipoprotein; FBS, fasting blood sugar; MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; CDT, Clock Drawing Task; RAVLT, Rey Auditory Verbal Learning Test; TMT-A, Trail Making Test A; TMT-B, Trail Making Test B; HAMD-17, 17-item Hamilton Depression Rating Scale. P1, patients group compared with control group; P2, patients with MCI compared with control group and patients without MCI.",2,articles/f19/pmcid_5346640/tables/table_000.csv
5346640,T2,Table 2,Comparison of the fractional anisotropy and mean diffusivity values between cognitive normal controls and all patients with lacunar infarction,"Abbreviation: CN, cognitive normal controls; LI, lacunar infarction; LI-No, lacunar infarction non-mild cognitive impairment; MCI, mild cognitive impairment; FA, fractional anisotropy; MD, mean diffusivity.",2,articles/f19/pmcid_5346640/tables/table_001.csv
5346640,T3,Table 3,Spatial navigation tests for cognitively normal controls and lacunar infarction patients,"Abbreviation: CN, cognitively normal controls; LI-Non MCI, lacunar infarction patient with non mild cognitive impairment; LI-MCI, lacunar infarction patient with mild cognitive impairmen AVE, allo-ego vision; EV, ego vision; AV, allo vision; DV, delayed vision.",2,articles/f19/pmcid_5346640/tables/table_002.csv
5346640,T4,Table 4,Regression coefficients (linear regression analysis) between egocentric in patients and DTI markers,"Mode2 has been adjusted by gender, age, education, the history of hypertension, diabetes mellitus, daily Smoking and drinking.",3,articles/f19/pmcid_5346640/tables/table_003.csv
5346640,T5,Table 5,Regression coefficients (linear regression analysis) between allocentric in patients and DTI markers,"Mode2 has been adjusted by gender, age, education, the history of hypertension, diabetes mellitus, daily Smoking and drinking.",3,articles/f19/pmcid_5346640/tables/table_004.csv
10559725,T1,Table 1,Participant characteristics.,"SD, standard deviation; IQR, interquartile range; CV, cerebrovascular; TIA, transient ischemic attack; WMH, white matter hyperintensity; TICV, total intracranial volume.",1,articles/0ce/pmcid_10559725/tables/table_000.csv
10559725,T2,Table 2,Baseline and longitudinal change in white matter measures.,"aAll groups differ with p <0.001, rmANOVA. bAll groups differ with p <0.01, rmANOVA. cAll groups differ with p <0.001 except penumbra: No Growth vs. NAWM, rmANOVA. dMixed effects linear regression was used to estimate mean annual change as a tissue × time interaction, with NAWM as the reference tissue group. *p <0.05. **p <0.01. ***p <0.001. CI, 95% confidence interval; WMH, white matter hyperintensity; NAWM, normal appearing white matter; FW, free water; FATissue, fractional anisotropy corrected for FW; MDTissue, mean diffusivity corrected for FW; FLAIR, fluid attenuated inversion recovery MRI; rmANOVA, repeated-measures ANOVA.",1,articles/0ce/pmcid_10559725/tables/table_001.csv
11294966,zoi240835t1,Table 1. ,Baseline Demographic and Clinical Characteristicsa,"SI conversion factor: To convert polyunsaturated fatty acid to millimoles per liter, multiply by 0.0355.aBaseline covariates were evaluated and confirmed for balance across the 2 groups using t-statistics for continuous variables and χ2 statistics for categorical variables (sex, race/ethnicity, education, apolipoprotein E ε4 status, Clinical Dementia Rating of 0, histories).bBody mass index is calculated as weight in kilograms divided by height in meters squared.",2,articles/6e2/pmcid_11294966/tables/table_000.csv
11294966,zoi240835t2,Table 2. ,ω-3 Polyunsaturated Fatty Acid Effects on the Main Outcomes in All Participants and by APOE*E4 Carrier Status Over 3 Years Under the Intention to Treat Protocola,"Abbreviation: APOE*E4, apolipoprotein E ε4 allele.aThe intention-to-treat cohort includes all randomly assigned participants with at least 1 follow-up magnetic resonance imaging scan (n = 87).bAnnualized changes were calculated from primary mixed-effects models as time trajectories for ω-3 and placebo groups.cLinear response difference was taken as the treatment-time interaction coefficient from the primary mixed-effects models.dOmega-3 treatment effect sizes were taken as the t-statistic from the primary mixed-effects model for the treatment-time interaction.eCohen d was calculated from the primary mixed-effects models using t-statistic and appropriate df for each outcome.",2,articles/6e2/pmcid_11294966/tables/table_001.csv
11294966,zoi240835t3,Table 3. ,Adverse Events by Experimental Group,"aAdverse events are defined according to the Medical Dictionary for Regulatory Activities terminology. Rates between groups across categories were similar (Fisher exact test, P = .60).bFisher exact test, P = .82.cFisher exact test, P = .36.",2,articles/6e2/pmcid_11294966/tables/table_002.csv
7909688,pone.0247748.t001,Table 1,Clinical overview of the enrolled patients.,Clinical characteristics of the enrolled patients.,1,articles/b7d/pmcid_7909688/tables/table_000.csv
7909688,pone.0247748.t002,Table 2,Overview of the administered cognitive and neuropsychological tests.,"Overview of the cognitive and neuropsychological tests administered to the patients and/or their parents. The number of sub-evaluations of each test is reported and, where applicable, aggregated indexes calculated from the sub-evaluations scores are shown. Test between brackets are additional. Subtests indicated with (*) contribute to the calculation of Index Freedom from Distractibility, while those indicated with (**) contribute to the calculation of Index Processing Speed.",1,articles/b7d/pmcid_7909688/tables/table_001.csv
7909688,pone.0247748.t003,Table 3,Significant associations found for the first and the second analysis and the domain analysis.,"List of the ROIs in which we found a significant association (i.e. p <0.05) between cognitive and neuropsychological evaluation score and both dose values and MD values. On the left the results of the first analysis which considered all the ROIs, while on the right are showed the results of the second analysis performed excluding ROIs with mean doses higher than 75% of the prescription. Preliminary cut-off dose values and AUC values were obtained in the analysis performed for the ROIs having an association with dose with p<0.01. The third column highlights the associations significant also for the domain analysis.",2,articles/b7d/pmcid_7909688/tables/table_002.csv
6918918,jad-72-jad190446-t001,Table 1,Participants’ demographic characteristics,"asignificantly different between groups, χ2 = 9.95, 3 df, p = 0.02; bsignificantly different between groups, F(3, 267)=8.7, p < 0.001; csignificantly different between groups, F(3, 267)=2.7, p < 0.05; dsignificantly different between groups, F(3, 267)=184.3, p < 0.001.",1,articles/f75/pmcid_6918918/tables/table_000.csv
6918918,jad-72-jad190446-t002,Table 2,Most frequently selected features for diagnostic group discrimination,1Highest selection frequency was 71%; 2highest selection frequency was 88%.,3,articles/f75/pmcid_6918918/tables/table_001.csv
9927845,brb32863-tbl-0001,TABLE 1,"Descriptive and group comparison of demographic, main neuropsychological data, and biomarkers, significance adjusted for age and education (years)","Note: Mean ± standard deviation/Median (Interquartile range). Statistical analysis: ANCOVA with Bonferroni post hoc test. Pfeffer: Pfeffer Functional Activities Questionnaire.Abbreviations: Aβ, amyloid β peptide; AD, Alzheimer's disease; CDR, Clinical Dementia Rating; MMSE, Mini Mental State Examination; NA, not available; p‐Tau, phosphorylated‐tau; RAVLT, Rey Auditory Verbal Learning Test; t‐Tau, total tau protein; A7, Rey Auditory Verbal Learning Test‐delayed recall.aDifferent from controls.bDifferent from aMCI.*p < .05**p < .01***p < .001.",2,articles/b16/pmcid_9927845/tables/table_000.csv
5334426,Tab1,Table 1,Acquisition parameters,"T1w = T1-weighted, fMRI = functional magnetic resonance imaging, DTI = diffusion tensor imaging, FOV = field of view, TE = echo time, TR = repetition time, ASSET = array spatial sensitivity encoding technique, TI = inversion time*TE for DTI was set to the minimum. This number represents the average TE. The range of TE was 81.9-90.8 ms",1,articles/f86/pmcid_5334426/tables/table_000.csv
5334426,Tab2,Table 2,Demographic characteristics,"PhFTD = phenocopy FTD, BvFTD = behavioural FTD, N = sample size, values given as mean (SD), MMSE = Mini-mental State Examination",1,articles/f86/pmcid_5334426/tables/table_001.csv
6296345,t1-medscimonit-24-8910,Table 1,A summary of the multimodal MRI to assess leukoaraiosis with cognitive impairment.,,1,articles/738/pmcid_6296345/tables/table_000.csv
6706343,t0005,Table 1,"Cross-sectional demographic and clinical characteristics, and gait performance of the Gait and Brain participants included in this study.","* indicates p value was obtained by running ANCOVA using age, sex, BMI, years of education and MMSE scores as confounding variables of no interest. Mean ± standard deviation where applicable; (% of N listed at top of column); [range: minimum to maximum].",1,articles/156/pmcid_6706343/tables/table_000.csv
6706343,t0010,Table 2,Association between WMI as a predictor variable and previous number of falls.,"* Significant at the p < 0.05 level; ** significant at the p < 0.01 level; unadjusted model uses the RD of the forceps minor to predict number of falls. † adjusted for age, number of years of education, gender, BMI and MMSE scores and number of comorbidities †† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities and counting gait velocity ††† adjusted for age, number of years of education, gender, BMI and MMSE scores, number of comorbidities, counting gait velocity and WMH volume. χ2 - Likelihood Ratio Chi-Square, df - degrees of freedom.",2,articles/156/pmcid_6706343/tables/table_001.csv
6706343,t0015,Table 3,Parameters estimates for negative binomial regression with multiple predictors.,⁎Significant at the p < .05 level (in bold); IRR: Incident Rate Ratios.,2,articles/156/pmcid_6706343/tables/table_002.csv
8921113,Tab1,Table 1,Demographic and biomarker characteristics of the study participants,"Age and cognitive data (ADAS-Cog 13) were reported as mean (standard deviation). Education years, fluid biomarker levels, and white matter hyperintensity volume were reported as median (range)",1,articles/cbf/pmcid_8921113/tables/table_000.csv
8921113,Tab2,Table 2,"Linear model coefficients accounting for the effects of demographic factors, cortical FBP SUVR, and adjusted NAWM and WMH FBP SUVR on CSF and plasma biomarkers among A + individuals","Linear models including age, sex, clinical diagnosis, cortical FBP SUVR, and NAWM (Model 1) or WMH (Model 2) FBP SUVR as covariates were fitted to describe fluid biomarker levels (dependent variables). Model coefficients of continuous variables were reported as standardized βs. Categorical variable coefficients describe the change in z-score units of fluid biomarkers (references were CN and male sex)*p < 0.05, **p < 0.01, ***p < 0.001",2,articles/cbf/pmcid_8921113/tables/table_001.csv
8921113,Tab3,Table 3,"Linear mixed model time-interaction coefficients accounting for the effects of demographics, WMH volume, cortical FBP SUVR, and adjusted NAWM FBP SUVR on longitudinal change in ADAS-Cog 13","Linear mixed models included fixed effects of age, sex, education years, WMH volume, cortical FBP SUVR, and adjusted NAWM FBP SUVR, as well as their interactions with time. Coefficients represent the annual change in ADAS-Cog 13 (in baseline standard deviation units) with 1 standard deviation change of the baseline covariate.*p < 0.05, **p < 0.01, ***p < 0.001",1,articles/cbf/pmcid_8921113/tables/table_002.csv
4630483,T1,Table 1,Basic demographic and neuropsychological test results,"Values are means±SD. *GDS involves 30-item questions; †Scores of neuropsychological tests are shown in percentile scores. NC, normal controls; SMI, subjective memory impairment; MCI, mild cognitive impairment; GDS, geriatric depression scale; K-MMSE, Korean version of the Mini-Mental State Examination; CDR, clinical dementia rating; CDR-SB, CDR-sum of boxes; RCFT, Rey complex figure test; COWAT, controlled oral word association test.",1,articles/bc1/pmcid_4630483/tables/table_000.csv
4630483,T2,Table 2,Fractional anisotropy (FA) and mean diffusivity (MD) results,"Values are means±SD. NC, normal controls; SMI, subjective memory impairment; MCI, mild cognitive impairment; FA, fractional anisotropy; MD, mean diffusivity; HB, hippocampal body; AC, anterior cingulum; PC, posterior cingulum; Ant. CC, anterior corpus callosum; Post. CC, posterior corpus callosum.",1,articles/bc1/pmcid_4630483/tables/table_001.csv
4630483,T3,Table 3,Voxel based morphometric analysis results,"Regions of more atrophic gray matter (P<0.005, cluster level, uncorrected) were presented. NC, normal controls; SMI, subjective memory impairment; MCI, mild cognitive impairment.",2,articles/bc1/pmcid_4630483/tables/table_002.csv
4630483,T4,Table 4,Comparisons of hippocampal volume among the groups,"Values are means±SD. NC, normal controls; SMI, subjective memory impairment; MCI, mild cognitive impairment; TIV, total intracranial volume.",1,articles/bc1/pmcid_4630483/tables/table_003.csv
6535714,table1-1756286419843447,Table 1.,"Basic demographic features and MR scanning protocols of the multicentre setting. Magnetic resonance data from patients with PD and healthy controls were acquired at five German sites (Dresden, Frankfurt, Marburg, Tübingen, and Ulm). DTI data were transversally recorded in interleaved even order. T2-weighed FLAIR were sagittally recorded.","†Values are given as mean ± standard deviation (min–max).+Kruskal–Wallis analysis of variance on ranks.*Chi-square test.DTI, diffusion tensor imaging; F, female; FLAIR, fluid-attenuated inversion recovery; M, male; MR, magnetic resonance; PD, Parkinson’s disease; TE, time echo; TR, time repetition.",1,articles/7a1/pmcid_6535714/tables/table_000.csv
6535714,table2-1756286419843447,Table 2.,"Demographic, clinical and neuropsychological characteristics of all patients. Demographic, clinical, and neuropsychological characteristics of the total PD sample, cognitively normal (PD-N), mildly cognitively impaired (PD-MCI), demented patients (PD-D), and healthy controls. Data are given as mean ± standard deviation (min–max) except for sex.","†CERAD total score is the sum of six subscores‡and is sociodemographically corrected for normative data including age, education, and sex.15‡CERAD scores are given as z scores.*Unpaired two-sample Student’s t test for unequal variances for continuous variables and Chi-square test for categorical variables.+Kruskal–Wallis analysis of variance on ranks for PD-N, PD-MCI, PD-D and healthy controls for continuous variables and Chi-square test for categorical variables.CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; F, female; LEDD, levodopa-equivalent daily dose; M, male; MMSE, mini mental state examination; NA, not available/not applicable; PANDA, Parkinson neuropsychometric dementia assessment;13 PD, Parkinson’s disease; PD-D, patients with PD-associated dementia; PD-MCI, mildly cognitively impaired PD patients; PD-N, patients with PD with normal cognition; UPDRS, unified Parkinson’s disease rating scale.",1,articles/7a1/pmcid_6535714/tables/table_001.csv
7363568,t0005,Table 1,Baseline sample characteristics.,NfL = Neurofilament light chain; EYO = estimated years from expected symptom onset; MMSE = Mini-Mental State Examination.,1,articles/a3c/pmcid_7363568/tables/table_000.csv
7363568,t0010,Table 2,Main effect of serum NfL on DTI metrics in MC.,"Unstandardized regression coefficient B and adjusted p-values for serum NfL from a series of linear mixed effect models in each ROI, which included random intercepts for family, and fixed effects for age, sex, and NfL. Dependent variables were the average WM metrics (FA, MD, DA, and DR) from each ROI. N = 117. WM = White matter; NfL = Neurofilament light chain; ROI = region of interest; SE = standard error.",2,articles/a3c/pmcid_7363568/tables/table_001.csv
11564857,tb1,Table 1.,Subject Characteristics,"Demographic details on the 44 participants of the present study. The subjects' employment rates, studies, and sick leave times vary from 0 to 100%, with a possible combination of these. The sports that the sports-related concussion (SRC) athletes were involved in are listed in declining order. As controls were commonly involved in multiple athletic activities, specific numbers are not listed. The Sport Concussion Assessment Tool 5th edition (SCAT5) has a maximum symptom severity score of 132 and a maximum number of symptoms of 22. Significantly different p values at ≤ 0.05 are shown in bold.SD, standard deviation and IQR, interquartile range.",1,articles/449/pmcid_11564857/tables/table_000.csv
11564857,tb2,Table 2.,Neuropsychology Performances,"Psychometric tests include results converted into Z-scores from age-related norms and raw scores. Number and percent of sports-related concussion (SRC) athletes deviating from norms refers to ±1.5 Z, and from test-specific cutoffs; HADS-A > 8, HADS-D >8, MFS >10.5, and LiSat-11 “not satisfied with life as a whole.” The presented p values represent differences in raw total scale-score between SRC athletes and controls.IQR, inter-quartile range. RBANS, Repeatable Battery for the Assessment of Neuropsychological Status (12 subtests organized into five index scores and a global score); d2, d2 test of attention; SDMT. Symbol Digit Modalities Test; Digit span - WAIS-IV, Wechsler Adult Intelligence Scale – fourth edition. Self-report measures are presented as raw scores and include HADS-A, The Hospital Anxiety and Depression Scale – anxiety; HADS-D, the Hospital Anxiety and Depression Scale – Depression; MFS, the Mental Fatigue Scale; LiSat-11, the 11-item Life Satisfaction questionnaire; BRIEF-A, the Behaviour Rating Inventory of Executive Function-Adult version with two index scores and a global score – includes raw scores and Z-scores.",2,articles/449/pmcid_11564857/tables/table_001.csv
11564857,tb3,Table 3.,Global WM Metric Values,"The diffusion values in medians and inter quartile ranges (IQR) for the sports-related concussion (SRC) athletes (diffusion tensor imaging [DTI] n = 20 and diffusion kurtosis imaging [DKI] n = 19) and controls (DTI n = 21 and DKI n = 20). The global white matter (WM) metric values and the p values of the group comparisons are presented for the investigated metrics. DTI metrics are fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD), and DKI metrics are FA, MD, AD, RD, mean kurtosis (MK), axial kurtosis (AK) and radial kurtosis (RK). Significant p values ≤0.05 are bolded.",1,articles/449/pmcid_11564857/tables/table_002.csv
11564857,tb4,Table 4.,Permutation Analysis,"Columns show the name of the magnetic resonance imaging (MRI) metric with diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI). The permutation analysis includes 20 sports-related concussion (SRC) athletes and 21 controls for DTI, and 19 SRC athletes and 20 controls for DKI. DTI metrics are fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD), and DKI metrics are FA, MD, AD, RD, mean kurtosis (MK), axial kurtosis (AK), and radial kurtosis (RK). Three properties, the number of significant tracts (#T), p value from the permutation testing of the number of significant tracts expected under the null hypothesis, and the 95th percentile of the number of tracts that shows significant differences under the null hypothesis (i.e., the highest number of false positives expected), are shown for two different significance thresholds in the per-tract U tests, an alpha (ɑ) set to 0.05 and an ɑ set to 0.01. Significantly differing tracts are bolded: tracts with p values under the set ɑ and with number of differing tracts over the expected for the 95th percentile.",2,articles/449/pmcid_11564857/tables/table_003.csv
11564857,tb5,Table 5.,Correlation Analysis,"Spearman's correlation (rs) coefficient and p values for the correlations of neuropsychology tests (raw scores) and biomarkers with single white matter region of interest (WM ROI) values for the diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI) metrics. Included metrics for correlations are fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) for DTI, and FA, MD, AD, RD, mean kurtosis (MK), axial kurtosis (AK), and radial kurtosis (RK) for DKI. Included neuropsychology tests are the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the d2 test of attention (d2), Symbol Digit Modalities Test (SDMT), the Behaviour Rating Inventory of Executive Function-Adult version (BRIEF-A) whole scale and working memory, and the Hospital Anxiety and Depression Scale (HADS) anxiety and depression. Biomarkers include neurofilament light (NfL) and glial fibrillary acidic protein (GFAP). There were no significant correlations between neuropsychology tests and DTI or DKI metrics; however, NfL correlated significantly with several DTI and DKI metrics, shown in bold. Included SRC athletes in the correlation analyses are for DTI; RBANS 20, SDMT 20, d2 20, Mental Fatigue Scale (MFS) 20, BRIEF whole scale 20, BRIEF working memory 20, HADS anxiety 20, HADS depression 20, NfL 15, and GFAP 15, and for DKI; RBANS 19, SDMT 19, d2 19, MFS 19, BRIEF whole scale 19, BRIEF working memory 19, HADS anxiety 19, HADS depression 19, NfL 14, and GFAP 14.",1,articles/449/pmcid_11564857/tables/table_004.csv
7267920,hbm24878-tbl-0001,Table 1,Review of articles that have performed diffusion MRI analysis on the substantia nigra pars compacta in Parkinson's disease,Abbreviations: ↑: Increase; ↓: Decrease; DTI: Diffusion Tensor Imaging; FA: Fractional Anisotropy; HC: Healthy Controls; MD: Mean Diffusivity; NM‐MRI: Neuromelanin Magnetic Resonance Imaging; NM‐T1: Neuromelanin sensitive T1; PD: Parkinson's disease; RD: Radial Diffusivity; ROI‐Region Of Interest; SNc: Substantia Nigra pars compacta; T1w: T1 weighted; T2w: T2 weighted.,1,articles/e61/pmcid_7267920/tables/table_000.csv
7267920,hbm24878-tbl-0002,Table 2,Demographic and clinical characteristics of patients with Parkinson's disease and healthy controls,"Abbreviations: F: Female; LEDD: Levodopa equivalent daily dose; M: Male; MMSE: Mini mental status examination; UPDRS: Unified Parkinson's disease rating scale, *: UPDRS III (OFF score) was available for 110 subjects.",1,articles/e61/pmcid_7267920/tables/table_001.csv
7267920,hbm24878-tbl-0003,Table 3,FDR corrected (p‐value = .05) results of independent t test for diffusion measures between healthy controls and patients with Parkinson's disease,"Abbreviations: AD: Axial diffusivity; ADL: AD of left SNc, ADR: AD of right SNc; FA: Fractional anisotropy; FAL: FA of left SNc; FAR: FA of right SNc; HC: Healthy controls; HCL: Left SNc of HC; HCR: Right SNc of HC; MD: Mean diffusivity; MDL: MD of left SNc; MDR: MD of right SNc; PD: Parkinson's disease; PDL: Left SNc of patients with PD, PDR: Right SNc of patients with PD; RD: Radial diffusivity; RDL: RD of left SNc, RDR: RD of right SNc; SD: Standard deviation; SNc: Substantia nigra pars compacta. ",2,articles/e61/pmcid_7267920/tables/table_002.csv
5683343,t0005,Table 1,Summary of ligand-based PET findings in DS and AD.,"Abbreviations: AD, Alzheimer's disease; DS, Down syndrome; FDDNP, 2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl)amino]-2-naphthyl}-ethylidene)malononitrile; PiB, Pittsburgh compound B.",1,articles/422/pmcid_5683343/tables/table_000.csv
5683343,t0010,Table 2,Summary of MRI findings in DS and AD.,"Abbreviations: AD, Alzheimer's disease; CSF, cerebrospinal fluid; DS, Down syndrome; MRI, magnetic resonance imaging; PiB, Pittsburgh compound B.",1,articles/422/pmcid_5683343/tables/table_001.csv
5683343,t0015,Table 3,Summary of EEG findings in DS and AD.,"Abbreviations: AD, Alzheimer's disease; DS, Down syndrome; EEG, electroencephalography; EKG, electrocardiography; EMG, electromyography; EOG, electrooculography.",1,articles/422/pmcid_5683343/tables/table_002.csv
4361402,pone.0119714.t001,Table 1,Locations of the covariant FA changes for each IC spatial map in AD patients compared to HCs,,1,articles/81a/pmcid_4361402/tables/table_000.csv
4236070,pone-0112638-t001,Table 1,"Demographic and clinical data of control subjects and patients with PD, MSA and PSP.","*For patients taking levodopa drug treatment, scores given in the ‘on’ state.†From Parkinson’s Plus Scale (Cerebellar Score, maximum 24; Occulomotor Score, maximum 21).MSA = multiple systems atrophy; PSP = progressive supranuclear palsy; PD = Parkinson’s disease; MSA-P = multiple system atrophy parkinsonian variant; MSA-C = multiple system atrophy cerebellar variant; H&Y = Hoehn and Yahr; ADL = activities of daily living; UPDRS III = Unified Parkinson Disease Rating Scale–part III; MMSE = Mini Mental State Examination; DRS = Mattis Dementia Rating Scale.",1,articles/5d8/pmcid_4236070/tables/table_000.csv
4236070,pone-0112638-t002,Table 2,"White matter regions of fractional anisotropy changes between PSP, MSA, PD and HC.","All results reported at p<0.05, TFCE and Bonferroni corrected (corrected alpha = 0.0167).",2,articles/5d8/pmcid_4236070/tables/table_001.csv
4236070,pone-0112638-t003,Table 3,"White matter regions of mean diffusivity changes between PSP, MSA, PD and HC.","All results reported at p<0.05, TFCE and Bonferroni corrected (corrected alpha 0.0167).",2,articles/5d8/pmcid_4236070/tables/table_002.csv
4053642,t0025,Table S3,"Effect sizes of Fa, Da, and Dr in significant clusters from the ROI analysisa.","aValues are Cohen's d. d > 0.2 constitutes a small effect size, d > 0.5 constitutes a medium effect size, and d > 0.8 constitutes a large effect size.",1,articles/1a4/pmcid_4053642/tables/table_000.csv
4053642,t0030,Table S1,Summary of ROI results with atrophy correction.,aFWE = family wise error correction for multiple comparisons.,1,articles/1a4/pmcid_4053642/tables/table_001.csv
4053642,t0035,Table S2,Summary of whole brain results with atrophy correction.,ap(FWE) = p-value after family wise error correction for multiple comparisons.,2,articles/1a4/pmcid_4053642/tables/table_002.csv
4053642,t0005,Table 1,Baseline characteristics of participants (n = 139)a.,FH = parental family history of Alzheimer's disease; APOE4 = the varepsilon 4 allele of the apolipoprotein E gene; PiB = Pittsburgh compound B.,1,articles/1a4/pmcid_4053642/tables/table_003.csv
4053642,t0010,Table 2,Cognitive Testing Scores.,"aRAVLT = Rey Auditory Verbal Learning Test, TMT = Trail Making Test.",2,articles/1a4/pmcid_4053642/tables/table_004.csv
4053642,t0015,Table 3,Summary of ROI resultsa.,aAtrophy correction did not change the overall pattern of results. Atrophy-corrected data are presented in Inline Supplementary Table S1.,1,articles/1a4/pmcid_4053642/tables/table_005.csv
4053642,t0020,Table 4,Summary of whole brain resultsb.,ap(FWE) = p-value after family wise error correction for multiple comparisons.,2,articles/1a4/pmcid_4053642/tables/table_006.csv
8435601,T1,Table 1,"Age, gender, dominant hand, rest motor-threshold (RMT) of the four study groups: Healthy control (HC); Subjective cognitive decline (SCD); Amnestic Mild Cognitive Impaired (aMCI) and Dementia.",,1,articles/013/pmcid_8435601/tables/table_000.csv
8435601,T2,Table 2,T1 weighted volume analysis of GM in the four study groups.,,1,articles/013/pmcid_8435601/tables/table_001.csv
8435601,T3,Table 3,DTI- fractional anisotropy (FA) analysis of WM fibers in the four study groups.,,2,articles/013/pmcid_8435601/tables/table_002.csv
8435601,T4,Table 4,DTI- Mean Diffusivity (MD) analysis of WM fibers in the four study groups.,,2,articles/013/pmcid_8435601/tables/table_003.csv
2842443,pone-0009811-t001,Table 1,Demographic and clinical information.,Key: SD — standard deviation; CON — healthy controls; AD — Alzheimer's disease; MMSE — mini-mental state examination; CDR-SB — Clinical Dementia Rating-Sum of Boxes.,1,articles/a50/pmcid_2842443/tables/table_000.csv
2842443,pone-0009811-t002,Table 2,Classification results.,"The accuracy rate, specificity, sensitivity, and F-score of the classification are listed when the volumes, shape pattern, mean FA values, and FA map of the deep white matter tracts were respectively used as features in the classification.",1,articles/a50/pmcid_2842443/tables/table_001.csv
3285682,pone-0032441-t001,Table 1,Demographic and Cognitive Characteristics of the Sample Groups.,"Values are mean ± standard deviation. Abbreviations: MCIna, non-amnestic Mild Cognitive Impairment; MCIa, amnestic Mild Cognitive Impairment; MMSE, Mini-Mental State Examination. For gender the number in brackets is the chi-square p-value. An F-value and a P-value are calculated following an anova. Post-hoc Tukey tests were performed when group differences were found with anova. Significant differences between specific groups are indicated in the far right columns (Con>MCIa, Con>MCIna, MCIna>MCIa). √ indicates the presence of significant difference.",2,articles/61f/pmcid_3285682/tables/table_000.csv
4863525,tbl0005,Table 1,Demographics of HD and control cohort.,Mean and standard error of the mean shown. ISCED: International Standard Classification of Education; UHDRS: United Huntington's Disease Rating Scale; TFC: Total Functional Capacity.,1,articles/e69/pmcid_4863525/tables/table_000.csv
3715470,tab1,Table 1,Demographic data of healthy controls and patients with behavioral variant frontotemporal dementia (bvFTD).,"M: male, F: female. Age: age in years. Education: education in years. MMSE: Mini Mental Status Examination. Duration: years since symptom onset. CDR-SB: Clinical Dementia Rating Sum of Boxes. FTLD-CDR: Frontotemporal Lobar Degeneration modified Clinical Dementia Rating, Sum of Boxes. FBI: Frontal Behavioral inventory, total score, FBI 1-12: sum of FBI item 1 to 12, FBI 12-22: sum of FBI item 12 to 22. All values are median values, with range.",1,articles/bf3/pmcid_3715470/tables/table_000.csv
3715470,tab2,Table 2,Parameters of cortical and white matter integrity in patients with behavioral variant frontotemporal dementia (bvFTD) and healthy controls (HC).,"Effect size: Cohens d P-values refers to Student’s t test, with *: significant at the p 0.008 level and NS: not significant. AUC: area under curve in ROC analysis to discriminate HC and bvFTD. #: AUC significantly different from random (at p 0.008 level). ACC thickness: thickness of anterior cingulate cortex (ACC), in mm. ACC VBM: gray matter voxel integrity of ACC. FA: fractional anisotropy, MD: mean diffusivity, rD: radial diffusivity, aD axial diffusivity, all between landmark 1 and 2 (LM12) from the QuTE analysis. rh, lh: right and left hemisphere. Values are mean, +/- one standard deviation.",1,articles/bf3/pmcid_3715470/tables/table_001.csv
11187968,acn352071-tbl-0001,Table 1,Demographic and clinical data of the subjects included in the study.,"CDR, clinical dementia rating; cSVD, cerebral small vessel disease; MMSE, mini mental‐state examination; n.a., not applicable; SD, standard deviation.",1,articles/dc5/pmcid_11187968/tables/table_000.csv
11187968,acn352071-tbl-0002,Table 2,Different impact of individual factors on WM FA.,"Table showing coefficients and pFDR‐values of the LMEs selected by the multimodal inference to test the effect of individual factors on FA values. Predictors that were not included in at least one LME are not reported. Results are expressed as “β coefficient; pFDR‐value”. Significant results are highlighted in bold.cSVD, cerebral small vessel disease; fasc., fasciculus; FDR, false discovery rate; FRS, Framingham risk score; LMEs, linear mixed effect models; long., longitudinal; WM, white matter; “/”, predictor not included in the selected model.",1,articles/dc5/pmcid_11187968/tables/table_001.csv
11187968,acn352071-tbl-0003,Table 3,Different impact of individual factors on WM MD.,"Table showing coefficients and pFDR‐values of the LMEs selected by the multimodal inference to test the effect of individual factors on MD values. Predictors that were not included in at least one LME are not reported. Results are expressed as “β coefficient; pFDR‐value”. Significant results are highlighted in bold.cSVD, cerebral small vessel disease; fasc., fasciculus; FDR, false discovery rate; FRS, Framingham risk score; LMEs, linear mixed effect models; long., longitudinal; WM, white matter; “/”, predictor not included in the selected model.",1,articles/dc5/pmcid_11187968/tables/table_002.csv
4137565,T1,Table 1,Methodological differences between analysis pipelines.,,1,articles/e0b/pmcid_4137565/tables/table_000.csv
4137565,T2,Table 2,Fornix ROI detectability by each method in synthetic FA reduction sensitivity experiments. Note increased detection ability by the VBA-based pipelines.,,1,articles/e0b/pmcid_4137565/tables/table_001.csv
3853114,t0005,Table 1,"Demographic and medical history descriptive statistics for Normal Controls (NC), Amnestic MCI (aMCI), and Alzheimer's disease (AD) subjects (n = 41).",Note: TIA = Transient Ischemic Attack.,2,articles/e0b/pmcid_3853114/tables/table_000.csv
3853114,t0010,Table 2,"ANCOVA post-hoc results for normal control (NC), amnestic MCI (aMCI) and Alzheimer's disease (AD) subjects, controlling for age, for each regional WMTI metric (n = 41).","Note: Asterisks indicate significant omnibus ANCOVA results for each regional metric, where *p < 0.05, **p < 0.01. WMTI = white matter tract integrity, AWF = axonal water fraction, Daxon = intra-axonal diffusivity, extra-axonal axial (De,∥) and radial (De,⊥) diffusivities.",2,articles/e0b/pmcid_3853114/tables/table_001.csv
3853114,t0015,Table 3,Spearman's correlations between age-residualized WMTI metrics in late-myelinating tracts and the semantic verbal fluency z-score (n = 40).,"Note: WMTI = white matter tract integrity, AWF = axonal water fraction, Daxon = intra-axonal diffusivity, extra-axonal axial (De,∥) and radial (De,⊥) diffusivities.",2,articles/e0b/pmcid_3853114/tables/table_002.csv
7591030,pone.0236384.t001,Table 1,Demographic information.,"Values are given as mean and standard deviation (std).Abbreviations: bvFTD: behavioural variant frontotemporal dementia; FTLD-CDR = frontotemporal lobar degeneration Clinical Dementia Rating; MMSE: Mini Mental State Examination.*According to International Behavioral Variant FTD Consortium Criteria [24]. + 6 patients fulfill definite bvFTD criteria according to neuropathological examination, 2 according to genetic examination, and one according to both. Demographic factors and clinical characteristics were compared using Chi-square (x2) and Mann-Whitney U tests [Sex: x2 = 0, p > 0.9; Age: U = 155, p = 0.052; MMSE: U = 13.5, p < 0.001].",1,articles/5be/pmcid_7591030/tables/table_000.csv
8044349,T1,Table 1,"The group difference of clinical and neuropsychological data among AD, SIVD patients, and NC.","Note: AD, Alzheimer’s disease; SIVD, subcortical ischemic vascular dementia; NC, normal control; AVLT-IR, the auditory verbal learning test immediate recall; AVLT-DR, the auditory verbal learning test delayed recall; MoCA, Montreal cognitive assessment; MMSE, Mini Mental State Examination; NS, no significance.",2,articles/843/pmcid_8044349/tables/table_000.csv
8044349,T2,Table 2,The group difference of topological parameters by network analysis.,"Note: Eglob, global efficiency; Eloc, local efficiency; NS, no significance; AD, Alzheimer’s disease; SIVD, subcortical ischemic vascular dementia; NC, normal control.",1,articles/843/pmcid_8044349/tables/table_001.csv
8044349,T3,Table 3,The group difference of nodal betweenness centrality in AD vs. NC and the diagnostic efficiency of the nodes in the differentiation between groups.,"Note: AD, Alzheimer’s disease; NC, normal control; AUC, area under curve.",1,articles/843/pmcid_8044349/tables/table_002.csv
8044349,T4,Table 4,The group difference of nodal betweenness centrality in SIVD vs. NC and the diagnostic efficiency of the nodes in the differentiation.,"Note: SIVD, subcortical ischemic vascular dementia; NC, normal control; AUC, area under curve.",1,articles/843/pmcid_8044349/tables/table_003.csv
8044349,T5,Table 5,The diagnostic efficiency of nodal betweenness centrality in differentiating SIVD and AD.,"Note: The nodes in this table refer to Tables s 3, 4. AD, Alzheimer’s disease; SIVD, subcortical ischemic vascular dementia; AUC, area under curve.",1,articles/843/pmcid_8044349/tables/table_004.csv
3368882,pone-0037720-t001,Table 1,Linear correlation among CSF biomarkers and age.,Significant correlation at P<.05 *.Significant at p<.001 Ŧ.,1,articles/dff/pmcid_3368882/tables/table_000.csv
3368882,pone-0037720-t002,Table 2,Regions where CSF biomarkers were significantly correlated with FA and MD in the voxel-wise analyses.,MNI: Montreal Neurological Institute; k: cluster size; T-Tau: Total Tau; P-Tau: Phosphorylated Tau; WM: White Matter; L: Left; R: Right.× No relationship with any regions at FDR corrected threshold p<.05.− No group differences in any region at FDR corrected threshold p<.05.,1,articles/dff/pmcid_3368882/tables/table_001.csv
3368882,pone-0037720-t003,Table 3,Percent of regional overlap between statistical parametric mapping result maps.,"All results maps were the product of a linear correlation analysis, where the CSF measures (T-Tau and T-Tau/Aβ42) were used to predict the diffusion measures (MD, axial and radial diffusivity). T-Tau: Total Tau; MD: Mean Diffusivity; Rad: Radial; Ax: Axial; Diff: Diffusivity.*Result map shown in Figure 1.",1,articles/dff/pmcid_3368882/tables/table_002.csv
6933911,Tab1,Table 1,Participant demographics,"APOE4, Apolipoprotein E ε4 carriers; MAPT/GRN, Microtubule-associated protein Tau / progranulin carriers.a11 MAPT 28 GRN.b30 heterozygotes, 7 homozygotes.cValues denote mean (SD); education values were missing for three MAPT/GRN carriers and two MAPT/GRN controls.*statistically significant at p < 0.05.",2,articles/5bb/pmcid_6933911/tables/table_000.csv
6933911,Tab2,Table 2,Cluster information,"Cluster information for significant clusters of reduced FA in APOE4 carriers compared to controls. Minimum cluster size was 10.APOE4, Apolipoprotein E ε4 carriers; IFOF, Inferior fronto-occipital fasciculus",2,articles/5bb/pmcid_6933911/tables/table_001.csv
4354903,pone.0120197.t001,Table 1,Demographic summary of the studied cohort.,Statistics are indicated as follows: Mean ±SD (RANGE)L>R: Left Hemisphere hypometabolism AsymmetryR>L: Right Hemisphere hypometabolism Asymmetry,1,articles/67d/pmcid_4354903/tables/table_000.csv
4354903,pone.0120197.t002,Table 2,Neuropsychological testing results from the 10 cases presented.,"All tests scores are corrected referring to respective Italian normative data (see methods).*: These are raw scores, as it was not possible to correct scores for Years of Education and Age.**: These scores refer to a modified version of the PPT.§: This patient underwent similar naming and comprehension tests from a different battery (BADA); see text for details.°: Numeric scores were not available.Bold scores are pathological.",1,articles/67d/pmcid_4354903/tables/table_001.csv
4354903,pone.0120197.t003,Table 3,18F-FDG-PET group and commonalities SPM analyses.,"Location, T-value and cluster size (K) of peaks of significant hypometabolism in svPPA group, divided by means of analysis approach. Labels are obtained by WFUPickAtlas SPM5 Toolbox. See Methods in text for details.",2,articles/67d/pmcid_4354903/tables/table_002.csv
4354903,pone.0120197.t004,Table 4,Table showing ROIs significantly correlated to Confrontation Naming Test percentages scores.,Significance was set at P uncorrected <0.05. Structural Regions of Interest were extracted by normalized and published ATLAS (see text for details). P-values and coordinates are relative to the activation peaks of each ROI (see also Fig. 1C).,1,articles/67d/pmcid_4354903/tables/table_003.csv
4354903,pone.0120197.t005,Table 5,Probabilistic Tractography Results.,"A) mean FA values and B) mean MD values extracted from the bilateral uncinate fasciculus and the bilateral inferior longitudinal fasciculus. From left to right, columns indicate mean values in control group, standard deviation in control group, 5th percentile (FA: lower FA, lower white-matter integrity) or 95th percentile (MD values: higher the MD index, greater the microstructural degeneration) of the distribution of microstructural indices in healthy controls, values of case 1, values of case 3, values of case 10. Patients’ values being lower than the 5th percentile (FA) or higher the 95th percentile (MD) of the distribution healthy controls’ values are marked in red.* marks significant values.",1,articles/67d/pmcid_4354903/tables/table_004.csv
3184226,Tab1,Table 1,Demographic data and the neuropsychologic test results,"AD Alzheimer's disease, MCI mild cognitive impairment, CN cognitively normal, MMSE Mini-Mental State Examination ScoreThe data are presented as the mean (standard deviation)aThere are no statistically significant differences between the groups (p > 0.05)bThere are statistically significant differences between the AD group and the other groups (p < 0.0005), but not between the MCI and CN groups (p > 0.215)",1,articles/c09/pmcid_3184226/tables/table_000.csv
3184226,Tab2,Table 2,The significantly different regions when comparing between the AD and MCI groups (AD > MCI) using the MD with (gmMD) and without (nMD and pMD) minimizing the effects of the background gradients (corrected FDR (p < 0.01) as the cluster level; one-way ANOVA tests),"gm geometric mean, Neg negative, Pos positive, BA Brodmann area, R. right, L. left, WM white matter, GM gray matter",2,articles/c09/pmcid_3184226/tables/table_001.csv
3184226,Tab3,Table 3,The significantly different regions when comparing between the AD and CN groups (AD > CN) using the MD with (gmMD) and without (nMD and pMD) minimizing the effects of the background gradients (corrected FDR (p < 0.01) as the cluster level; one-way ANOVA tests),"R. right, L. left",2,articles/c09/pmcid_3184226/tables/table_002.csv
3184226,Tab4,Table 4,The significantly different regions when comparing between the AD and MCI groups (AD > MCI) using the FA maps with (gmFA) and without (nFA and pFA) minimizing the effects of the background gradients (corrected FDR (p < 0.01) as a cluster level; one-way ANOVA tests),"R. right, L. left",2,articles/c09/pmcid_3184226/tables/table_003.csv
3184226,Tab5,Table 5,The significantly different regions when comparing between the AD and CN groups (AD > CN) using the FA maps with (gmFA) and without (nFA and pFA) minimizing the effects of the background gradients (corrected FDR (p < 0.01) as a cluster level; one-way ANOVA tests),"R. right, L. left",2,articles/c09/pmcid_3184226/tables/table_004.csv
3184226,Tab6,Table 6,Summaries of the common and different regions from Tables 2 and 3 for the mean diffusivity (MD),"R. right, L. left",1,articles/c09/pmcid_3184226/tables/table_005.csv
3184226,Tab7,Table 7,Summaries of the common and different regions from Tables 2 and 3 for fractional anisotropy (FA),"R. right, L. left",1,articles/c09/pmcid_3184226/tables/table_006.csv
3184226,Tab8,Table 8,The ROI data and results of the corresponding statistical test for the mean diffusivity (MD) values,"Rt right, Lt left, AD Alzheimer's disease, MCI mild cognitive impairment, CN cognitive normal, Gm geometric mean, neg negative, p positiveThe ROIs are listed in the table above. The significant level was used with p = 0.016 (p = 0.05/3 times repeated) because we repeated the same tasks three times among the three groups",2,articles/c09/pmcid_3184226/tables/table_007.csv
3184226,Tab9,Table 9,The ROI data and results of the corresponding statistical test for the fractional anisotropy (FA) values,"Rt right, Lt left, AD Alzheimer's disease, MCI mild cognitive impairment, CN cognitive normal, Gm geometric mean, neg negative, p positiveThe ROIs are listed in the table above. The significant level was used with p = 0.016 (p = 0.05/3 times repeated) because we repeated the same tasks three times among the three groups",2,articles/c09/pmcid_3184226/tables/table_008.csv
8453576,jnr24851-tbl-0001,TABLE 1,Description and operationalization of neurocognitive functioning measures,"Abbreviations: ANT, attention network test; DS, digit span; GT, grid task; SST, stop signal task.",1,articles/db1/pmcid_8453576/tables/table_000.csv
8453576,jnr24851-tbl-0002,TABLE 2,Baseline characteristics,"Abbreviations: BMI, body‐mass index; M, mean; SD, standard deviation; SES, socioeconomic status.aAccording to the reference values by Cole and Lobstein (2012).bThe average level of parental education ranged from 0 (no education) to 7 (post‐doctoral education).cComponent scores derived from four motor skills subtests including: Jumping Sideways, Moving Sideways, Backwards Balancing, and Ball Skills.",1,articles/db1/pmcid_8453576/tables/table_001.csv
8453576,jnr24851-tbl-0003,TABLE 3,Results of linear regression analysis relating cardiovascular fitness to neurocognitive functioning components,"Abbreviation: SES, socioeconomic status.aCovariates significantly related to the neurocognitive functioning component.",1,articles/db1/pmcid_8453576/tables/table_002.csv
8453576,jnr24851-tbl-0004,TABLE 4,Results of linear regression analysis relating gross motor skills to neurocognitive functioning components,"Abbreviation: SES, socioeconomic status.aCovariates significantly related to the neurocognitive functioning component.",1,articles/db1/pmcid_8453576/tables/table_003.csv
8453576,jnr24851-tbl-0005,TABLE 5,Results of linear regression analysis relating DTI parameters to cardiovascular fitness and gross motor skills,aCorrected for Scanning Site and Grade.bCorrected for Scanning Site.c10−5 mm2/s.,1,articles/db1/pmcid_8453576/tables/table_004.csv
6514143,T1,Table 1,Demographic and neuropsychological data for mTBI and control participants.,"mTBI, mild traumatic brain injury; TMT-A, Trail-making test part A; RPCS, Rivermead post-concussion symptoms questionnaire; PCL-C, Posttraumatic Stress Disorder checklist – Civilian version; DSC, Wechsler Adult Intelligence Scale WAIS-III Digit Symbol Coding score; FDS and BDS, forward digit span and backward digit span of the Wechsler Adult Intelligence Scale WAIS-III; VFT, Verbal fluency test; Beck, Beck Depression Inventory 2nd edition BDI-II; FSS, Fatigue Severity Scale; ISI, Insomnia Severity Index. The results are thresholded at P < 0.05.",1,articles/bd8/pmcid_6514143/tables/table_000.csv
5996902,T1,Table 1,Summary of the main features of Alzheimer's disease and vascular dementia.,,1,articles/1fc/pmcid_5996902/tables/table_000.csv
5996902,T2,Table 2,Demographic and clinical evaluation.,"Demographic and clinical scores for healthy controls (HC), Alzheimer's disease (AD), and vascular dementia (VaD) groups. Values are expressed as mean (SD). MMSE, Mini Mental State Examination. p-values show statistically significant differences between HC, AD and VaD groups.*p < 0.05 between HC and AD or VaD;†p < 0.05 between AD and VaD.",2,articles/1fc/pmcid_5996902/tables/table_001.csv
5996902,T3,Table 3,Diffusion changes between HC and AD.,"Regions of significant alterations identified as FA reductions and as MD, RD, and AxD increases. WBA, widespread brain alteration; WCA, widespread cerebrum alteration; CRBL, cerebellum; ThR, thalamic radiation; PhT, parahippocampal tract; CC, corpus callosum; CST, corticospinal tract; CB, cingulum bundle.",1,articles/1fc/pmcid_5996902/tables/table_002.csv
5996902,T4,Table 4,Diffusion changes between HC and VaD.,"Areas of significant alterations identified as FA reductions and as MD, RD, and AxD increases. WBA, widespread brain alteration; PhT, parahippocampal tract; CC, corpus callosum; CST, corticospinal tract; CB, cingulum bundle.",1,articles/1fc/pmcid_5996902/tables/table_003.csv
5996902,T5,Table 5,Diffusion changes between AD and VaD.,"Areas of significant alterations identified as FA reductions and as MD, RD, and AxD increases. CRBL, cerebellum; ThR, thalamic radiation; PhT, parahippocampal tract; CC, corpus callosum; CST, corticospinal tract; SLF, superior longitudinal fasciculus.",1,articles/1fc/pmcid_5996902/tables/table_004.csv
5996902,T6,Table 6,Fazekas correlations with DTI derived parameters.,"Pearson correlations between Fazekas score and DTI-based parameters for all patients, Alzheimer's disease (AD), and vascular dementia (VaD) patients. CC, corpus callosum. Significance was set at p < 0.01.",1,articles/1fc/pmcid_5996902/tables/table_005.csv
5996902,T7,Table 7,ARWMC basal ganglia correlations with DTI derived parameters.,"Pearson correlations between ARWMC score and DTI-based parameters for all patients, Alzheimer's disease (AD), and vascular dementia (VaD) patients. CC, corpus callosum. Significance was set at p < 0.01.",1,articles/1fc/pmcid_5996902/tables/table_006.csv
5996902,T8,Table 8,Neuropsychological correlations with DTI derived parameters.,"Pearson correlations between neuropsychological tests and DTI-based parameters for all patients, Alzheimer's disease (AD), and vascular dementia (VaD) patients. MD, mean diffusivity; CC, corpus callosum. Significance was set at p < 0.05.",1,articles/1fc/pmcid_5996902/tables/table_007.csv
9421487,t0005,Table 1,"Overview about the cohort studies included in the OPTIMAL project. The table shows the number of patients enrolled, the respective inclusion criteria and the type of dementia diagnosis given in each study.","SVD = small vessel disease, WMH = white matter hyperintensities, MCI = mild cognitive impairment.",1,articles/80d/pmcid_9421487/tables/table_000.csv
9421487,t0010,Table 2,"Overview over the cohorts. Clinical markers, imaging markers and sample sizes both at baseline and longitudinal are shown.","DTI = Diffusion tensor imaging, MD Median = Mean diffusivity Median of the WM histogram, PC1 = Scores of the first principal component, PSMD = Peak width of skeletonized mean diffusivity, DSEG θ = Diffusion tensor image segmentation θ, Geff = Global efficiency network measure.",1,articles/80d/pmcid_9421487/tables/table_001.csv
9421487,t0015,Table 3a,"Cross-sectional analysis between DTI and Global Cognition while accounting for clinical markers. All imaging markers were associated with impaired cognitive function in the severe SVD (SCANS), mild SVD (RUN DMC) and MCI cohort (HARMONISATION).","MD Median = mean diffusivity median of the WM histogram, PC1 = scores of the first principal component, PSMD = peak width of skeletonized mean diffusivity, DSEG θ = diffusion tensor image segmentation θ, Geff = global efficiency network measure, β = standardized regression coefficient, 95 % CI = 95 % confidence interval, AIC = Akaike information criterion, P-Value = statistical value of significance with p < 0.05.",3,articles/80d/pmcid_9421487/tables/table_002.csv
9421487,t0020,Table 3b,"Cross-sectional analysis between DTI and Global Cognition or TMT-B while accounting for the clinical markers. In severe SVD and monogenic SVD all imaging markers were associated with impaired cognitive function. Only MD median, DSEG θ and Geff were significantly related to impaired cognitive function in the community cohort with normal neurological functioning.","MD Median = mean diffusivity median of the WM histogram, PC1 = scores of the first principal component, PSMD = peak width of skeletonized mean diffusivity, DSEG θ = diffusion tensor image segmentation θ, Geff = global efficiency network measure, β = standardized regression coefficient, 95 % CI = 95 % confidence interval, AIC = Akaike information criterion, P-Value = statistical value of significance with p < 0.05.",3,articles/80d/pmcid_9421487/tables/table_003.csv
9421487,t0025,Table 4,"Baseline DTI measures predicting dementia conversion while accounting for the clinical markers. Baseline PSMD and PC1 measures predicted dementia conversion in SCANS, RUN DMC and HARMONISATION. In RUN DMC MD median and DSEG was not associated with dementia. In HARMONISATION baseline Geff did not predict dementia conversion.","MD Median = mean diffusivity median of the WM histogram, PC1 = scores of the first principal component, PSMD = peak width of skeletonized mean diffusivity, DSEG θ = diffusion tensor image segmentation θ, Geff = global efficiency network measure, AIC = Akaike information criterion, HR = hazard ratio, AUC = area under the curve, AIC = Akaike information criterion, 95 % CI = 95 % confidence interval, P-Value = statistical value of significance with p < 0.05.",3,articles/80d/pmcid_9421487/tables/table_004.csv
9421487,t0030,Table 5,Change in DTI measures in each cohort studies. There were significant changes in all measures in all cohorts except for PRESERVE and CADASIL. In PRESERVE there was a significant change DSEG and MD Median but not for PSMD and Geff. In CADASIL there was only a marginally significant change for Geff.,"MD Median = mean diffusivity median of the WM histogram, PC1 = scores of the first principal component, PSMD = peak width of skeletonized mean diffusivity, DSEG θ = diffusion tensor image segmentation θ, Geff = global efficiency network measure.P-Value = statistical value of significance with p < 0.05.",3,articles/80d/pmcid_9421487/tables/table_005.csv
9421487,t0035,Table 6,Change in DTI measures associated with dementia conversion while accounting for the clinical markers. Change in DTI was consistently associated with dementia conversion only in severe SVD but not in mild SVD or MCI. The AUC was highest and AIC lowest for DSEG. Change in MD Median was associated with dementia conversion in HARMONISATION.,"MD Median = Mean diffusivity Median of the aWM histogram, PC1 = Scores of the first principal component, PSMD = Peak width of skeletonized mean diffusivity, DSEG θ = Diffusion tensor image segmentation θ, Geff = Global efficiency network measure, AIC = Akaike information criterion, HR = hazard ratio, OR = Odd’s ratio, AUC = area under the cruve, AIC = Akaike information criterion, 95 % CI = 95 % confidence interval, P-Value = statistical value of significance with p < 0.05.",3,articles/80d/pmcid_9421487/tables/table_006.csv
9421487,t0040,Table 7,Sample size estimation per treatment arm. Sample size estimation was lowest for DSEG and PSMD in the sporadic SVD cohorts SCANS and RUN DMC. DSEG and MD median required the lowest minimum sample size in CADASIL.,"RCT = Randomized controlled trial, MD Median = Mean diffusivity Median of the WM histogram, PC1 = Scores of the first principal component, PSMD = Peak width of skeletonized mean diffusivity, DSEG θ = Diffusion tensor image segmentation θ, Geff = Global efficiency network measure.",3,articles/80d/pmcid_9421487/tables/table_007.csv
9826950,tbl0001,Table 1,Patient physical characteristics time 1 to time 2.,*For patient change + represents increase and - represents decrease.,1,articles/e1f/pmcid_9826950/tables/table_000.csv
9826950,tbl0002,Table 2,Patient v Control's Neuropsychological Assessment t1 to t2.,"*ACE, Addenbrooke's cognitive examination; VOSP, Visual Object and Space Perception battery; FCSRT, Free and Cued Selective Reminding Test; INECO frontal screen. Patients raw scores are reported and mean scores for controls.",2,articles/e1f/pmcid_9826950/tables/table_001.csv
9826950,tbl0003,Table 3,"Total scores, standard deviations (SD), Z-case control (Zcc) scores, confidence intervals from a modified paired samples t-test for patient and control group on the Spatial Battery at Time 2.",⁎Significant differences for RK compared to controls are marked in bold. Trend towards significance are marked in italics. P values represents a two-tailed probability that case score differs from controls.,2,articles/e1f/pmcid_9826950/tables/table_002.csv
9826950,tbl0004,Table 4,SLF Tracts of Interest Patient vs Controls.,"*Standard deviation in parenthesis. Rh SLFP, right hemisphere superior longitudinal fasciculus parietal; lh SLFP, left hemisphere superior longitudinal fasciculus parietal; rh SLFT, right hemisphere superior longitudinal fasciculus temporal; lh SLFT, left hemisphere superior longitudinal fasciculus temporal.",1,articles/e1f/pmcid_9826950/tables/table_003.csv
9826950,utbl0001,,,,1,articles/e1f/pmcid_9826950/tables/table_004.csv
9826950,utbl0002,,,,1,articles/e1f/pmcid_9826950/tables/table_005.csv
4513187,t0005,Table 1,Demographic and neuropsychological characteristics of patient and healthy control groups.,"Mean (standard deviation) values shown; maximum scores are shown in parentheses after names of tests.Significant group differences in t tests p < 0.05 relative to the healthy control group are shown in bold.BPVS, British Picture Vocabulary Scale; bvFTD, behavioural variant frontotemporal dementia; D-KEFS, Delis–Kaplan Executive Function System; GNT, Graded Naming Test; n/a, not available; NART, National Adult Reading Test; RMT, Recognition Memory Test; sec, seconds; svPPA, semantic variant primary progressive aphasia; TASIT, the Awareness of Social Inference Test; VOSP, Visual Object and Space Perception; WASI, Wechsler Abbreviated Scale of Intelligence (see also Supplementary material on-line).",1,articles/db8/pmcid_4513187/tables/table_000.csv
4513187,t0010,Table 2,Summary of DTI correlations with emotion identification in patient groups.,"Diffusion tensor tractography (DTI) associations of altered white matter diffusivity metrics associated with TASIT emotion identification score are summarised. Cluster numbering indexes statistically independent anatomical associations within each contrast generated using the FSL cluster command. Results are corrected for multiple comparisons at whole brain level using family-wise error correction (p = 0.05) and ordered by statistical significance and size (number of voxels in the cluster). Peak co-ordinates and anatomical associations are based on centre-of-gravity of cluster and are displayed in MNI standard space.bvFTD, behavioural variant frontotemporal dementia; svPPA, semantic variant primary progressive aphasia.",1,articles/db8/pmcid_4513187/tables/table_001.csv
4513187,t0015,Table 3,Summary of DTI correlations with sarcasm identification in patient groups.,Diffusion tensor tractography (DTI) associations of altered white matter diffusivity metrics associated with TASIT total sarcasm identification score are summarised. Cluster numbering indexes statistically independent anatomical associations within each contrast generated using the FSL cluster command. Results are corrected for multiple comparisons at whole brain level using family-wise error correction (p = 0.05) and ordered by statistical significance and size (number of voxels in the cluster). Peak co-ordinates and anatomical associations are based on centre-of-gravity of cluster and are displayed in MNI standard space.,1,articles/db8/pmcid_4513187/tables/table_002.csv
4513187,t0020,Table 4,Summary of VBM correlates of sarcasm identification in patient groups.,"Voxel-based morphometry (VBM) associations of TASIT total sarcasm identification score are summarised. All correlations shown are positive and significant after family-wise error correction for multiple comparisons at whole brain level (p < 0.05). bvFTD, behavioural variant frontotemporal dementia; L, left hemisphere; OFC, orbitofrontal cortex; R, right hemisphere; svPPA; semantic variant primary progressive aphasia; TL, temporal lobe.",1,articles/db8/pmcid_4513187/tables/table_003.csv
8059162,Tab1,Table 1,Subject demographic information,,1,articles/a10/pmcid_8059162/tables/table_000.csv
8059162,Tab2,Table 2,JHU atlas ROI comparisons of DTI parameters and the episodic memory composite score (EMCS),"*Corrected for family-wise error rate, imaging site, chronological age, and premorbid cognitive ability",1,articles/a10/pmcid_8059162/tables/table_001.csv
7212692,T1,Table 1,Basic statistics for the 10 contributing data sets.,"MRi-Share, magnetic resonance imaging subcohort of Internet-based Students HeAlth Research Enterprise; BIL&GIN, Brain Imaging of Lateralization study at Groupe d'Imagerie Neurofonctionnelle; SYS cohort, Saguenay Youth Study; ASPSF, Austrian Stroke Prevention Study Family; OATS, Older Australian Twin Study; LBC 1936, Lothian Birth Cohort; MAS, Memory and Ageing Study; TIV, total intracranial volume estimated with Freesurfer 5.3 version except “*” with FreeSurfer 6.0 version. †data subsample size < 30 (not included in the age category statistical analysis).",1,articles/694/pmcid_7212692/tables/table_000.csv
7212692,T2,Table 2,Diffusion-weighted imaging acquisition the 10 contributing data sets.,see Table 1 legend for the meaning of data set abbreviated names and Supplementary Material section for a more detailed description of these data sets.*Multi-shell acquisition.,1,articles/694/pmcid_7212692/tables/table_001.csv
7212692,T3a,Table 3A,"Basic statistics of axial diffusivity (AD, in mm2 s−1 × 10−4) average across a white matter skeleton for each age category and each contributing data set.","Values are mean (S.D. and range [min, max] across the age category sample). See Table 1 legend for the meaning of data set abbreviated names.",1,articles/694/pmcid_7212692/tables/table_002.csv
7212692,T3b,Table 3B,"Basic statistics of radial diffusivity (RD, in mm2 s−1 × 10−4) average across a white matter skeleton for each age category and each contributing data set.","Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).",1,articles/694/pmcid_7212692/tables/table_003.csv
7212692,T3c,Table 3C,"Basic statistics of mean diffusivity (MD, in mm2 s−1 × 10−4) average across a white matter skeleton for each age category and each contributing data set.","Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).",1,articles/694/pmcid_7212692/tables/table_004.csv
7212692,T3d,Table 3D,"Basic statistics of peak width skeletonized mean diffusivity (PSMD, in mm2 s−1 × 10−4) for each age category and each contributing data set.","Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).",1,articles/694/pmcid_7212692/tables/table_005.csv
7212692,T3e,Table 3E,"Basic statistics of fractional anisotropy (FA, unitless) average across individual FA skeleton for each age range category and each contributing data set.","Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).",1,articles/694/pmcid_7212692/tables/table_006.csv
7212692,T4,Table 4,"ANOVA effect of age (estimate (standard error) and significance p-value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual FA skeletons).","Values are in mm2 s−1 year-−1 × 10−6 for AD, RD, and MD, in mm2 s−1 year−1 × 10−7 for PSMD, and in year−1 × 10−3 for FA.",2,articles/694/pmcid_7212692/tables/table_007.csv
7212692,T5,Table 5,"ANOVA effect of sex and TIV (estimate (standard error) and significance p value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual FA skeletons).","Values for the effects of sex are in mm2 s−1 × 10−6 for AD, RD, MD, and PSMD and in ×10−3 for FA, and for the effects of TIV are in mm2 s−1 cm−3 × 10−6 for AD, RD MD, and PSMD and in cm−3 × 10−5 for FA.",2,articles/694/pmcid_7212692/tables/table_008.csv
11497668,alz13879-tbl-0001,TABLE 1,Participant characteristics in the Framingham Heart Study.,"Abbreviations: BMI, body mass index; FLI, free leptin index; HVOT, Hooper Visual Organization Test.; IQR, interquartile range; MRI, magnetic resonance imaging; NP, neuropsychological evaluation; PSMD, peak width of skeletonized mean diffusivity; SD, standard deviation; sOB‐R, soluble leptin receptor; TMT, Trail Making Test; WHR, waist‐to‐hip ratio; WMH, white matter hyperintensity.aPrevalent cardiovascular disease includes history of transient ischemic attack, coronary heart disease, congestive heart failure, or peripheral vascular disease.",1,articles/9e1/pmcid_11497668/tables/table_000.csv
11497668,alz13879-tbl-0002,TABLE 2,Associations of leptin markers with neuropsychological test scores (n = 2262).,"Note: Results from linear regression models with the respective neuropsychological test score as the outcome and the respective leptin marker as the main predictor. Models are adjusted for age, sex, education, diabetes mellitus, body mass index, systolic blood pressure, antihypertensive medication use, current smoking, prevalent cardiovascular disease, and time interval between blood draw and neuropsychological assessment. Values represent beta coefficients (β), and their corresponding standard errors (SE) and raw p‐values (p). Statistically significant findings after false discovery rate control at 5% using the Benjamini‐Hochberg procedure are indicated in bold.Abbreviations: FLI, free leptin index; HVOT, Hooper Visual Organization Test.;sOB‐R, soluble leptin receptor; TMT, Trail Making Test.aThese variables have been natural log‐transformed to normalize their distributions.bScores were multiplied by −1 so that higher scores reflect better cognitive performance.",2,articles/9e1/pmcid_11497668/tables/table_001.csv
11497668,alz13879-tbl-0003,TABLE 3,Associations of leptin markers with MRI markers of brain atrophy and vascular injury (n = 2028).,"Note: Results from linear regression models with the respective MRI marker as the outcome and the respective leptin marker as the main predictor. Models are adjusted for age, sex, diabetes mellitus, body mass index, systolic blood pressure, antihypertensive medication use, current smoking, prevalent cardiovascular disease, and time interval between blood draw and MRI acquisition. Values represent beta coefficients (β), and their corresponding standard errors (SE) and raw p values (p). Statistically significant findings after false discovery rate control at 5% using the Benjamini‐Hochberg procedure are indicated in bold.Abbreviations: FLI, free leptin index, MRI, magnetic resonance imaging; PSMD, peak width of skeletonized mean diffusivity.; sOB‐R, soluble leptin receptor; WMH, white matter hyperintensity.aThese variables have been natural log‐transformed to normalize their distributions.bas percentage of total cranial volume.cModels are further adjusted for total cranial volume.",2,articles/9e1/pmcid_11497668/tables/table_002.csv
11497668,alz13879-tbl-0004,TABLE 4,Participant characteristics in the MarkVCID‐1 sample (n = 89).,"Abbreviations: BMI, body mass index; IQR, interquartile range; MRI, magnetic resonance imaging; NPX, Normalized Protein eXpression; PSMD, peak width of skeletonized mean diffusivity; SD, standard deviation; TMT, Trail Making Test.; WMH, white matter hyperintensity.",1,articles/9e1/pmcid_11497668/tables/table_003.csv
11497668,alz13879-tbl-0005,TABLE 5,Associations of leptin markers with MRI and cognitive outcomes in different sex subgroups.,"Note: Values represent beta coefficients (β), and their corresponding standard errors (SE) and p‐values (p). Statistically significant findings at p ≤0.05 are indicated in bold.Abbreviations: FLI, free leptin index; HVOT, Hooper Visual Organization Test; MRI, magnetic resonance imaging; sOB‐R, soluble leptin receptor.aLinear regression models with the respective MRI marker or neuropsychological test score as the outcome and the respective leptin marker, sex, as well as their product term as the main predictors. Values represent the p‐value of the respective product term (p for interaction). Only significant findings at p ≤0.1 are presented.bLinear regression models with the respective MRI marker or neuropsychological test score as the outcome and the respective leptin marker as the main predictor, conducted by sex subgroups.cModels are adjusted for age, diabetes mellitus, body mass index, systolic blood pressure, antihypertensive medication use, current smoking, prevalent cardiovascular disease, and time interval between blood draw and MRI acquisition.das percentage of total cranial volume.eThese variables have been natural log‐transformed to normalize their distributions.fModels are adjusted for age, education, diabetes mellitus, body mass index, systolic blood pressure, antihypertensive medication use, current smoking, prevalent cardiovascular disease, and time interval between blood draw and neuropsychological assessment.gScores were multiplied by ‐1 so that higher scores reflect better cognitive performance.",2,articles/9e1/pmcid_11497668/tables/table_004.csv
11497668,alz13879-tbl-0006,TABLE 6,Associations of leptin markers with MRI and cognitive outcomes in different WHR subgroups.,"Note: Values represent beta coefficients (β), and their corresponding standard errors (SE) and p‐values (p). Statistically significant findings at p ≤0.05 are indicated in bold.Abbreviations: FLI, free leptin index; HVOT, Hooper Visual Organization Test; MRI, magnetic resonance imaging; sOB‐R, soluble leptin receptor; WHR, waist‐to‐hip ratio; WMH, white matter hyperintensity volume.aLinear regression models with the respective MRI measure or neuropsychological test score as the outcome and the respective leptin marker, WHR, as well as their product term as the main predictors. Values represent the p‐value of the respective product term (p for interaction). Only significant findings at p ≤ 0.1 are presented.bLinear regression models with the respective MRI measure or neuropsychological test score as the outcome and the respective leptin marker as the main predictor, conducted in different WHR subgroups.cModels are adjusted for age, sex, diabetes mellitus, body mass index, systolic blood pressure, antihypertensive medication use, current smoking, prevalent cardiovascular disease, and time interval between blood draw and MRI acquisition.dThese variables have been natural log‐transformed to normalize their distributions.eModels are further adjusted for total cranial volume.",2,articles/9e1/pmcid_11497668/tables/table_005.csv
4801877,T1,Table 1,Fornix microstructure and hippocampal microstructure and volume.,"FA, fractional anisotropy; MD, mean diffusivity; Vol, volume. N = 25 subjects.",1,articles/29b/pmcid_4801877/tables/table_000.csv
4801877,T2,Table 2,Linear mixed effect models (random intercept models) for recall performance (adjusted for time point and age (centered)).,"FA, fractional anisotropy; MD, mean diffusivity. N = 25 subjects/124 measures. *in 103.",3,articles/29b/pmcid_4801877/tables/table_001.csv
7284130,t0005,Table 1,Cohort characteristics at baseline including a summary of MRI findings. Means ± standard deviations are reported for normally distributed continuous measures. Number of individuals with the specified medical history are reported for each cohort. ANOVA group comparison p-values reported.,,1,articles/5f3/pmcid_7284130/tables/table_000.csv
7284130,t0010,Table 2,Summary of neuropsychological assessment scores and MRI findings. Means ± standard deviations are reported for normally distributed continuous measures. Median and interquartile range are reported for the WMH volume as they were not normally distributed. Number of individuals with 1 or more lacunes or CMBs are reported. ANOVA comparison group p-values reported.,,1,articles/5f3/pmcid_7284130/tables/table_001.csv
7284130,t0015,Table 3,PSMD and mean MD and their associations with cognitive scores. Standardized beta-coefficients and p-values are shown.,,1,articles/5f3/pmcid_7284130/tables/table_002.csv
5279696,t0005,Table 1,"Study demographics, cognitive scores and imaging metrics at baseline.",aCN v. early MCI (p < 0.05).,1,articles/9ff/pmcid_5279696/tables/table_000.csv
5279696,t0010,Table 2,Longitudinal Model B for executive function.,Bold values indicate significance at p < 0.05.,2,articles/9ff/pmcid_5279696/tables/table_001.csv
5279696,t0015,Table 3,Longitudinal Model B for memory.,Bold values indicate significance at p < 0.05.,2,articles/9ff/pmcid_5279696/tables/table_002.csv
5279696,t0020,Table 4,Longitudinal model for executive function with MD component coefficient predictors.,Bold values indicate significance at p < 0.05.,2,articles/9ff/pmcid_5279696/tables/table_003.csv
3674338,Tab1,Table 1,Demographic characteristics of the subjects,"PD Parkinson’s disease, PDD Parkinson’s disease with dementia, MMSE Mini-Mental State Examination, NA not applicable, NS not significant (P > 0.05)aMMSE scores were significantly lower in PDD patients than in controls (P < 0.01) or PD patients (P < 0.01), but the scores did not differ significantly between controls and PD patients",1,articles/1ca/pmcid_3674338/tables/table_000.csv
3674338,Tab2,Table 2,Comparison of mean diffusivity (MD) and fractional anisotropy (FA) in the genu of the corpus callosum in patients and control subjects,"GCC genu of the corpus callosum, PD Parkinson’s disease, PDD Parkinson’s disease with dementia, CN control subjectsaValues are means ± standard deviationbDiffusivity values are expressed as 10−3 mm2/scStatistical significance (P < 0.05)",1,articles/1ca/pmcid_3674338/tables/table_001.csv
11494636,jhd-13-jhd240018-t001,Table 1,Comparison of clinical assessments and demographic information between three groups,"SD, standard deviation; BMI, body mass index; STIT, Stroop Interference Test; SDMT, Symbol Dicit Modality Test; CFT, Category Fluency Test of animals; BDI-II, Beck Depression Inventory II; MMSE, Mini-Mental State Examination; CAP, CAG age product; TFC, total functional capacity; N/A, not applicable; *Cases with missing values were excluded. p, p values for ANCOVA analysis, p1, p values for post hoc between HC and m& lCAP groups, p2, p values for post hoc between HC and hCAP groups, p3, p values for post hoc between m& lCAP and hCAP groups.",1,articles/e28/pmcid_11494636/tables/table_000.csv
11494636,jhd-13-jhd240018-t002,Table 2,The number of brain regions with different MK or FA values in multiple comparisons of three groups,"No., number; HC, healthy control; m& lCAP, medium and low CAP group; hCAP, high CAP group.",1,articles/e28/pmcid_11494636/tables/table_001.csv
11494636,jhd-13-jhd240018-t003,Table 3,ROC and Youden Index analyses using MK and FA values,"HC, healthy controls; m& lCAP, medium and low CAP; hCAP, high CAP; AUC, area under curve.",1,articles/e28/pmcid_11494636/tables/table_002.csv
10344700,tbl0001,Table 1a,Baseline characteristics of study population.,,1,articles/43a/pmcid_10344700/tables/table_000.csv
10344700,tbl0002,Table 1b,Summary statistics of cognitive outcomes by Year.,Values are presented as mean (SD) unless otherwise stated.,1,articles/43a/pmcid_10344700/tables/table_001.csv
10344700,tbl0003,Table 2,Association of baseline MD measures with cognitive scores over time.,aModel I: adjusted for follow-up time.,2,articles/43a/pmcid_10344700/tables/table_002.csv
10344700,tbl0004,Table 3,Association of baseline FA measures with cognitive scores over time.,aModel I: adjusted for follow-up time.,2,articles/43a/pmcid_10344700/tables/table_003.csv
10344700,tbl0005,Table 4,Ratio of absolute mean differences in cognitive scores for Year 2 to Year 0 with the same change in DTI measures and the same profile for the other covariates.,"Values are presented as OR (95%CI), p values.Estimates were adjusted for demographic factors (age, sex, race, baseline diagnosis, education), cardiovascular risk factors (smoking status, hypertension, hyperlipidemia, diabetes), risk factors for cerebrovascular disease (white matter hyperintensities, number of lacunes, number of cerebral microbleeds, total brain volume) and interaction term between DTI measure and follow-up.#: For these cognitive z-score and DTI measure combinations, their DTI effects for each timepoint was non-significant (i.e., p<0.05/12 = 0.004 for domain-specific cognitive z-score, and p<0.05 for global z-score). Although some the combinations had wide 95%CIs, all had p-values > 0.05.-: For these cognitive z-score and DTI measure combinations, their p-value for interaction were non-significant. Hence ratio is 1.",1,articles/43a/pmcid_10344700/tables/table_004.csv
10344700,utbl0001,,,"Logistic regression was performed with outcome binarised on the difference of cognition scores at Year 2 and at baseline, where a negative difference is considered an event.",2,articles/43a/pmcid_10344700/tables/table_005.csv
6072645,t0005,Table 1,MRI sequence parameter settings.,"Scan protocol of whole-brain near-isotropic 3DT1-weighted (3DT1w), diffusion-weighted imaging (DWI), and resting-state functional MRI T2*-weighted MRI (rs-fMRI) on a 3T scanner at the Leiden University Medical Centre.Abbreviations: TR: repetition time; TE: echo time.",1,articles/e10/pmcid_6072645/tables/table_000.csv
6072645,t0010,Table 2,Demographics.,Abbreviations: MMSE: mini-mental state examination.,1,articles/e10/pmcid_6072645/tables/table_001.csv
6072645,t0015,Table 3,ROC characteristics.,Presymptomatic FTD mutation carriers versus controls classification. Multimodal represents the best combination from our step-wise multimodal procedure (i.e. WMD & AxD). Bold: best-performing model. Italic: mean AUC significantly higher than chance level after family-wise error rate correction.Abbreviations: AxD: axial diffusivity; FA: fractional anisotropy; FCor: full correlations between ICA components; FWER Corr: family-wise error rate corrected; GMD: grey matter density; MD: mean diffusivity; PCor: L1-regularised partial correlations between ICA components; RD: radial diffusivity; WMD: white matter density; AUC: area under the ROC curve.,1,articles/e10/pmcid_6072645/tables/table_002.csv
6072645,t0020,Table 4,Multimodal classification performance.,"Mean AUC values from 50 repetitions. Multimodal models result from step-wise addition of measures to the best performing classification model of the previous step, starting with the best performing single MRI measure (i.e. RD). Bold: best performing model. Italic: mean AUC significantly higher than chance level after family-wise error rate correction.Abbreviations: AxD: axial diffusivity; FA: fractional anisotropy; FCor: full correlations between ICA components; GMD: grey matter density; MD: mean diffusivity; PCor: L1-regularised partial correlations between ICA components; RD: radial diffusivity; WMD: white matter density; AUC: area under the ROC curve.",1,articles/e10/pmcid_6072645/tables/table_003.csv
7151065,healthcare-08-00057-t001,Table 1,Demographic Data.,Abbreviation: a—The p value was obtained using a two-sample two-tailed t-test; b—The p-value was obtained using non-parametric (Mann–Whitney) test. Note: MMSE: The Mini-Mental State Exam; MoCA: The Montreal Cognitive Assessment.,2,articles/29d/pmcid_7151065/tables/table_000.csv
7151065,healthcare-08-00057-t002,Table 2,Topological parameters of brain functional networks used in this study.,"(Notes: Cp: clustering coefficient; Lp: characteristic path length; Eloc: local efficiency; Eglob: global efficiency; S, K: sparsity (S) and wiring cost (K); a: a scalar parameter, a; Kc: a cutoff degree, Kc; Knodal: degree of a node; Cp-nodal: nodal cluster coefficient; Eloc-nodal: nodal local efficiency; Enodal: nodal efficiency).",1,articles/29d/pmcid_7151065/tables/table_001.csv
7151065,healthcare-08-00057-t003,Table 3,Comparison of network attributes between Tai Chi group and Walking group.,Notes: Lp: Shortest Path Length; Cp: Aggregation Coefficient; sigma: small-world Attribute; λ: normalized characteristic path length of network; γ: normalized clustering coefficient; Eloc: Local Efficiency. Eglob: Global Efficiency; M = mean; SD = standard deviation. *p < 0.05.,2,articles/29d/pmcid_7151065/tables/table_002.csv
11917016,Tab1,Table 1,Correlation between ALPS indices and amyloid beta42/40 ratio,"Abbreviations: ALPS_R, ALPS_L: calculated ALPS index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS index, by calculating the mean of Index for right and left hemishphere; adj-R²: adjusted R²; SE: Standard error; * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex, years of education and diagnose (ADvsHC) as confounding variables",3,articles/5fc/pmcid_11917016/tables/table_000.csv
11917016,Tab2,Table 2,Correlation between ALPS indices and amyloid beta42/40 ratio in AD group,"Abbreviations: ALPS_R, ALPS_L: calculated ALPS index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS index, by calculating the mean of Index for right and left hemishphere; adj-R²: adjusted R²; SE: Standard error; * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex, and years of education as confounding variables",3,articles/5fc/pmcid_11917016/tables/table_001.csv
11917016,Tab3,Table 3,Group differences between AD (Alzheimers diesease dementia patients) and HC (healthy controls) in the DTI_ALPS-Index,"Abbreviation: ALPS_R, ALPS_L: calculated ALPS-Index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS-Index, by calculating the mean of Index for right and left hemisphere. SD: Standard deviation.* significant difference with P < 0.05. Participants with WMH contamination of the ALPS calculation were omitted from the analysis. Calculated using an ANOVA adjusted for age and sex",1,articles/5fc/pmcid_11917016/tables/table_002.csv
11917016,Tab4,Table 4,Correlation between ALPS indices and Amyloid-beta 42,"Abbreviations: ALPS_R, ALPS_L: calculated ALPS index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS index, by calculating the mean of Index for right and left hemishphere; adj-R2: adjusted R2; SE: Standard error; * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex years of education and diagnose (ADvsHC) as confounding variables",3,articles/5fc/pmcid_11917016/tables/table_003.csv
11917016,Tab5,Table 5,Correlation between ALPS indices and Amyloid-beta 42 in AD,"Abbreviations: ALPS_R, ALPS_L: calculated ALPS index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS index, by calculating the mean of Index for right and left hemishphere; adj-R2: adjusted R2; SE: Standard error; * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex, and years of education as confounding variables",3,articles/5fc/pmcid_11917016/tables/table_004.csv
11917016,Tab6,Table 6,Correlation between ALPS indices and WMH found in the 5 mm-sphere- ROI in the 3 cohorts,"Abbreviations: ALPS_R, ALPS_L: calculated ALPS-Index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS-Index, by calculating the mean of Index for right and left hemishphere. * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex, diagnose and years of education as confounding variable",3,articles/5fc/pmcid_11917016/tables/table_005.csv
11917016,Tab7,Table 7,Correlation between ALPS indices and WMH found in the 5 mm-sphere- ROI with the 3 cohorts combined (n = 48),"Abbreviations: aR ²= adjusted R squared; SE: Standard Error; ALPS_R, ALPS_L: calculated ALPS-Index on right R and left L hemisphere of the brain. ALPS_comb: combined ALPS-Index, WMH_R, WMH_L: volume of WMH in 5 mm sphere ROI on right and left hemisphere, WMH_comb: left and right side combined. * significant difference with P < 0.05. Calculated with multivariate linear regression analyses, using age, sex, diagnose and cohort as confounding variable",3,articles/5fc/pmcid_11917016/tables/table_006.csv
7851406,t0005,Table 1,Demographic Information for UKBB sample used in this research. Controls were derived as subjects with no self-reported psychiatric or neurological illness.,,1,articles/9f1/pmcid_7851406/tables/table_000.csv
6664227,t0005,Table 1,Demographics and clinical data of TBI patients.,"Table of patient demographics and psychiatric classification (MDD = Major depressive disorder, NON-MDD = no classification of major depressive disorder). PTA = Post-traumatic amnesia. RTA = Road traffic accident. OD = once daily.",1,articles/977/pmcid_6664227/tables/table_000.csv
6664227,t0010,Table 2,Neuropsychology performance for TBI patients and controls.,"Mean and SD of neuropsychological test scores for patients and controls are presented. WMS-II=Wechsler memory scale, second edition. LM = Logical memory. WTAR = Wechsler adult test of reading, WASI=Wechsler abbreviated scale of intelligence.",1,articles/977/pmcid_6664227/tables/table_001.csv
7321261,molecules-25-02472-t001,Table 1,Demographic information of the subjects.,(1) Keys: AD—Alzheimer’s disease; MCI—mild cognitive impairment; NC—normal control; and CDR—Clinical Dementia Rating. (2) Data is presented as means ± standard deviations. Statistical group significance was obtained using Kruskal–Wallis test [28].,1,articles/31b/pmcid_7321261/tables/table_000.csv
7321261,molecules-25-02472-t002,Table 2,Resulting p-values of differences across three groups evaluated by different measures on DK68 parcellation.,Keys: AD—Alzheimer’s disease; MCI—mild cognitive impairment; NC—normal controls; IPF—integrated persistent feature; BNP—Betti number plot; CPL—characteristic path length; GE—global efficiency; NS—nodal strength; Mod—modularity; CC—clustering coefficient; and EC—eigenvector centrality.,1,articles/31b/pmcid_7321261/tables/table_001.csv
7321261,molecules-25-02472-t003,Table 3,Resulting p-values of differences across three groups validated by three parcellations.,"(1) Parcellations: DK84, Desikan-Killiany atlas with 84 regions [31]; AAL90, automated anatomical labeling atlas with 90 regions [38]; DK272, subdivision Desikan-Killiany atlas with 272 regions [40]. (2) Keys: AD, Alzheimer’s disease; MCI, mild cognitive impairment; NC, normal controls; IPF, integrated persistent feature; BNP, Betti number plot; CPL, characteristic path length; GE, global efficiency; NS, nodal strength; Mod, modularity; CC, clustering coefficient; EC, eigenvector centrality. (3) Significances: a, p < 0.01; b, 0.01 ≤ p < 0.05; c, 0.05 ≤ p < 0.1; ns, p ≥ 0.1. (4) Trends: ↑, AD > NC or MCI > NC or AD > MCI; ↓, AD ≤ NC or MCI ≤ NC or AD ≤ MCI.",1,articles/31b/pmcid_7321261/tables/table_002.csv
7321261,molecules-25-02472-t004,Table 4,Resulting p-values of differences validated by different connectivity definitions.,Keys: AD—Alzheimer’s disease; MCI—mild cognitive impairment; NC—normal controls; FA—fractional anisotropy; IPF—integrated persistent feature; BNP—Betti number plot; CPL—characteristic path length; GE—global efficiency; NS—nodal strength; Mod—modularity; CC—clustering coefficient; and EC—eigenvector centrality.,1,articles/31b/pmcid_7321261/tables/table_003.csv
7163793,cns13283-tbl-0001,Table 1,"Successful identification rate for each of 20 fiber tracts in HC, WMH‐NC and WMH‐MCI","Abbreviations: AF_L, left arcuate fasciculus; AF_R, right arcuate fasciculus; ATR_L, left anterior thalamic radiation; ATR_R, right left anterior thalamic radiation; CC_L, left cingulum cingulate; CC_R, right cingulum cingulate; CH_L, left cingulum hippocampus; CH_R, right cingulum hippocampus; CST_L, left corticospinal tract; CST_R, right corticospinal tract; HC, health control; IFOF_L, left inferior fronto‐occipital fasciculus; IFOF_R, right inferior fronto‐occipital fasciculus; ILF_L, left inferior longitudinal fasciculus; ILF_R, right inferior longitudinal fasciculus; MCI, mild cognitive impairment; NC, normal cognition; SLF_L, left superior longitudinal fasciculus; SLF_R, right superior longitudinal fasciculus; UF_L, left uncinate fasciculus; UF_R, right uncinate fasciculus; WMH, white matter hyperintensities.",2,articles/b34/pmcid_7163793/tables/table_000.csv
7163793,cns13283-tbl-0002,Table 2,Demographic and neuropsychological data,"NoteValues are presented as the mean ± standard error (SE).Abbreviations: AVLT‐DR, Auditory Verbal Learning Test‐delayed recall; BNT, Boston Naming Test; CVF, category verbal fluency; DST, Digit Span Test; HC, health control; MCI, mild cognitive impairment; MMSE, mini mental state examination; MoCA‐BJ, Beijing version of the Montreal Cognitive Assessment; NC, normal cognition; Stroop A, B and C, Stroop Color and Word Tests A, B, and C; TMT‐A and TMT‐B, Trail Making Test‐A and B; VR‐DR, visual reproduction‐delay recall; WMH, white matter hyperintensities; WMS, Wechsler Memory Scale.aThe p value was obtained by χ2 test.bThe p value was obtained by one‐way ANOVA.*Indicates a statistical difference between groups, P < .05.",2,articles/b34/pmcid_7163793/tables/table_001.csv
7163793,cns13283-tbl-0003,Table 3,"Accuracy, sensitivity, and specificity of the discrimination analyses derived from the RF between WMH‐NC VS WMH‐MCI","Abbreviations: AD, axial diffusivity; ATR_R, right anterior thalamic radiation; CC_R, right cingulum cingulate; CST_R, right corticospinal tract; FA, fractional anisotropy; IFOF_R, right inferior fronto‐occipital fasciculus; ILF_L, left inferior longitudinal fasciculus; ILF_R, right inferior longitudinal fasciculus; MCI, mild cognitive impairment; MD, mean diffusivity; NC, normal cognition; RD, radial diffusivity; RF, random forest; SLF_L, left superior longitudinal fasciculus; WMH, white matter hyperintensities.",1,articles/b34/pmcid_7163793/tables/table_002.csv
5608410,pone.0185239.t001,Table 1,Sample characteristics of the study population.,"AD = Alzheimer's disease, CVD = cardiovascular disease, ICV = intracranial volume, MMSE = mini mental state examination, VV = ventricle volume, WMH = white matter hyperintensities.aWMH volume ≤ 0.5% of the total intracranial volume, corresponding approximately to Fazekas score 0−1.bWMH volume ≥ 1% of the total intracranial volume, corresponding approximately to Fazekas score 2−3.",1,articles/8d9/pmcid_5608410/tables/table_000.csv
5608410,pone.0185239.t002,Table 2,"Comparison of MD and FA between the matched subgroups of cognitively healthy elderly with lowera and higherb WMH load, respectively, using a two-tailed Student’s t-test.","Values denote parameter estimates in the respective tract (mean±SD). Effect size is expressed as Cohen’s d. As expected, relatively large effect sizes are seen in regions where WMH are common (e.g. the SLF).CST = corticospinal tract, DC = dorsal cingulum, FA = fractional anisotropy, MD = mean diffusivity, SLF = superior longitudinal fasciculus, VC = ventral cingulum, WMH = white matter hyperintensities.aWMH volume ≤ 0.5% of the total intracranial volume, corresponding approximately to Fazekas score 0–1.bWMH volume ≥ 1% of the total intracranial volume, corresponding approximately to Fazekas score 2–3.* denote p < 0.05.",2,articles/8d9/pmcid_5608410/tables/table_001.csv
5608410,pone.0185239.t003,Table 3,"Multivariate linear regression analyses of MD and FA in the dorsal and ventral cingulum, the SLF, and the CST in cognitively healthy elderly (n = 132) and prodromal AD subjects (n = 83) unadjusted (model 1) and adjusted (model 2) for WMH volume, respectively.","In model 1, the dependent variable was MD or FA for each tract (the dorsal and ventral cingulum, the SLF, and the CST) and the independent variable were having prodromal AD or not. In model 2, WMH volume was added as an additional independent variable. Only standardized β for having aMCI or not and WMH volume are reported here. Results indicate that some of the differences in MD and FA between prodromal AD subjects and cognitively healthy elderly were largely driven by unequal WMH load between the groups rather than disease-specific alterations NAWM).AD = Alzheimer's disease, CST = corticospinal tract, DC = dorsal cingulum, FA = fractional anisotropy, MD = mean diffusivity, NAWM = normal-appearing white matter, SLF = superior longitudinal fasciculus, VC = ventral cingulum, WMH = white matter hyperintensities.* denote p < 0.05n.s. denote non-significant.",2,articles/8d9/pmcid_5608410/tables/table_002.csv
5608410,pone.0185239.t004,Table 4,"Effect size of group mean expressed as Cohen’s d and group size (n, patient group + control group) for WMH in the present study and various pathological conditions previously studied using DTI.","Only white matter tracts with significant differences in group mean are reported here.AD = Alzheimer’s disease; FA = fractional anisotropy; MCI = mild cognitive impairment; MD = mean diffusivity; PD = Parkinson’s disease; SZ = schizophrenia, WMH = white matter hyperintensities.",1,articles/8d9/pmcid_5608410/tables/table_003.csv
6543025,t0005,Table 1,MRI sequence parameter settings.,"Scan protocol of whole-brain near-isotropic 3DT1-weighted (3DT1w), diffusion-weighted imaging (DWI), and resting-state functional MRI T2⁎-weighted MRI (rs-fMRI) on a 3 T scanner at the Leiden University Medical Centre.Abbreviations: TR: repetition time; TE: echo time.",1,articles/912/pmcid_6543025/tables/table_000.csv
6543025,t0010,Table 2,Demographics.,Abbreviations: MMSE: mini-mental state examination.,1,articles/912/pmcid_6543025/tables/table_001.csv
6543025,t0015,Table 3,ROC characteristics.,Presymptomatic FTD mutation carriers versus controls classification. Multimodal represents the best combination from our step-wise multimodal procedure (i.e. RD & WMD). Bold: best-performing model. Italicised: mean AUC significantly higher than chance level after family-wise error rate correction.Abbreviations: AxD: axial diffusivity; FA: fractional anisotropy; FCor: full correlations between ICA components; FWER Corr: family-wise error rate corrected; GMD: grey matter density; MD: mean diffusivity; PCor: L1-regularised partial correlations between ICA components; RD: radial diffusivity; WMD: white matter density; AUC: area under the ROC curve.,1,articles/912/pmcid_6543025/tables/table_002.csv
6543025,t0020,Table 4,Multimodal classification performance.,"Mean AUC values from 50 repetitions. Multimodal models result from step-wise addition of measures to the best performing classification model of the previous step, starting with the best performing single MRI measure (i.e. RD). Bold: best performing model. Italicised: mean AUC significantly higher than chance level after family-wise error rate correction.Abbreviations: AxD: axial diffusivity; FA: fractional anisotropy; FCor: full correlations between ICA components; GMD: grey matter density; MD: mean diffusivity; PCor: L1-regularised partial correlations between ICA components; RD: radial diffusivity; WMD: white matter density; AUC: area under the ROC curve.",1,articles/912/pmcid_6543025/tables/table_003.csv
7662133,T1,TABLE 1,"Sample characteristics, overall and stratified by race.","Values are Mean ± SD (Range) unless otherwise stated. *Indicates multiplied by factor of 1,000,000. pVIQ, predicted verbal intelligence quotient derived from Word Reading, i.e., the Wechsler Test of Adult Reading; HAM-D, Hamilton Depression Rating Scale; MMSE, Mini Mental State Examination; FSRP-10, Framingham Stroke Risk Profile 10 year percent risk of stroke; IL-6, Interleukin-6; CRP, C-reactive protein; IL1-β, Interleukin 1-beta; pg/mL, picograms per milliliter; WMH, white matter hyperintensities; FA, fractional anisotropy; MD, mean diffusivity; MWF, myelin water fraction; NAWM, normal appearing white matter. Bolded entries indicate significance at or below a p-value of 0.05.",1,articles/912/pmcid_7662133/tables/table_000.csv
7662133,T2,TABLE 2,"Unadjusted bivariate correlations between predictors, outcomes, and a priori covariates in the overall sample.","Values are Pearson correlation (continuous) or point-biserial correlation (dichotomous) r-values. IL-6, Interleukin-6; CRP, C-reactive protein; IL1-β, Interleukin 1-beta; pVIQ, predicted verbal intelligence quotient derived from Word Reading, i.e., the Wechsler Test of Adult Reading; FSRP-10, Framingham Stroke Risk Profile 10 year percent risk of stroke; ICV, Intracranial Volume. Bolded entries indicate significance at or below a p-value of 0.05.",1,articles/912/pmcid_7662133/tables/table_001.csv
7662133,T3,TABLE 3,Associations between inflammatory markers and cognition in the overall sample.,"IL-6, Interleukin-6; CRP, C-reactive protein; IL1-β, Interleukin 1-beta. Bolded entries indicate significance at or below a p-value of 0.05 after adjustment for age, sex, predicted verbal IQ derived from word reading scores from the Wechsler Test of Adult Reading, race, and the Framingham Stroke Risk Profile 10 year percent risk of stroke.",1,articles/912/pmcid_7662133/tables/table_002.csv
7662133,T4,TABLE 4,Associations between inflammatory markers and white matter metrics in the overall sample.,"IL-6, Interleukin-6; CRP, C-reactive protein; IL1-β, Interleukin 1-beta. Bolded entries indicate significance at or below a p-value of 0.05 after adjustment for age, sex, predicted verbal IQ derived from word reading scores from the Wechsler Test of Adult Reading, race, and the Framingham Stroke Risk Profile 10 year percent risk of stroke.",1,articles/912/pmcid_7662133/tables/table_003.csv
2732263,T1,Table 1,Demographic and clinical summary,"*MMSE scores in FTD and Alzheimer's disease were significant lower than in CN (P < 0.001), but not significantly different between FTD and Alzheimer's disease.",1,articles/aec/pmcid_2732263/tables/table_000.csv
2732263,T2,Table 2,Group differences from TOI analysis of regional FA values as a function of diagnosis; the synopsis of the findings from the voxel-wise analysis,a No region showed significant lower FA in Alzheimer's disease when compared to FTD (AD<FTD).b No region showed significant lower FA in Alzheimer's disease when compared to FTD (AD<FTD).a.CC/p.CC = anterior/posterior corpus callosum; L.a.Cg/R.a.Cg = Left/Right anterior cingulum; L.p.Cg/R.p.Cg = Left/Right posterior cingulum; L.d.Cg/R.d.Cg = Left/Right descending cingulum; L.Unc/R.Unc = Left/Right uncinate fasciculus; L.CST/R.CST = Left/Right corticospinal tract.,3,articles/aec/pmcid_2732263/tables/table_001.csv
2732263,T3,Table 3,Group differences from TOI analysis of regional radial diffusivity (Dra) values as a function of diagnosis; the synopsis of the findings from voxel-wise analysis,a No region showed significant increased Dra in Alzheimer's disease when compared to FTD (AD>FTD).b No region showed significant increased Dra in Alzheimer's disease when compared to FTD (AD>FTD).a.CC/p.CC = anterior/posterior corpus callosum; L.a.Cg/R.a.Cg = Left/Right anterior cingulum; L.p.Cg/R.p.Cg = Left/Right posterior cingulum; L.d.Cg/R.d.Cg = Left/Right descending cingulum; L.Unc/R.Unc = Left/Right uncinate fasciculus; L.CST/R.CST = Left/Right corticospinal tract.,3,articles/aec/pmcid_2732263/tables/table_002.csv
2732263,T4,Table 4,Group differences from TOI analysis of regional axial diffusivity (Dax) values as a function of diagnosis; the synopsis of the findings from voxel-wise analysis,a No region showed significant increased Dax in Alzheimer's disease when compared to FTD (AD>FTD).b No region showed significant increased Dax in Alzheimer's disease when compared to FTD (AD>FTD).a.CC/p.CC = anterior/posterior corpus callosum; L.a.Cg/R.a.Cg = Left/Right anterior cingulum; L.p.Cg/R.p.Cg = Left/Right posterior cingulum; L.d.Cg/R.d.Cg = Left/Right descending cingulum; L.Unc/R.Unc = Left/Right uncinate fasciculus; L.CST/R.CST = Left/Right corticospinal tract.,3,articles/aec/pmcid_2732263/tables/table_003.csv
5561637,Tab1,Table 1,Subjects’ clinical and demographic features,"Abbreviations: AD Alzheimer’s disease, AD + CeVD Alzheimer’s disease with cerebrovascular disease, ANOVA Analysis of variance, C/N Chinese/non-Chinese, CDR-SB Clinical Dementia Rating Sum of Boxes, HC Healthy control subjects, MMSE Mini Mental State Examination, VaD Vascular dementia, WMH White matter hyperintensityValues represent mean (SD). The WMH visual rating was measured by the age-related WM change scale score. A subset of patients with complete cognitive scores was used for brain-cognition association analysesa Group mean was different from HC on the basis of post hoc pairwise comparisons (p < 0.05)b Group differences at p < 0.05 significance levelc Group mean was different from the AD group (p < 0.05)",1,articles/34f/pmcid_5561637/tables/table_000.csv
3388101,pone-0037021-t001,Table 1,Demographic and Cognitive Characteristics of the Sample Groups.,"Values are mean (SD). Abbreviations: Con, control; MCI, Mild cognitive Impairment; MMSE, Mini-Mentral State Examination. Significant differences between male and female groups are marked in bold where p<0.05 using a t-test.",2,articles/6a5/pmcid_3388101/tables/table_000.csv
7456903,T1,Table 1,Characteristics of participants (n = 130).,"Keys: SD, standard deviation; 1n = 106; 2n = 123; 3n = 123; 4n = 121; 5n = 109.",1,articles/4a8/pmcid_7456903/tables/table_000.csv
7456903,T2,Table 2,"Linear regression model including WM-MD change over-time as a dependent variable and age, sex, level of education and ApoE4 status as explicative variables.","Model Fit R = 0.344, R2 = 0.118.",1,articles/4a8/pmcid_7456903/tables/table_001.csv
7456903,T3,Table 3,Matrix of correlation between MRI biomarkers changes.,Δ: difference between baseline and follow-up MRI data. aPearson’s correlation coefficient. *p < 0.05. ***p < 0.001.,1,articles/4a8/pmcid_7456903/tables/table_002.csv
6920239,Tab1,Table 1,Demographic and clinical variables,"NESB, non-English speaking background; FSIQ, full scale IQ calculated using the Weschler Adult Intelligence Scale-III short form (Crawford 2008); BDI, =Beck Depression Inventory; BAI, =Beck Anxiety Inventory; PRMQ, Prospective and Retrospective Memory Questionnaire; CPE, CNS penetration effectivenessMetabolic comorbidities: diabetes, anti-hypertensive medication, hypercholesterolemia medication1Time in years",1,articles/127/pmcid_6920239/tables/table_000.csv
6920239,Tab2,Table 2,Mean (SD) z-scores for cognitive performance,"All analyses controlled for age, years in education, and non-English speaking background",1,articles/127/pmcid_6920239/tables/table_001.csv
6920239,Tab3,Table 3,"The relationship between clinical, psychiatric, lifestyle, and DTI variables and cognitive function","All analyses controlled for age, years in education, and non-English speaking backgroundCPE, CNS penetration efficiency; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; MD, mean diffusivity; FA, fractional anisotropy",2,articles/127/pmcid_6920239/tables/table_002.csv
6920239,Tab4,Table 4,The relationship between anxiety and DTI variables and cognitive function,"All analyses controlled for age, years in education, and non-English speaking background",2,articles/127/pmcid_6920239/tables/table_003.csv
6384328,t0005,Table 1,Comparison of demographic variables between the groups from our cohort and the ADNI cohort.,"Note: Data are presented as means ± standard deviations. Primary cohort means our cohort; Validation cohort means the ADNI cohort; AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; MMSE, Mini–Mental State Examination (MMSE); MoCA, Montreal Cognitive Assessment; t-test/χ2 means the statistics in the demographic variables comparisons between primary cohort and the ADNI cohort; * denotes a significant difference with a p value <.05.",3,articles/94f/pmcid_6384328/tables/table_000.csv
6384328,t0010,Table 2,Comparison of mean FA among the groups from our cohort.,"Note: Data are presented as means ± standard deviations. AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus. AF, arcuate fasciculus. L, left; R, right. Least significant difference test was used in multiple comparisons. n1: n2: n3 means the successfully traced number of AD, MCI, and NC subjects in each fiber.",2,articles/94f/pmcid_6384328/tables/table_001.csv
6384328,t0015,Table 3,Comparison of mean MD among the groups from our cohort.,"Note: Unless otherwise specified, data reflect the MD values × 10−3 mm2 s−1 presented as means ± standard deviations. AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. Least significant difference test was used in multiple comparisons. n1: n2: n3 means the successfully traced number of AD, MCI, and NC subjects in each fiber.",2,articles/94f/pmcid_6384328/tables/table_002.csv
6384328,t0020,Table 4,Number of points with significant difference in pointwise comparison of tract profiles across 20 fiber tracts after permutation based FWE correction from our cohort.,"Note: AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic radiation; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. FWE corrected with p value <.05.",2,articles/94f/pmcid_6384328/tables/table_003.csv
6384328,t0025,Table 5,"Summary of change in mean FA, mean MD, location of points with significant difference in pointwise comparison of tract profiles across 20 fiber tracts among the groups from our cohort.","Note: AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. +, difference between the groups; −, no difference between the groups; A, difference in anterior part of the fiber; P, difference in posterior part of the fiber; S, difference in superior part of the fiber; M, difference in middle part of the fiber; T, difference in the temporal lobe part of the fiber; W, difference in the entire fiber. FDR correction was used in comparison in mean FA with a p value<.05. FWE correction was used in point wised location changes with a p value<.05.",2,articles/94f/pmcid_6384328/tables/table_004.csv
6384328,t0030,Table 6,Number of points with significant difference in pointwise comparison of tract profiles across 20 fiber tracts from the ADNI cohort after permutation based FWE correction.,"Note: AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic radiation; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. FWE corrected with p value <.05.",2,articles/94f/pmcid_6384328/tables/table_005.csv
6384328,t0035,Table 7,Summary of change in the location of points with significant difference in pointwise comparison of tract profiles across 20 fiber tracts among the groups from the ADNI cohort.,"Note: AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. R, right; A, difference in anterior part of the fiber; P, difference in posterior part of the fiber; M, difference in middle part of the fiber; T, difference in the temporal lobe part of the fiber; F, difference in the frontal lobe part of the fiber. FDR correction was used in comparison in mean FA with a p value<.05. FWE correction was used in point wised location changes with a p value<.05.",2,articles/94f/pmcid_6384328/tables/table_006.csv
6384328,t0040,Table 8,Summary of change in the location of points with significant difference in pointwise comparison of tract profiles across 20 fiber tracts among the groups between our cohort and the ADNI cohort.,"Note: AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. +, difference between the groups; −, no difference between the groups; A, difference in anterior part of the fiber; P, difference in posterior part of the fiber; S, difference in superior part of the fiber; M, difference in middle part of the fiber; T, difference in the temporal lobe part of the fiber; W, difference in the entire fiber. FDR correction was used in comparison in mean FA with a p value<.05. FWE correction was used in point wised location changes with a p value<.05.",3,articles/94f/pmcid_6384328/tables/table_007.csv
11582681,dad270023-tbl-0001,TABLE 1,Subject Demographics.,"Abbreviations: IQR, interquartile range; NfL, neurofilament light chain.",1,articles/120/pmcid_11582681/tables/table_000.csv
11582681,dad270023-tbl-0002,TABLE 2,Spearman (ρ) correlations between neurofilament light chain and white matter tract.,"Note: Reported p values denote unadjusted p values; FDR‐adjusted p value < 0.05 are denoted by (*) and < 0.1 (**).Abbreviations: ILF, inferior longitudinal fasciculus; L, left; R, right; SLF, superior longitudinal fasciculus.",2,articles/120/pmcid_11582681/tables/table_001.csv
11582681,dad270023-tbl-0003,TABLE 3,Spearman (ρ) correlations between neurofilament light chain and white matter tract among subjects with Centiloid > 20 (n = 14).,"Note: Given the secondary nature of these analyses and the small sample size, p values are not provided.Abbreviations: ILF, inferior longitudinal fasciculus; L, left; R, right; SLF, superior longitudinal fasciculus.",2,articles/120/pmcid_11582681/tables/table_002.csv
10426141,Tab1,Table 1,Patient Demographics and Clinical Characteristics,"Computed tomography negative (CT-negative) = Marshall 1, Computed tomography positive (CT-positive) = Marshall 2–6. Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery*For the injury severity score (ISS), there was no information available for 2 patients in the TBI cohortaIndependent samples T-testbChi-SquarecFisher's Exact Test anddMann–Whitney U-test all with 0.05 significance level",1,articles/78d/pmcid_10426141/tables/table_000.csv
10426141,Tab2,Table 2,Comparison of neurofilament light levels between mild traumatic brain injury patients and orthopedic injury controls. The comparison between the diffusion metrics of the mTBI subgroup,"aMann-Whitney U test, p-values show the difference between Orthopedic Injury Controls and the patient groupsbGeneralized linear model where age and sex are used as confounders, p-values represent the comparison between patient groups onlymTBI mild traumatic brain injury, CT Computed tomography, NF-L Neurofilament light, FA Fractional anisotropy, MD Mean diffusivity, AD Axial diffusivity, RD Radial diffusivity, IQR Interquartile range, SD Standard deviation",2,articles/78d/pmcid_10426141/tables/table_001.csv
10426141,Tab3,Table 3,Correlation between admission neurofilament light (NF-L) levels and diffusion measures (adjusted for age and sex),"Computed tomography negative (CT-negative) = Marshall 1, Computed tomography positive (CT-positive) = Marshall 2–6. Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery. FA Fractional anisotropy, MD Mean diffusivity, AD Axial diffusivity, RD Radial diffusivity",2,articles/78d/pmcid_10426141/tables/table_002.csv
4312919,hbm22468-tbl-0001,Table 1,Comparison of fractional anisotropy changes in studies of frontotemporal dementia using diffusion tensor imaging,"Tracts listed are bilateral unless otherwise stated. A statistical threshold of P <0.05 was used for citing tracts with significant change from individual papers. AD, Alzheimer's disease; ANCOVA, analysis of covariance; AF, Arcuate Fasciculus; ATR, anterior thalamic radiation; CB, cingulum bundle; CC, corpus callosum; Controls, older healthy control participants; CST, corticospinal tract; DTI, diffusion tensor imaging; FDT, FMRIB diffusion toolbox; bvFTD, frontotemporal dementia; ILF, inferior longitudinal fasciculus; MANOVA, Multivariate analysis of variance; PRIDE, Philips Research Integrated Device Environment; ROI, region of interest; SLF, superior longitudinal fasciculus; SPM8, Statistical Parametric Mapping version 8; TBSS, tract based spatial statistics; UF, uncinate fasciculus.",1,articles/715/pmcid_4312919/tables/table_000.csv
4312919,hbm22468-tbl-0002,Table 2,"Summary of demographic, clinical and neuropsychological data for all groups","Group comparisons significant at P < 0.05 are shown in bold.aNeuropsychological data not collected for one patient with bvFTD and two patients with AD.AD, Alzheimer's disease; BPVS, British Picture Vocabulary Scale; DKEFS, Delis‐Kaplan Executive Function System; F, female; bvFTD, frontotemporal dementia; M, male; MMSE, Mini‐Mental State Examination score; ns, non‐significant. PIQ, performance IQ; SD, standard deviation (values shown in italics); VIQ, verbal IQ; VOSP, Visual Object and Space Perception battery. See Supporting Information for details of neuropsychological tests used.",2,articles/715/pmcid_4312919/tables/table_001.csv
4312919,hbm22468-tbl-0003,Table 3,Unadjusted diffusion data by metric and region of interest,Only region of interests where at least one metric had greater than 50% extent are displayed. % extent is the percentage of significant voxels divided by total number of voxels within the masked region of the skeleton. Complete data on each metric and region of interest are provided in Supporting Information.,3,articles/715/pmcid_4312919/tables/table_002.csv
4312919,hbm22468-tbl-0004,Table 4,Unadjusted diffusion data by metric and region of interest,Regions of interest where at least one metric had greater than 50% extent are displayed. % extent is the percentage of significant voxels divided by total number of voxels within the masked region of the skeleton. Complete data on each metric and region of interest are provided in Supporting Information.,3,articles/715/pmcid_4312919/tables/table_003.csv
4863900,Tab1,Table 1,Subject characteristics,"Data are means ± SEM or median [interquartile range]Fazekas score for white matter lesions: 0 indicates no lesions; 1 indicates punctate foci; 2 indicates beginning confluence of foci; 3 indicates large confluent areasOGTT oral glucose tolerance test, NEFA non-esterified fatty acids, T2DM type 2 diabetes patients*Statistically significant different from lean (post-hoc Bonferroni corrected P < 0.05)†Statistically significant different from lean and obese (post-hoc Bonferroni corrected P < 0.05)",1,articles/8b4/pmcid_4863900/tables/table_000.csv
4863900,Tab2,Table 2,Between-group differences in white matter volume and integrity,"T t-statistic, P-FWEp-value Family-Wise Error corrected for multiple comparisons, R right, L left, MNI Montreal Neurological Institute coordinates in mmNA not applicable",1,articles/8b4/pmcid_4863900/tables/table_001.csv
4863900,Tab3,Table 3,Associations between white matter parameters and demographic and clinical characteristics,"aMean axial diffusivity value for the significant voxels in the comparison between T2DM patients and lean controlsbMean white matter volume of the two significant VBM clusters in the comparison between T2DM patients and lean controls. With these values correlations with biomedical variables were calculated in all subjects (lean, obese and T2DM)",2,articles/8b4/pmcid_4863900/tables/table_002.csv
11364465,TB1,Table 1,"Longitudinal statistical parametric mapping (SPM) demonstrated differences in the linear time dependence of fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) maps between trainees and untrained subjects. To compare the differences at day 84 between trained and non-trained subjects, as well as the difference between days 28 and 84 for the trained subjects, the mean cluster of the linear changes was extracted and analyzed using Welch’s t-test and Bayesian statistics. The Bayes factor (BF01) is reported, where a value >1 indicates a preference for the null (H0) hypothesis. R = right, L = left.",,2,articles/8b4/pmcid_11364465/tables/table_000.csv
11364465,TB2,Table 2,"Correlations at baseline between fractional anisotropy (FA), axial diffusivity (AD), and response time (RT). R = right, L = left.",,1,articles/8b4/pmcid_11364465/tables/table_001.csv
11364465,TB3,Table 3,"Longitudinal statistical parametric mapping (SPM) analysis showing differences in the linear and quadratic time dependence for fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) between upper limb trainees and lower limb trainees. R = right, L = left.",,1,articles/8b4/pmcid_11364465/tables/table_002.csv
11364465,TB4,Table 4,"Results from the in-time (i.e. no time shift in the same brain area contralateral hemisphere) and time-lag analysis (i.e. time shift in the corticospinal tract to contralateral cerebellum) for fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD).",,1,articles/8b4/pmcid_11364465/tables/table_003.csv
4684097,jhd-4-3-jhd150160-t001,Table 1,"Comparisons of demographic, clinical and behavioral characteristics of premanifest and early-HD gene-carrier participants; FET = Fisher’s Exact Test",,1,articles/978/pmcid_4684097/tables/table_000.csv
4684097,jhd-4-3-jhd150160-t002,Table 2,Tracts in which reduced FA was significantly correlated with increased levels of HADS depression for those with high CPO; FWE–corrected threshold of p <  0.05,,2,articles/978/pmcid_4684097/tables/table_001.csv
4684097,jhd-4-3-jhd150160-t003,Table 3,Tracts in which reduced FA was correlated with increased levels of irritability/aggression in those with low CPO; FWE-corrected threshold of p <  0.05,,2,articles/978/pmcid_4684097/tables/table_002.csv
5364534,t1,Table 1,Sample characteristics.,"§MMSE missing for 5 MCI, and 2 SCI.§§Years of education not available for 1 SCI, 4 MCI, 7 AD.†% ε4+ denotes the percentage of participants with known APOE status who had at least one ε4 allele.*Significant main effect of group (P < 0.05) based on univariate linear models. “>” and “<” denote significant group differences (P < 0.05) in the indicated direction based on post-hoc testing using Bonferroni-correction for three comparisons.",1,articles/78c/pmcid_5364534/tables/table_000.csv
3348019,T1,Table 1,10 fiber pathways of the hippocampus found in the human brain,,1,articles/92b/pmcid_3348019/tables/table_000.csv
3348019,T2,Table 2,33 Alzheimer-related genes with many PPIs,,1,articles/92b/pmcid_3348019/tables/table_001.csv
11851321,alz14453-tbl-0001,TABLE 1,"Participants’ demographics, clinical factors, imaging features, and cognitive status","Abbreviations: ALPS, diffusion analysis along the perivascular space; FHS, Framingham Heart Study; UCD_ADRC, University of California Davis Alzheimer's Disease Research Center; UCSF_MAC, University of California San Francisco Memory and Aging Center; UDS3‐EF, composite scores of executive functions derived from the Uniform Data Set (v3.0).",2,articles/ce8/pmcid_11851321/tables/table_000.csv
11851321,alz14453-tbl-0002,TABLE 2,Linear regression and mediation results for the association between ALPS index and EF,"Model1: regressing out Demographics, Model2: regressing out Demographics + VRFs, Model3: regressing out Demographics + VRFs + WMHV.Abbreviations: ALPS, diffusion analysis along the perivascular space; FHS, Framingham Heart Study; UCD_ADRC, University of California Davis Alzheimer's Disease Research Center; UCSF_MAC, University of California San Francisco Memory and Aging Center; UDS3‐EF, composite scores of executive functions derived from the Uniform Data Set (v3.0); WM‐FW, mean free water in the white matter; WMHV, white matter hyperintensity volume log‐transformed and normalized by total intracranial volume.*p < 0.05.**p < 0.01.***p < 0.001.",2,articles/ce8/pmcid_11851321/tables/table_001.csv
7025138,tbl0001,Table 1,Demographic and clinical characteristics of the ADNI participants,,1,articles/b6f/pmcid_7025138/tables/table_000.csv
7025138,tbl0002,Table 2,The number of participants considered for the imaging-clinical/cognition correlation analyses across the five disease categories.,,1,articles/b6f/pmcid_7025138/tables/table_001.csv
7025138,tbl0003,Table 2a,Known pathways enriched in the gene modules significantly correlated with DTI-features in specific brain regions. The column Corrected p-value shows corrected p values for the Spearman's rank correlation between the indicated DTI feature and gene expression module.,,1,articles/b6f/pmcid_7025138/tables/table_002.csv
7025138,tbl0004,Table 3,"Set-based association for 23 IGAP loci and the FA feature using all the common variants (MAF ≥ 0.05) in the neighborhood of the identified risk gene corresponding to each AD risk locus. Empirical p-values were calculated using 20,000 permutations in PLINK.",,1,articles/b6f/pmcid_7025138/tables/table_003.csv
7025138,tbl0005,Table 4,Association of rs2203712 in CELF1 with neuroimaging phenotypes,,1,articles/b6f/pmcid_7025138/tables/table_004.csv
3430626,pone-0043993-t001,Table 1,"Demographics, cognition and behaviour - Comparison on demographics and cognitive tests across ALS, bvFTD and ALS-FTD groups.",F-values indicate significant differences across groups; Tukey post hoc tests compare differences between group pairs.***p<0.001; NS = non-significant.Kruskal-Wallis Test and Mann-Whitney U test were applied for disease duration.ALS = amyotrophic lateral sclerosis; ALS-FTD = ALS with frontotemporal dementia; bvFTD = behavioural variant frontotemporal dementia.ACE-R = Addenbrooke’s Cognitive Examination revised; CBI-R = Cambridge Behavioural Inventory Revised.,1,articles/eec/pmcid_3430626/tables/table_000.csv
6083450,t0005,Table 1,Demographics and clinical characteristics (n = 55).,"Note. SD, standard deviation; AD: Alzheimer's disease; MOCA: Montreal Cognitive Assessment; BVMT-R: Brief visuospatial memory test-revised (participants here had a percentile below the average of age- and education-adjusted population norm); LOC: Locus of control.",1,articles/74f/pmcid_6083450/tables/table_000.csv
11506346,brainsci-14-00975-t001,Table 1,Demographic characteristics of healthy controls and pwMS.,"EDSS: Expanded Disability Status Scale; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; OAB: overactive bladder; pwMS: patients with MS; USP: Urinary Symptom Profile; USP-OAB: USP OAB sub-score. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Chi Square test, student’s t-test, and Mann–Whitney U test. a: statistical difference between HCs and pwMS; b: statistical difference between MS-no-LUTS and MS-OAB. *: p < 0.05; **: p < 0.01.",1,articles/b04/pmcid_11506346/tables/table_000.csv
11506346,brainsci-14-00975-t002,Table 2,"FA values of mean skeleton in HCs, pwMS, and pwMS sub-groups.",FA: fractional anisotropy; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; pwMS: patients with MS. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Mann–Whitney U test. *: p < 0.05; **: p < 0.01.,1,articles/b04/pmcid_11506346/tables/table_001.csv
11506346,brainsci-14-00975-t003,Table 3,Correlations between FA values and clinical scores.,Spearman’s correlations between FA value and age; EDSS and USP-OAB sub-score were tested in HCs and pwMS. EDSS: Expanded Disability Status Scale; FA: fractional anisotropy; MS: multiple sclerosis; N/A: not applicable; p: p-value of correlation; pwMS: patients with MS; r: Spearman’s correlation coefficient (two-tailed); USP-OAB: Urinary Symptom Profile OAB sub-score. *: p < 0.05; **: p < 0.01.,1,articles/b04/pmcid_11506346/tables/table_002.csv
5329061,T1,Table 1,"The 45 participants of the study and their corresponding class, sex, age and educational level.",,2,articles/8bc/pmcid_5329061/tables/table_000.csv
5329061,T2,Table 2,P-values by age and educational level on binary discrimination.,,1,articles/8bc/pmcid_5329061/tables/table_001.csv
5329061,T3,Table 3,"Performance results of the base classifiers as well as the ensemble in AD-CT, AD-MCI, and MCI-CT classification tasks.",All the listed classifiers were tested within a five-fold cross validation module.Feature selection was used for all the base classifiers as it improved their performance.The best results for each column were bolded.,3,articles/8bc/pmcid_5329061/tables/table_002.csv
5329061,T4,Table 4,"Accuracy metric 95% confidence intervals for the ensemble classifier with feature selection in AD-CT, AD-MCI, and MCI-CT classification tasks.",,2,articles/8bc/pmcid_5329061/tables/table_003.csv
5329061,T5,Table A1,Statistical comparison of the key DTI biomarkers at the group level.,"*p < 0.05,**p < 0.01.",3,articles/8bc/pmcid_5329061/tables/table_004.csv
5329061,T6,Table A2,Quantitative results for diagnostic propose of AD and amnesic MCI.,,1,articles/8bc/pmcid_5329061/tables/table_005.csv
4629464,T1,Table 1,Demographic and clinical features.,"Values are expressed as mean ± SD.aThe p-values were calculated using the one-way ANOVA; Bonferroni post hoc test was also performed when F-test was significant.bMain interaction among groups: F2,42 = 0.743, p = 0.482.cThe p-values were calculated using chi-squared test: χ12=0.47,p=0.977.dThe p-values were calculated using the independent-samples t-test: t26 = −0.291, p = 0.773.eMain interaction among groups: F2,42 = 0.92, p = 0.912.fThe p-values were calculated using the independent-samples t-test: t26 = 0.045; p = 0.565.gMain interaction among groups: F2,42 = 30.435, p < 0.001; post hoc: controls vs. AD, p < 0.001; controls vs. DLB, p < 0.001 and AD vs. DLB, p = 1.000.hMain interaction among groups: F2,41 = 70.276, p < 0.001; post hoc: controls vs. AD, p < 0.001; controls vs. DLB, p < 0.001 and AD vs. DLB, p = 0.242.iMain interaction among groups: F2,42 = 88.905, p < 0.001; post hoc: controls vs. AD, p < 0.001; controls vs. DLB, p < 0.001 and AD vs. DLB, p = 1.000.jKruskal–Wallis main interaction among groups: χ22=4.985,P=0.083.AD, Alzheimer’s Disease; CAF, clinician assessment of fluctuations; DLB, dementia with Lewy bodies; CDR, Clinical Dementia Rating, DRS, Dementia Rating Scale; FAB, frontal assessment battery; MMSE, mini mental state examination; NPI, neuropsychiatric inventory; UPDRSIII, Unified Parkinson’s Disease Rating Scale-motor section III; DHWM, hyperintense signal abnormalities in the deep white matter.",1,articles/770/pmcid_4629464/tables/table_000.csv
4629464,T2,Table 2,Mean DTI-metrics values of left and right white matter tracts for each group.,"aValues ×10−3 mm2/s.Table reports the DTI-metrics values (mean ± SD) and the statistical outcomes (derived from t-test for independent samples and Bonferroni’s correction) for tracts showing significant differences among groups. Bold characters indicate statistically significant results. The complete statistical results for each metric and tract were reported in Tables S1–S4 in Supplementary Material.AD, Alzheimer’s Disease; DLB, dementia with Lewy bodies; FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; DA, axial diffusivity; ATR, anterior thalamic radiation, CAB, cingulum-angular (infracallosal) bundle, CCG, cingulum-cingulate gyrus (supracallosal) bundle, ILF, inferior longitudinal fasciculus, UNC, uncinate fasciculus.",1,articles/770/pmcid_4629464/tables/table_001.csv
10877805,Tab1,Table 1,Demographic data of participants along AD continuum,"The log-transformed WMH volume is used to represent the burden of white matter hyperintensity (WMH)The choroid volume (mm3)/TIV (ml)*103 is used to represent choroid plexus volumeCN Cognitive normal, MCI Mild cognitive impairment, AD Alzheimer’s disease, TIV Total intracranial volume, WMH White matter hyperintensity, PVS Perivascular spaceaOne CN − and 4 CN + participants without the information of APOE status",1,articles/ac7/pmcid_10877805/tables/table_000.csv
10877805,Tab2,Table 2,The association of basal ganglia PVS and white matter PVS with WMH burden and Aβ in amyloid positive participants,"Model 1: age, sex, and TIV were included as covariatesModel 2: age, sex, TIV, and APOE status were included as covariatesTIV Total intracranial volume, WMH White matter hyperintensity, PVS Perivascular space",2,articles/ac7/pmcid_10877805/tables/table_001.csv
10877805,Tab3,Table 3,The association between glymphatic markers and cognitive domains,"PVS Perivascular space, FDR False discovery rate",2,articles/ac7/pmcid_10877805/tables/table_002.csv
11303796,Tab1,Table 1,Demographic and clinical data for LLD and HC groups.,"All results are given as mean ± and standard deviation (std) and the range for LLD and HC. AES Apathy Evaluation Scale, MADRS Montgomery-Asberg Depression Rating Scale, DRS Mattis Dementia Rating Scale, TMT Trail Making Test, TMT B-A difference in scores between versions B and A of the Trail Making test, t Student’s t statistics, U Mann–Whitney U statistics, \documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\chi ^2$$\end{document}χ2 Chi-squared statistics.",1,articles/18a/pmcid_11303796/tables/table_000.csv
3792746,t0035,Table S1,"Distribution of study
participants by diagnostic group across each of
the 14 acquisition sites. We report the
p-values from a
χ2 test
between the actual and expected distribution of
subjects, which we estimated based on the total
number of subjects in each diagnostic group, as a
proportion of the total, across sites. Although
numbers for some sites are small, there is no
evidence that any site is enrolling a
statistically divergent proportion of subjects in
each category.",,1,articles/128/pmcid_3792746/tables/table_000.csv
3792746,t0040,Table S2,"Atlas TBSS ROI average
anisotropy and diffusivity. While many regions
were statistically significant (Benjamini and Hochberg,
1995), here we highlight regions
with the “top 10” significant
p-values (greatest effect
sizes) when comparing mean values between
diagnostic groups. We also note the total number
of significant ROIs (after FDR correction) out of
the 43 tested and the critical FDR
p-value.",,2,articles/128/pmcid_3792746/tables/table_001.csv
3792746,t0045,Table S3,"Atlas TBSS ROI average
anisotropy and diffusivity. Here we highlight
regions with the 10 lowest FDR significant
(Benjamini and Hochberg, 1995)
p-values (greatest effect
sizes) when assessing cognitive test score
associations in the entire study population. We
also note the total number of significant ROIs
(after FDR correction) out of the 43 tested and
the critical FDR
p-value.",,2,articles/128/pmcid_3792746/tables/table_002.csv
3792746,t0050,Table S4,"Atlas TBSS ROI average
anisotropy and diffusivity. Here we highlight
regions with the 10 lowest FDR significant
(Benjamini and Hochberg, 1995)
p-values (greatest effect
sizes) when assessing cognitive test score
associations in MCI subjects. We also note the
total number of significant ROIs (after FDR
correction) out of the 43 tested and the critical
FDR
p-value.",,2,articles/128/pmcid_3792746/tables/table_003.csv
3792746,t0005,Table 1,"Demographics and clinical scores for the
participants.",Bold signifies significant (i.e. p < 0.05).,2,articles/128/pmcid_3792746/tables/table_004.csv
3792746,t0010,Table 2,"Index of 43 ROIs from the WM tract atlas (Mori et al., 2008) followed by
their abbreviations.",,1,articles/128/pmcid_3792746/tables/table_005.csv
3792746,t0015,Table 3,"Atlas ROI average anisotropy and diffusivity. While many
regions were statistically significant (Benjamini and Hochberg, 1995), here we highlight regions
with the “top 10” significant p-values (greatest effect
sizes) when comparing mean values between diagnostic groups (in the left column
we show the diagnostic groups being compared). We also note the total number of
significant ROIs (after FDR correction) out of the 43 tested and the critical
FDR p-value.",,2,articles/128/pmcid_3792746/tables/table_006.csv
3792746,t0020,Table 4,"Atlas ROI average anisotropy and diffusivity. Here we
highlight regions with the 10 lowest FDR significant (Benjamini and Hochberg, 1995)
p-values (greatest effect sizes) when assessing
cognitive test score associations in the entire study population. We also note
the total number of significant ROIs (after FDR correction) out of the 43 tested
and the critical FDR p-value.",,2,articles/128/pmcid_3792746/tables/table_007.csv
3792746,t0025,Table 5,"Atlas ROI average anisotropy and diffusivity. Here we
highlight regions with the “top 10” FDR significant (Benjamini and Hochberg, 1995)
p-values (greatest effect sizes) when assessing
cognitive test score associations within diagnostic subgroups. We also note the
total number of significant ROIs (after FDR correction) out of the 43 tested and
the critical FDR p-value.",,2,articles/128/pmcid_3792746/tables/table_008.csv
3792746,t0030,Table 6,"Cognitive correlates of the average anisotropy and
diffusivity in different atlas regions of interest. Here we highlight regions
with the “top 10” FDR significant (Benjamini and Hochberg, 1995)
p-values (greatest effect sizes) when assessing executive
function (ADNI-EF) and memory (ADNI-MEM) composite neuropsychological score
associations in the entire study population. We also note the total number of
significant ROIs (after FDR correction) out of the 43 tested and the critical
FDR p-value.",,2,articles/128/pmcid_3792746/tables/table_009.csv
10177535,cells-12-01220-t001,Table 1,Characteristics of AD and control group.,"Data are expressed as mean ± standard deviation. MMSE—the Mini-Mental State Examination, n.s.—not significant.",1,articles/4b8/pmcid_10177535/tables/table_000.csv
10177535,cells-12-01220-t002,Table 2,"Overview of the DTI parameters in patients with Alzheimer’s disease and controls. NT = the number of tracts, TL = tract length, TV = tract volume, QA = quantitative anisotropy, nQA = normalized quantitative anisotropy, GFA = generalized fractional anisotropy, unit = stands for absolute numbers, AD = Alzheimer‘s disease patients, ctrl = healthy control group. The data are reported as mean values ± standard deviation (SD); * p ≤ 0.01, ** p ≤ 0.001.",,1,articles/4b8/pmcid_10177535/tables/table_001.csv
10177535,cells-12-01220-t003,Table 3,"The difference in the basal ganglia structures volumes and the total brain volume in Alzheimer’s disease patients and controls as estimated by FreeSurfer. The values are reported in µm3, n.s. = not significant.",,1,articles/4b8/pmcid_10177535/tables/table_002.csv
9014677,table1-0271678X211058803,Table 1.,Baseline characteristics of participants.,"Values are reported as means (standard deviation) or as numbers and
frequency in %.",1,articles/0c7/pmcid_9014677/tables/table_000.csv
11680639,Tab1,Table 1,Clinical data and PSMD value of SIVD and NC,"Note: Continuous Variables, for example age, education, MoCA scores, SAT and PSMD, were presented as mean± standard deviation. SIVD, subcortical ischemic vascular disease; NC, normal control; MoCA, montreal cognitive assessment; SAT, speed-accuracy trade-Off; PSMD, peak width of skeletonized mean diffusivity",1,articles/eb1/pmcid_11680639/tables/table_000.csv
11680639,Tab2,Table 2,The difference of gait parameters between SIVD and NC,"Note: Continuous Variables were presented as mean± standard deviation. SIVD, Subcortical ischemic vascular disease; NC, normal control",1,articles/eb1/pmcid_11680639/tables/table_001.csv
11680639,Tab3,Table 3,"The relationships among gait parameters, cognition function and PSMD","MoCA, montreal cognitive assessment; SAT, speed-accuracy trade-off; PSMD, peak width of skeletonized mean diffusivity",1,articles/eb1/pmcid_11680639/tables/table_002.csv
11680639,Tab4,Table 4,The relationships between gait parameters and the FA values of white matter tracts,"Note: FA, Fractional anisotropy; GCC, Genu of corpus callosum; BCC, Body of corpus callosum; SCC, Splenium of corpus callosum; R-ACR, Right Anterior corona radiata; L-ACR, Left Anterior corona radiata",1,articles/eb1/pmcid_11680639/tables/table_003.csv
11680639,Tab5,Table 5,The relationships between gait parameters and the MD values of white matter tracts,"Note: MD, Mean diffusivity; GCC, Genu of corpus callosum; BCC, Body of corpus callosum; SCC, Splenium of corpus callosum; R-SCR, Right Superior corona radiata; L-SCR, Left Superior corona radiata; L-EC, Left External capsule; R-SLF, Right Superior longitudinal fasciculus; L-SLF, Left Superior longitudinal fasciculus",1,articles/eb1/pmcid_11680639/tables/table_004.csv
7934686,tomography-07-00003-t001,Table 1,Subject characteristics and clinical scores.,"Group demographics for each acquisition with the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Alzheimer’s Disease Assessment Scale (ADAS) scores, given as mean (SD). * Significant differences across groups and acquisitions.",1,articles/368/pmcid_7934686/tables/table_000.csv
7934686,tomography-07-00003-t002,Table 2,Fitting algorithms and software tools used in this study.,Fitting algorithms and software tools used in this study. The default for AFNI is –nonlinear.,1,articles/368/pmcid_7934686/tables/table_001.csv
7934686,tomography-07-00003-t003,Table 3,Summary of results for FA by combining all fits and all acquisitions.,Summary of results for FA by combining all fits and all acquisitions. The ‘Volume %’ is the percent volume of the clusters within the corresponding brain area. No significant differences were observed between HC and MCI groups during post hoc comparisons.,1,articles/368/pmcid_7934686/tables/table_002.csv
3839877,pone-0081419-t001,Table 1,Background information for the total sample and for the two age groups.,"* p < 0.05, ** p < 0.01, *** p < 0.001, significantly different from the 60-72 years age groupNote. FA = fractional anisotropy, MD = mean diffusivity, CCG = cingulum cingulate gyrus, CHC = cingulum hippocampus, CS = corticospinal tract, FMAJ = forceps major, FMIN = forceps minor, IFOF = inferior fronto-occipital Fasciculus, SLF = superior longitudinal Fasciculus, PS = perceptual speed, EM = episodic memory, SM = semantic memory, LET_FLU = letter fluency, CAT_FLU = category fluency. All FA and MD variables have been multiplied with 100 to make the variances more similar to those of the cognitive variables.",3,articles/8e6/pmcid_3839877/tables/table_000.csv
3839877,pone-0081419-t002,Table 2,Correlations of FA and MD in the seven latent white matter tracts to performance in the five cognitive domains for the total sample and for the two age groups.,"*p < 0.05Note. FA = fractional anisotropy, MD = mean diffusivity, CCG = cingulum cingulate gyrus, CHC = cingulum hippocampus, CS = corticospinal tract, FMAJ = forceps major, FMIN = forceps minor, IFOF = inferior fronto-occipital Fasciculus, SLF = superior longitudinal Fasciculus, PS = perceptual speed, EM = episodic memory, SM = semantic memory, LET_FLU = letter fluency, CAT_FLU = category fluency. All analyses were adjusted for age.",2,articles/8e6/pmcid_3839877/tables/table_001.csv
3839877,pone-0081419-t003,Table 3,Correlation coefficients of FA and MD to perceptual speed before and after exclusion of persons in a preclinical dementia phase.,"* p < 0.05, **p < 0.01Note. FA = fractional anisotropy, MD = mean diffusivity, CCG = cingulum cingulate gyrus, CHC = cingulum hippocampus, CS = corticospinal tract, FMAJ = forceps major, FMIN = forceps minor, IFOF = inferior fronto-occipital Fasciculus, SLF = superior longitudinal fasciculus. All analyses were adjusted for age.",3,articles/8e6/pmcid_3839877/tables/table_002.csv
8824472,table1,Table 1.,Demographics.,,1,articles/2f7/pmcid_8824472/tables/table_000.csv
3632543,pone-0061014-t001,Table 1,Demographics of SVD and control groups.,BP–Blood Pressure; DM–Diabetes Mellitus; BMI–Body Mass Index. All values are Mean (SD) or proportion (%) as specified. Independent sample t-test or Chi-squared analysis used as appropriate.,1,articles/6ff/pmcid_3632543/tables/table_000.csv
3632543,pone-0061014-t002,Table 2,MRI results in SVD cases and controls.,"Values: Mean (Standard Deviation). Quartile descriptives: Minimum, lower quartile, median, upper quartile, maximum; NBV–Normalised Brain Volume, WMH–White Matter Hyperintensity.CMB–Cerebral Microbleed.",1,articles/6ff/pmcid_3632543/tables/table_001.csv
3632543,pone-0061014-t003,Table 3,DTI Histogram Group Results.,Std. Deviation–Standard Deviation; Peak Location–mode of the histogram; Peak Height–normalised frequency of the mode. Test results in bold are significant at p<0.05 level (uncorrected).,1,articles/6ff/pmcid_3632543/tables/table_002.csv
3632543,pone-0061014-t004,Table 4,Predictors of key cognitive domains in SVD.,"Values show Standardised regression coefficients: β (p-value) for predictor variables in regression models of: EF-Executive Function, and PS–Processing Speed.1Single variable models control for effects of age, gender and NART-IQ. Values in Bold remain significant after multiple comparisons correction (Holm-Bonferroni).2Multiple variable models include all the terms indicated as well as age, gender and NART-IQ. A subset of variables were included in the multi-predictor models, as described in the statistical analysis part of the methods section. Models were highly significant: EF: R2 = 0.60; F(8,105) = 19.8, p<0.0001; PS: R2 = 0.49; F(8,105) = 12.8, p<0.0001. Significant terms in each model are highlighted in bold.",2,articles/6ff/pmcid_3632543/tables/table_003.csv
3776403,T1,Table 1,D-KEFS test scores used as variables in the PCA with loading for each variable,Scores with the strongest loading on each component are indicated in bold type.,2,articles/304/pmcid_3776403/tables/table_000.csv
3776403,T2,Table 2,Scaled scores on the D-KEFS battery in ALS and PLS patients,Scaled scores are normed for age and education. Normal mean = 10; SD = 3. Subscores used as variables in the PCA are in bold.,2,articles/304/pmcid_3776403/tables/table_001.csv
3776403,T3,Table 3,"Characteristics of the patient and control groups, and subsets participating in imaging studies","Values represent means±SD, except for the male:female ratio. * p < 0.05 vs. ALS. 1 Studies with atlas-based analysis.",2,articles/304/pmcid_3776403/tables/table_002.csv
3776403,T4,Table 4,Association of neuropsychological test performance with diffusion properties of white matter tracts,,1,articles/304/pmcid_3776403/tables/table_003.csv
10393263,tab1,Table 1,Baseline and follow up characteristics of study cohort (n = 531).,"Detailed demographic, clinical characteristics, neuroimaging data and cognitive outcomes in the high (above median) versus low (below median) ICC score groups. Entries are mean (SD) or n and %, as indicated. Significant results are shown in bold (p < 0.05). *Global assessment of stenosis in the cranio-cervical vessels on CTA. λ⊥, axial diffusivity; λ||, radial diffusivity; FA, fractional anisotropy; GM, gray matter; ICV, intracranial volume; IQR, interquartile range; MD, mean diffusivity; MoCA, Montreal Cognitive Assessment; MRI, Magnetic resonance imaging; NAWM, normal-appearing white matter; NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation; T2DM, Type 2 diabetes mellitus; TIA, transient ischemic attack; WM, white matter.",1,articles/935/pmcid_10393263/tables/table_000.csv
10393263,tab2,Table 2,"Multiple regression models exploring the relation between ICC score, advanced MRI measures, and long-term cognitive function.","Multiple regression models exploring the association between the ICC score, advanced brain MRI measures and long-term cognitive function. Model 1 – unadjusted. Model 2 – adjusted for age, gender, education years and vascular risk factors: history of hypertension, T2DM, dyslipidemia. Model 3 – adjusted for age, gender, education years, stroke severity (NIHSS) and the presence of acute lesion in MRI. Significant results (p < 0.05) are shown in bold. ICC, Intra cranial calcium; MRI, magnetic resonance imaging; DA, axial diffusivity; λ⊥, axial diffusivity; λ||, radial diffusivity; GM, gray matter; ICV, intracranial volume; MD, mean diffusivity; NAWM, normal-appearing white matter; SE, standard error; T2DM, Type 2 diabetes mellitus; WM, white matter; TIA, transient ischemic attack; NIHSS, National Institutes of Health Stroke Scale. Entries are mean (SD) or n and %, as indicated. Significant results are shown in bold (p < 0.05).",2,articles/935/pmcid_10393263/tables/table_001.csv
10393263,tab3,Table 3,Univariate and multivariate predictors of post-stroke-cognitive-impairment (PSCI) within 24 months from stroke.,"Univariate and multivariate predictors of post-stroke-cognitive-impairment (PSCI) within 24 months from stroke. PSCI was defined as a diagnosis of either MCI or dementia throughout the 24 months follow-up. CI, confidence interval; ICC, Intra cranial calcium; MRI, Magnetic Resonance Imaging. Significant results are shown in bold (p < 0.05).",1,articles/935/pmcid_10393263/tables/table_002.csv
8500888,Tab1,Table 1,Sample characteristics,"* Composite scores computed as the average of demographically adjusted z-scores of measures within that cognitive domain** Hippocampal volume was normalized by dividing by total intracranial volume and then multiplying by 1,000Abbreviations: FSRP = updated Framingham Stroke Risk Profile (Dufouil et al. 2017); GDS = Geriatric Depression Scale; DRS = Dementia Rating Scale; ANART = American National Adult Reading Test; VIQ = verbal intelligence quotient",1,articles/b1d/pmcid_8500888/tables/table_000.csv
8500888,Tab2,Table 2,Multiple hierarchical linear regression models for association of fornix MWF and memory functioning adjusting for demographics and vascular risk burden,Abbreviations: FSRP = updated Framingham Stroke Risk Profile (Dufouil et al. 2017); MWF = myelin water fraction* Note males served as the reference groupStatistically significant (p < .05) results appear in bold font,1,articles/b1d/pmcid_8500888/tables/table_001.csv
8500888,Tab3,Table 3,"Multiple hierarchical linear regression models for association of fornix MWF and memory functioning adjusting for demographics, vascular risk burden, hippocampal volume, and fornix DTI FA",Abbreviations: MWF = myelin water fraction; DTI = diffusion tensor imaging; FA = fractional anisotropy; FSRP = updated Framingham Stroke Risk Profile (Dufouil et al. 2017)* Note males served as the reference group; Statistically significant (p < .05) results appear in bold font,1,articles/b1d/pmcid_8500888/tables/table_002.csv
5539622,Tab1,Table 1,"Demographics, Aβ and neuropsychological test scores for each participant group","Aβ and test scores are corrected for age, sex and educationValues are shown as mean ± standard error unless otherwise notedap < 0.01, compared to HC; bp < 0.001, compared to HC; cp < 0.001, compared to MCI, with Bonferroni correction for multiple comparisonsAβ amyloid-β, AD Alzheimer’s disease, ANART-VIQ, American National Reading Test Verbal IQ, CERAD-DR Consortium to Establish a Registry for Alzheimer’s Disease delayed recall, CVLT-LFR California Verbal Learning Test long delay free recall, CVLT-SFR California Verbal Learning Test short delay free recall, DRS Dementia Rating Scale, FAQ Functional Assessment Questionnaire, HC healthy controls, LMI Logical Memory immediate, LMD Logical Memory delayed, MCI mild cognitive impairment",1,articles/6c5/pmcid_5539622/tables/table_000.csv
5539622,Tab2,Table 2,Partial correlations (r) between memory test scores and RSI and DTI measures,"Correlations corrected for age, sex, and education*p < 0.01, **p < 0.001CERAD-DR Consortium to Establish a Registry for Alzheimer’s Disease delayed recall, CVLT-LFR California Verbal Learning Test long delay free recall, CVLT-SFR California Verbal Learning Test short delay free recall, DTI diffusion tensor imaging, FA fractional anisotropy, IF isotropic free water diffusion, IFOF inferior fronto-occipital fasciculus, ILF inferior longitudinal fasciculus, LMI Logical Memory immediate, LMD Logical Memory delayed, MD mean diffusivity, ND neurite density, RSI restriction spectrum imaging",1,articles/6c5/pmcid_5539622/tables/table_001.csv
5539622,Tab3,Table 3,"Beta values for predictors of neuropsychological test scores, with model F and R2 values using RSI and DTI metrics","Values corrected for age, sex, and education*All regression models significant at p < 0.001CERAD-DR Consortium to Establish a Registry for Alzheimer’s Disease delayed recall, CVLT-LFR California Verbal Learning Test long delay free recall, CVLT-SFR California Verbal Learning Test short delay free recall, DRS Dementia Rating Scale, DTI diffusion tensor imaging, FA fractional anisotropy, IF isotropic free water diffusion, IFOF inferior fronto-occipital fasciculus, LMI Logical Memory immediate, LMD Logical Memory delayed, ND neurite density, RSI restriction spectrum imaging",1,articles/6c5/pmcid_5539622/tables/table_002.csv
5539622,Tab4,Table 4,Pearson’s correlations (r) between discriminant scores and neuropsychological test scores,"*p < 0.01, **p < 0.001CERAD-DR Consortium to Establish a Registry for Alzheimer’s Disease delayed recall, CVLT-LFR California Verbal Learning Test long delay free recall, CVLT-SFR California Verbal Learning Test short delay free recall, DRS Dementia Rating Scale, DTI diffusion tensor imaging, LMI Logical Memory immediate, LMD Logical Memory delayed, RSI restriction spectrum imaging",1,articles/6c5/pmcid_5539622/tables/table_003.csv
9701560,T1,Table 1,Demographics.,Aß = amyloid-beta.WMH = White matter hyperintensities.CDR = Clinical dementia rating.PS1 = Presenilin 1 PS2 = Presenilin 2 APP = amyloid precursor protein. PET = Positron Emission Tomography.,1,articles/2cd/pmcid_9701560/tables/table_000.csv
9701560,T2,Table 2,p-values for each variable and their contribution to the linear models for each of the CSF Tau phosphorylation sites. Each variable is attributed to a known cause of WM decline with amyloid as a metric of disease severity and cortical GM as a proxy for GM atrophy. Only CSF pT205 significantly contributed to the model with a trend level seen for CSF pT217.,,1,articles/2cd/pmcid_9701560/tables/table_001.csv
5607539,brb3766-tbl-0001,Table 1,Demographic and clinical characteristics of participants,"AD, Alzheimer's dementia; K‐GDS, Korean Geriatric Depression Scales; MCI, Mild cognitive impairment; HC, Healthy control; CDR, Clinical Dementia Rating; MMSE, Mini‐Mental State Examination.As for the scores of CERAD‐K cognitive test and K‐GDS, complete data were available for 38 AD patients, 64 MCI patients, and 30 HCs, and one or more data were not available for the remaining subjects.aIndicates significance compared to HC group (p < .05).bIndicates significance compared to MCI group (p < .05).cWelch's ANOVA with Games‐Howell post hoc test. Otherwise, ANOVA with Tukey's post hoc test.",1,articles/0c8/pmcid_5607539/tables/table_000.csv
5607539,brb3766-tbl-0002,Table 2,Hippocampal subfields and fiber tracts that are significantly (p < .005) correlated with the latent variable(s) with regard to CERAD‐K total scores in three groups,"CA, Cornu Ammonis; FA, fractional anisotropy; MD, mean diffusivity; GC‐ML‐DG, granule cell layer‐molecular layer‐dentate gyrus; SFOF, superior fronto‐occipital fasciculus.Superscripts in healthy controls indicate 1st to 3rd latent variables.",1,articles/0c8/pmcid_5607539/tables/table_001.csv
9465649,T1,Table 1,Demographics and risk factors of the cohort.,,1,articles/93c/pmcid_9465649/tables/table_000.csv
9465649,T2,Table 2,Characteristics of the imaging parameters.,"Abbreviations: FW = free water, NAWM = normal appearing white matter, WMH = white matter hyperintensity, AD = axial diffusivity, FA = fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity; t = suffix for free water corrected tissue, nBV = normalized brain volume;*normalized and ln-transformed.",1,articles/93c/pmcid_9465649/tables/table_001.csv
9465649,T3,Table 3,"Partial correlation between imaging variables and EF with a speed component, adjusted for age.","Abbreviation: r = correlation coefficient, FW = free water, NAWM = normal appearing white matter, WMH = white matter hyperintensities, MD = mean diffusivity, FA = fractional anisotropy, AD = axial diffusivity, RD = radial diffusivity, t = suffix for free water corrected tissue,*exponentially transformed;**normalized and ln-transformed;***between group t-test (presented are T-score and p-value).",1,articles/93c/pmcid_9465649/tables/table_002.csv
9465649,T4,Table 4,"Significant linear regression results of EF with a speed component regressed on FW in specific white matter tracts. All analysis are corrected for age and the risk factors hypertension, diabetes, hypercholesterolemia, BMI and smoking. Results are uncorrected for multiple comparisons.","Abbreviations: B = regression coefficient, Std. error = standard error, VIF = variance inflation factor, R2 change = variance explained by the specific tract.",1,articles/93c/pmcid_9465649/tables/table_003.csv
11331623,Tab1,Table 1,Comparative analysis of clinical data between MCI stable and progression subgroups,"CDRS Clinical Dementia Rating Scale, ADAS Alzheimer’s Disease Assessment Scale, MMSE Mini-Mental State Examination, NA Not available because the variable is not included in the NACC database",3,articles/d81/pmcid_11331623/tables/table_000.csv
11331623,Tab2,Table 2,Predictive performances of different machine learning methods,"SD Standard deviation, RSD Relative standard deviation, KNN K-nearest neighbor, SVM Support vector machine, DT Decision tree",1,articles/d81/pmcid_11331623/tables/table_001.csv
11331623,Tab3,Table 3,Independent predictors of MCI status in univariate and multivariate logistic regression analysis,"OR Odds ratio, CI Confidence interval, CDRS Clinical Dementia Rating Scale, ADAS Alzheimer’s Disease Assessment Scale, MMSE Mini-Mental State Examination, SVM Support vector machine, NA Not available because the variable is not included in multiple variables",2,articles/d81/pmcid_11331623/tables/table_002.csv
5738235,t0005,Table 1,Main recorded quantitative data with comparison between men and women.,"BP, blood pressure; MMSE, mini-mental-state-examination; ADCmean, mean apparent diffusion coefficient.",1,articles/0ec/pmcid_5738235/tables/table_000.csv
5738235,t0010,Table 2,"Volume and anatomical locations of the significant grey matter clusters obtained through SPM linear regression models aimed at correlating the CMRGlc of brain grey matter voxels with the ADCmean values obtained from the overall white matter or from the white matter of each individual lobe, and with age and gender as covariables (p-value of 0.005, corrected for cluster volume (k = 39)).","ADCmean, mean apparent diffusion coefficient; BA, Brodmann areas.",1,articles/0ec/pmcid_5738235/tables/table_001.csv
5738235,t0015,Table 3,"Pearson coefficients between the ADCmean of the overall white matter or the CMRGlc of areas correlated with global ADCmean, and clinical and BP variables and neuropsychological test scores.","BP, blood pressure; MMSE, mini-mental-state-examination; ADCmean, mean apparent diffusion coefficient; CMRGlc, cerebral metabolic rate of glucose.",1,articles/0ec/pmcid_5738235/tables/table_002.csv
11521969,tab1,Table 1,DTI main analysis method.,,1,articles/76a/pmcid_11521969/tables/table_000.csv
8046043,hbm25342-tbl-0001,TABLE 1,Demographic information,"Notes: Data are presented as mean (SD) unless otherwise stated. Comparisons were made using analysis of variance (ANOVA) and the chi‐square test where appropriate. p values <.05 are marked in bold italics. p values <.05 resulting from post‐hoc Tukey analysis are labeled as given below.Abbreviations: AD, Alzheimer's disease; NC, normal cognition; SIVD, subcortical ischemic vascular disease.aBetween SIVD and NC.bBetween AD and NC.cBetween SIVD and AD.",2,articles/ca3/pmcid_8046043/tables/table_000.csv
8046043,hbm25342-tbl-0002,TABLE 2,Comparisons of quantitative DTI and DKI metrics,"Notes: Data are presented as mean ± SD unless otherwise stated. Analysis of covariance (ANCOVA) was used for controlling cofactors as stated in the table. Mean/axial/radial diffusivity is presented in units of 10−3 mm2 s−1. p values <.05 are marked in bold italics. 0.01 ≤ ηp2 < 0.06 denotes a small effect, 0.06 ≤ ηp2 < 0.14 denotes a median effect, while 0.14 ≤ ηp2 denotes a large effect.Abbreviations: DTI, diffusion tensor imaging; DKI, diffusion kurtosis imaging; SIVD, subcortical ischemic vascular disease; AD, Alzheimer's disease; NC, normal cognition; Daxial, axial diffusivity; Dradial, radial diffusivity; MD, mean diffusivity; FA, fractional anisotropy; Kaxial, axial kurtosis; Kradial, radial kurtosis; MK, mean kurtosis.",3,articles/ca3/pmcid_8046043/tables/table_001.csv
8046043,hbm25342-tbl-0003,TABLE 3,Discriminant analysis by different combinations of quantitative metrics,"Abbreviations: Daxial, axial diffusivity; Dradial, radial diffusivity; MD, mean diffusivity; FA, fractional anisotropy; Kaxial, axial kurtosis; Kradial, radial kurtosis; MK, mean kurtosis.a1,000 times of simple sampling from the biased‐corrected and accelerated percentile bootstrap after removal of the outliers, defined by those with absolute value of Z score >2.bThe classification accuracy of the Fazekas scale was derived by incorporating all components, including total score and scores of periventricular and deep white matter hyperintensities.cThe classification accuracies were derived by analyzing bilateral thalami and segregated thalamic regions, respectively.",1,articles/ca3/pmcid_8046043/tables/table_002.csv
8046043,hbm25342-tbl-0004,TABLE 4,Correlations between DKI metrics and cognition measures in all subjects (n = 77),"Note: The results were reported with partial correlation coefficients after controlling for age and education; the partial correlation coefficients with p values <.05 are marked in bold italics.Abbreviations: DKI, diffusion kurtosis imaging; PUL, pulvinar; ANT, anterior; MedioD, mediodorsal; VLD, ventral‐lateral‐dorsal; C, central; VA, ventral‐anterior; VLV, ventral‐lateral‐ventral; CDRSOB, Clinical Dementia Rating sum of box; MMSE, Mini‐Mental State Examination.Note: **p values <0.01. †p values <.05 after also controlling for the Fazekas Scale; *p values <.05.",2,articles/ca3/pmcid_8046043/tables/table_003.csv
7507145,gbb12656-tbl-0001,TABLE 1,SNPs that were used to build the GRSs.,"Note: 15 SNPs could be assigned to at least one of the pathways identified as showing enrichment for association with late‐onset AD. The pathway protein ubiquitination was excluded because none of the SNPS could assigned to this pathway. Notice that only immune/inflammatory response and endocytosis are completely independent pathways. Abbreviations: Immune resp., immune response; Cholesterol/lipid met., cholesterol/lipid metabolism; Synaptic trans., synaptic transmission; 1, OR extracted from reference 18; 2, OR extracted from reference 19; *, belongs to.",1,articles/f7f/pmcid_7507145/tables/table_000.csv
7507145,gbb12656-tbl-0002,TABLE 2,Summary of k‐means cluster analysis.,"Abbreviations: CI, confidence interval; FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation; SE, standard error.Note: Both models were adjusted by age, gender and four principal components of ancestry. Coefficients were calculated using z‐values therefore β represents change in terms of SD from the mean.",1,articles/f7f/pmcid_7507145/tables/table_001.csv
7507145,gbb12656-tbl-0003,TABLE 3,Summary of k‐means cluster analysis. ,"Abbreviations: FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation.Note: Analysis included children with moderate to severe intellectual disability (IQ lower than 70). Values for IQ, global FA and immune response GRS are showed for the two clusters that were computed.",2,articles/f7f/pmcid_7507145/tables/table_002.csv
4827723,t0005,Table 1,Demographic information and sample size used in each comparison.,,1,articles/d4d/pmcid_4827723/tables/table_000.csv
4536470,t0005,Table 1,Descriptive statistics of demographical data.,"NC, normal controls. p-Values of between group differences were calculated using the chi-square test for gender, and t-test for all other variables.",1,articles/139/pmcid_4536470/tables/table_000.csv
4536470,t0010,Table 2,"Descriptive statistics and group differences of network properties controlling for age, gender, education and white matter hypointensities.","Mean ± standard deviation. ANCOVA, analysis of covariance. Group differences are controlled for age, gender and white matter hypointensity volume. CC, clustering coefficient, L, shortest paths, Eglobal, global efficiency, CCnorm, normalized clustering coefficient, Lnorm, normalized shortest paths, N, number of connected nodes, E, number of edges, C, total sum of edge weights.",1,articles/139/pmcid_4536470/tables/table_001.csv
4536470,t0015,Table 3,"Descriptive statistics and group differences of markers of neurodegeneration, and global properties of gray matter and white matter controlling for age, gender, education and white matter hypointensities.","Mean ± standard deviation. Group differences are controlled for age, gender and white matter hypointensity volume. ANCOVA, analysis of covariance. FDG-PET, fludeoxyglucose positron emission tomography. GM, gray matter. WM, white matter. FA, fractional anisotropy. MD, mean diffusivity.",1,articles/139/pmcid_4536470/tables/table_002.csv
11025752,pone.0292576.t001,Table 1,Demographic information and cognitive data for APOE groups.,"Note. M and SD represent mean and standard deviation, respectively. F statistics with p-values reported from ANOVA, X2 statistic with p-value reported for categorical sex variable.",1,articles/2f8/pmcid_11025752/tables/table_000.csv
11025752,pone.0292576.t002,Table 2,Correlational data for APOE groups.,Note. Values represent Pearson correlation coefficients with lower and upper limits of the 95% confidence interval in brackets. *indicates p < .05 (no correlations showed significance).,1,articles/2f8/pmcid_11025752/tables/table_001.csv
3160749,T1,Table 1,Result of the ROC curve analysis to separate aMCI-converter from aMCI-stable patients.,"Results of the pair-wise comparison of ROC curves between the DTI score and single-modality approaches (vs. DTI score), and the MRI score and single-modality approaches (vs. MRI score), are shown in the two right columns.*MD, λ||, and λ⊥: mm2/s; T2: ms.",1,articles/6ef/pmcid_3160749/tables/table_000.csv
9903216,table1-0271678X221135658,Table 1.,"Mild Stroke Study 3 demographics, OCTA data, co-morbid eye disease,
vascular risks, and comprehensive brain imaging data at baseline.","AMD: age-related macular degeneration. BG: basal ganglia. CSO:
centrum semiovale. CVR: cerebrovascular reactivity. FA: fractional
anisotropy. ICV: inter cranial volume. MD: mean diffusivity. NAWM:
normal appearing white matter. PVS: perivascular spaces. SBP:
systolic blood pressure. WMH: white matter hyperintensity.aPVS volume as a percentage of the region of interest,
either CSO or BG. ICV volume and PVS counts as mean (SD), other
volumes have non-normal distributions and so presented as medians
(interquartile range, Q1–Q3).",1,articles/39d/pmcid_9903216/tables/table_000.csv
3852215,T1,Table 1,Characteristics of the sample (n = 129).,"*1: primary school without diploma,2: primary school validated with diploma,3: short secondary school, long secondary school and university level.",1,articles/d8a/pmcid_3852215/tables/table_000.csv
5992887,T1,Table 1,Causes and manifestations of non-alcoholic Wernicke's encephalopathy in three psychiatric patients with Korsakoff syndrome.,"aAge at the time of Wernicke's encephalopathy.bPatient 1 had also muscle weakness.cInformation from hospital records. N/A, Not available.",2,articles/4c7/pmcid_5992887/tables/table_000.csv
5992887,T2,Table 2,Results of memory tests for three psychiatric patients with non-alcoholic Korsakoff syndrome.,"Values outside brackets are z-scores from the distribution of normative values. Values inside brackets are the difference between the memory test quotient and the general cognitive level quotient. Values of −1.5 or less (z-score), or 15 or more (quotient difference) are in bold.aAge (years) at the neuropsychological examination.bWechsler Adult Intelligence ScaleIII, letter - number span subset.cWechsler Adult Intelligence Scale–III, visual span subset.dHopkins Verbal Learning Test–Revised (HVLT-R), sum of the first three learning trials.eWechsler Memory Scale-III (WMS-III) logical memory I.fBrief Visuospatial Memory Test-Revised (BVMT-R), sum of the first three learning trialsgHVLT-R, delayed free recall trial (trial 4).hWMS-III, logical memory II.iBVMT-R, delayed free recall trial (trial 4).jHVLT-R, recognition trial.kWMS-III, logical memory recognition score + 24 (presumed perfect Verbal Paired Associates recognition). According to Lezak, Howieson, Bigler, and Tranel, Neuropsychological assessment, 5th edition (2012), page 527.",1,articles/4c7/pmcid_5992887/tables/table_001.csv
5992887,T3,Table 3,Results of non-memory tests for three psychiatric patients with non-alcoholic Korsakoff syndrome.,"Values are z-scores from the distribution of normative values. Values ≤ −1.5 are in bold.aAge at the neuropsychological examination.bTrail Making Test.cWechsler Adult Intelligence Scale–III, digit symbol subset.dWechsler Adult Intelligence Scale–III, vocabulary subtest.eWisconsin Card Sorting test.fThe category fluency test (animals) and the word fluency test (words starting with the letter “s”).gAverage of NAB Mazes test, WCST, TMT(A)—TMT(B), and fluency tests.",1,articles/4c7/pmcid_5992887/tables/table_002.csv
5992887,T4,Table 4,Fractional anisotropy (FA) values from diffusion tensor imaging for three psychiatric patients with non-alcoholic Korsakoff syndrome.,Z-scores represent the difference from the mean of controls with one standard deviation as the unit. Values ≤ −2 are in bold.aCorticostriatal projections.,1,articles/4c7/pmcid_5992887/tables/table_003.csv
5614750,t0005,Table 1,Summary of demographic and basic clinical data for all groups.,"bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; ANOVA, analysis of variance; Smx, symptom; yr, years; M, male; F, female; MMSE, Mini-Mental State Examination score; CDRTot, clinical dementia rating score total; CDRBox, CDR box score.",2,articles/a6d/pmcid_5614750/tables/table_000.csv
5065043,t0005,Table 1,Demographic and clinical datac.,"a and b denote the p-values for the ANOVA and Pearson's Chi-square test, respectively.",2,articles/bf8/pmcid_5065043/tables/table_000.csv
4529164,pone.0134766.t001,Table 1,Background information and data on perceptual speed for the cognitive and DTI subsamples.,"Note. DTI = diffusion tensor imaging, MMSE = Mini-Mental State Examination, APOE = apolipoprotein E, PS = perceptual speed.a based on self-report, inpatient register, use of oral glucose-lowering agent or insulin injection, or HbA1c ≥5.4%b ≥160/100 mm Hg or use of antihypertensive agents",1,articles/9b5/pmcid_4529164/tables/table_000.csv
4529164,pone.0134766.t002,Table 2,Background information for the DTI subsample (n = 89) stratified by APOE ε4 genotype.,"Note. DTI = diffusion tensor imaging, APOE = apolipoprotein E, MMSE = Mini-Mental State Examination.",1,articles/9b5/pmcid_4529164/tables/table_001.csv
4529164,pone.0134766.t003,Table 3,Data on white matter microstructure and WMH for the DTI subsample (n = 89).,"Note. WMH = white matter hyperintensities adjusted for ICV, DTI = diffusion tensor imaging, FA = fractional anisotropy, MD = mean diffusivity, CCG = cingulum cingulate gyrus, CHC = cingulum hippocampus, CS = corticospinal tract, FMAJ = forceps major, FMIN = forceps minor, IFOF = inferior fronto-occipital fasciculus, SLF = superior longitudinal fasciculus. The unit for MD was 10−9 m2/s. All FA and MD variables have been multiplied with 100 to make the variances more similar to those of the cognitive variables.",1,articles/9b5/pmcid_4529164/tables/table_002.csv
4529164,pone.0134766.t004,Table 4,Associations between APOE (any ε4 vs. no ε4) and white matter microstructure in seven tracts (n = 89).,"Note. APOE = apolipoprotein E, FA = fractional anisotropy, MD = mean diffusivity, CCG = cingulum cingulate gyrus, CHC = cingulum hippocampus, CS = corticospinal tract, FMAJ = forceps major, FMIN = forceps minor, IFOF = inferior fronto-occipital fasciculus, SLF = superior longitudinal fasciculus. All effects were adjusted for age.",2,articles/9b5/pmcid_4529164/tables/table_003.csv
4529164,pone.0134766.t005,Table 5,"Mediational models for APOE, white matter microstructure, and PS in the total sample (n = 652) and in the DTI subsample (n = 89).","Note. APOE = apolipoprotein E, PS = perceptual speed, DTI = diffusion tensor imaging, STD = standardized, FA = fractional anisotropy, MD = mean diffusivity, FMAJ = forceps major, CS = corticospinal tract. All effects were adjusted for age.",3,articles/9b5/pmcid_4529164/tables/table_004.csv
11067201,Tab1,Table 1,Comparative analysis of clinical data in the training and test sets,"Note. ADAS, Alzheimer’s disease assessment scale; APOE4, apolipoprotein E 4; CDRS, clinical dementia rating scale; MMSE, mini-mental state examination. * indicates p < 0.05",2,articles/421/pmcid_11067201/tables/table_000.csv
11067201,Tab2,Table 2,Results of univariate and multivariate logistic regression analyses,"Note. ADAS, Alzheimer’s disease assessment scale; APOE4, apolipoprotein E 4; CDR, clinical dementia rating scale; MMSE, mini-mental state examination",2,articles/421/pmcid_11067201/tables/table_001.csv
11067201,Tab3,Table 3,Performance of independent predictors and model in training and testing cohorts,"Note: a, b, and c indicate the comparison of diagnostic performance between the multimodal combination model and white marker, ADAS, and APOE4, respectively. * indicates p < 0.05",2,articles/421/pmcid_11067201/tables/table_002.csv
4334653,pone.0116330.t001,Table 1,Characteristic of the study participants (N = 338).,EKG: electrocardiogram; LVH: left ventricular hypertrophy; FSRP: Framingham Stroke Risk Profile; BP: blood pressure; BMI: body mass index; Hb: hemoglobin; hs-CRP: high-sensitive C-reactive protein; ARWMC: Age-related WM changes; FA: fractional anisotropy; MD: mean diffusivity; AD: axial diffusivity; TD: transverse diffusivity.,1,articles/e54/pmcid_4334653/tables/table_000.csv
4334653,pone.0116330.t002,Table 2,Pairwise correlation matrix of clinical measures in the participants.,"Data values represent the correlation coefficients.Gender is coded by male: 1 and female: 0.Log(FSRP score): log-transformed FSRP score; log(hs-CRP): log-transformed hs-CRP; log(ARWMC-total score): log-transformed ARWMC-total score.For other abbreviations, see Table 1.* p < 0.01.",1,articles/e54/pmcid_4334653/tables/table_001.csv
4334653,pone.0116330.t003,Table 3,The voxel-based DTI analysis of significant clusters that showed a significant positive correlation with homocysteine and MD.,MNI: Montreal Neurological Institute; WM: white matter; R: right side; L: left side.,2,articles/e54/pmcid_4334653/tables/table_002.csv
4334653,pone.0116330.t004,Table 4,The voxel-based DTI analysis of significant clusters that showed a significant positive correlation with homocysteine and AD.,MNI: Montreal Neurological Institute; WM: white matter; R: right side; L: left side.,2,articles/e54/pmcid_4334653/tables/table_003.csv
10165759,Tab1,Table 1,Participant demographics and clinical information,"Data are represented as the mean ± SD or median (p25-p75) values depending on the distribution of the variables. a Two sample t test; b Chi-square test; c Mann‒Whitney U test; *P < 0.05. PD-MCI Parkinson’s disease with mild cognitive impairment, PD-NC Parkinson’s disease with normal cognition, MDS-UPDRS-IIII Movement Disorder Society Unified Parkinson’s Disease Rating Scale-Part III, H&Y stage Hoehn and Yahr stage, LEDD levodopa equivalent daily dose, MMSE Minimum Mental State Examination, MoCA Montreal Cognitive Assessment, CDT Clock Drawing Test, AVLT Auditory Verbal Learning Test, TMT-A, TMT-B Trail Making Test A and B, HAMD Hamilton Depression Scale",1,articles/3b5/pmcid_10165759/tables/table_000.csv
10165759,Tab2,Table 2,Statistical descriptions and p values for all 7 selected features,"The ID numbering order is consistent with the SHAP value. “.R and.L” in the text indicate the right and left sides, respectively. All data are represented as the mean ± SD, and we applied two-sample t tests for comparisons between groups. *P < 0.05. PD-MCI Parkinson’s disease with mild cognitive impairment, PD-NC Parkinson’s disease with normal cognition, LDHk LDH using Kendall’s coefficient concordance, LDH LDH using Spearman’s rank correlation coefficient, MD mean diffusivity, RIC retrolenticular part of the internal capsule, PCT pontine crossing tract, ML medial lemniscus, ST fornix (cres)/stria terminalis, SLF Right superior longitudinal fasciculus, CH cingulum (hippocampus)",1,articles/3b5/pmcid_10165759/tables/table_001.csv
10165759,Tab3,Table 3,Classification performance of the different models,"DT decision tree, RF random forest, XGBoost eXtreme Gradient Boosting, PPV positive predictive value, NPV negative predictive value, AUC area under the receiver operating characteristic curve",2,articles/3b5/pmcid_10165759/tables/table_002.csv
6931233,tbl0001,Table 1,. Demographic and clinical characteristics.,Abbreviations: PPA = primary progressive aphasia; M = male; F = female; G = agrammatic PPA; S = semantic PPA; L = logopenic PPA; O = Mixed or Uncertain PPA type; PASS = Progressive Aphasia Severity Scale.,1,articles/c05/pmcid_6931233/tables/table_000.csv
11867789,hbm70171-tbl-0001,TABLE 1,AQP4 SNPs included in this study.,,1,articles/246/pmcid_11867789/tables/table_000.csv
11867789,hbm70171-tbl-0002,TABLE 2,Demographic data of participants at baseline.,"Note: Raw data were presented as mean (± standard deviation [SD]) or number (percentage, %) in tables unless otherwise noted. Data were compared using t‐tests or chi‐square tests.Abbreviations: All, the whole group; A+, Aβ positive; A−, Aβ negative; DTI‐ALPS, diffusion tensor image analysis along the perivascular space; FW, free water; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; PVS, perivascular space; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B.aOf the whole group, 133 did not have tau information.bOne amyloid‐negative participant without the DTI‐ALPS index due to image registration failure.",2,articles/246/pmcid_11867789/tables/table_001.csv
11867789,hbm70171-tbl-0003,TABLE 3,Associations between AQP4 SNPs and longitudinal glymphatic imaging markers change.,"Note: Reported are estimates and p‐values from linear mixed models with random intercepts and random slopes. The fixed effect of SNP*time was interpreted as the effect on longitudinal glymphatic change.Abbreviations: All, the whole group; A−, Aβ negative; A+, Aβ positive; DTI‐ALPS, diffusion tensor image analysis along the perivascular space; FW, free water; MD, mean diffusivity; SNP, single‐nucleotide polymorphism; VRFs, vascular risk factor score; WM, white matter.",3,articles/246/pmcid_11867789/tables/table_002.csv
11867789,hbm70171-tbl-0004,TABLE 4,Cross‐sectional associations between glymphatic imaging markers and cognitive measures in the whole group.,"Note: Bold and * meant corrected by FDR, β‐std, and standardized betas.Abbreviations: FW, free water; Logical delayed, Logical Memory‐Delayed Recall; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B; VRFs, vascular risk factor score.",3,articles/246/pmcid_11867789/tables/table_003.csv
11867789,hbm70171-tbl-0005,TABLE 5,Associations between baseline glymphatic imaging markers and longitudinal changes in cognitive measures in the whole group.,"Note: Reported are estimates and p‐values from linear mixed models with random intercepts and random slopes. The fixed effect of glymphatic marker*time was interpreted as the effect on longitudinal glymphatic change. Bold and * meant corrected by FDR.Abbreviations: FW, free water; Logical Delayed, Logical Memory‐Delayed Recall; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B; VRFs, vascular risk factor score.",3,articles/246/pmcid_11867789/tables/table_004.csv
5339687,t1,Table 1,Electrophysiology.,Means and standard deviations of electrophysiological data for preHD (n = 12) and healthy controls (n = 13). Abbreviations: LLR: long latency reflex; MEP: motor evoked potential; RMT: resting motor threshold; AMT: active motor threshold; CSP: cortical silent period.,1,articles/bc5/pmcid_5339687/tables/table_000.csv
5339687,t2,Table 2,Demographics and clinical characteristics.,"Data are shown as median (interquartile range), min–max. aFisher’s exact test; bMann-Whitney-U-test; cUnified Huntington’s Disease Rating Scale; dDisease burden score [age × (CAGn-35.5)]; eEstimated disease onset at a 60% certainty level according to refs 9 and 40; fSymbol Digit Modalities Test; NA, not applicable.",1,articles/bc5/pmcid_5339687/tables/table_001.csv
6700635,jad-70-jad190152-t001,Table 1,CSF biomarker levels of AD patients,*Normal values: Aβ42 > 580 pg/mL; Aβ42/Aβ40 > 0.068; Tau < 250 pg/mL; pTau (181) < 37 pg/mL; Tau/Aβ42 < 0.40; Aβ42/pTau > 15.8.,1,articles/fe1/pmcid_6700635/tables/table_000.csv
6700635,jad-70-jad190152-t002,Table 2,Demographics and clinical characteristics of all participants,"HC, healthy controls; AD, patients with Alzheimer’s disease; SD, standard deviation; MoCA, Montreal cognitive assessment; CDR, Clinical Dementia Rating; MMSE, Mini-Mental State Examination. Data are expressed as mean±S.D, except for ApoE that is expressed as percentage of ɛ4 carriers. MMSE and MoCA: higher scores correspond to better performance. Concerning BLAD affected domains they showed the following ratios of impairment in AD participants: (Memory, 16/17; Executive, 12/17; Language, 7/17; Constructive, 4/17; Calculation, 3/17).",1,articles/fe1/pmcid_6700635/tables/table_001.csv
6700635,jad-70-jad190152-t003,Table 3,"FA, MD, RD. and DA whole-brain values (mean±SD), for all participants","HC, healthy controls; AD, patients with Alzheimer’s disease; SD, standard deviation; FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; DA, axial diffusivity.*p-values <0.05 were considered statistically significant (corrected for multiple comparisons by using post-hoc Bonferroni correction for the number of metrics considered).",1,articles/fe1/pmcid_6700635/tables/table_002.csv
6700635,jad-70-jad190152-t004,Table 4,"White matter tracts’ FA correlated with INL thickness in patients with Alzheimer’s disease (n = 17), with the largest effects in terms of spatial extent",*p-values <0.05 were considered statistically significant (corrected for multiple comparisons by controlling for family-wise error rates). **Percentage of statistically significant voxels within each labelled tract.,1,articles/fe1/pmcid_6700635/tables/table_003.csv
4737469,tab1,Table 1,The demography and clinical scores of the subjects in the study. The p values are based on the two-sample t-tests except the gender. The gender ratio was examined by the Chi-squared test.,,1,articles/c3c/pmcid_4737469/tables/table_000.csv
4737469,tab2,Table 2,Names and abbreviations of the 90 ROIs defined in the AAL template.,"∗The odd and even indices indicate the regions in the left and right hemispheres, respectively.",1,articles/c3c/pmcid_4737469/tables/table_001.csv
4737469,tab3,Table 3,"The comparison of the global connectivity characteristics between the AD and the NC groups with the DTI and HARDI models, respectively.",,1,articles/c3c/pmcid_4737469/tables/table_002.csv
4508678,T1,Table 1,Patients' profile,"Separately within each group, patients are ordered according to corpus callosum fractional anisotropy (FA) values (greater to smaller). Modified Rankin Scale (mRS) and idiopathic normal pressure hydrocephalus (INPH) grading scale (C: cognitive impairment, G: gait disturbance, I: urinary incontinence) were assessed on the first visit to our outpatient clinic. PLIC: posterior limb of the internal capsule.",3,articles/bfa/pmcid_4508678/tables/table_000.csv
4508678,T2,Table 2,Correlations between fractional anisotropy values and symptoms scored by INPH grading scale and mRS,"INPH: idiopathic normal pressure hydrocephalus, mRS: modified Rankin Scale, PLIC: posterior limb of the internal capsule.",1,articles/bfa/pmcid_4508678/tables/table_001.csv
3432077,pone-0044074-t001,Table 1,Association diffusion parameters of the SLF and memory performance.,"Data are presented as standardized regression coefficients with 95% CI.Model 1: adjusted for age, sex, level of education.Model 2: Model 1+ adjustment for the planar diffusion coefficient, reflecting the degree of fiber organization complexity.aRegression coefficient is significantly larger for CSD compared to DTI based tractography, assessed with Steiger’s Z-statistic.",2,articles/016/pmcid_3432077/tables/table_000.csv
3432077,pone-0044074-t002,Table 2,Tabel 2. Association diffusion parameters of the CC and memory performance.,"Data are presented as standardized regression coefficients with 95% CI.Model 1: adjusted for age, sex, level of education.Model 2: Model 1+adjustment for the planar diffusion coefficient, reflecting the degree of fiber organization complexity.Regression coefficients obtained with DTI and CSD based FT did not differ significantly, assessed with Steiger’s Z-statistic.",2,articles/016/pmcid_3432077/tables/table_001.csv
3675157,pone-0065175-t001,Table 1,Sample characteristics by PIB and WMH pathologya status.,"aDefined as WMH volume ≥0.5% of total intracranial volume (ICV).bunavailable for 9 participants.cderived from FLAIR segmentation, available for 24 PiB−, 26 PiB+, 28 WMH−, 22 WMH+.dp-value from MANOVA, df = 1,55.ep-value from Pearson Chi-Square test.",2,articles/07c/pmcid_3675157/tables/table_000.csv
3675157,pone-0065175-t002,Table 2,Description of infarcts in 22 participants.,"1basal ganglia and/or thalamus.2midbrain, pons, medulla and/or cerebellum.",1,articles/07c/pmcid_3675157/tables/table_001.csv
3675157,pone-0065175-t003,Table 3,Least Squares Means FA values from 9 ROIs by PiB and WMH pathology statusa.,"aLeast squares means of FA values in PiB −/+ and WMH −/+ groups controlling for age, CDR, and presence of infarct.ap-values from MANCOVA, df = 1,50.",2,articles/07c/pmcid_3675157/tables/table_002.csv
3675157,pone-0065175-t004,Table 4,Effects of PiB positivity and WMH pathology on FA in subset of subjects with apoE genotypea.,"aPiB+WMH+: n = 13; PiB+WMH−: n = 14; PiB−WMH+: n = 14; PiB−WMH−: n = 16.bcontrolling for age, CDR, and presence of infarct, df = 1,41.cp-values from MANCOVA controlling for age, CDR, presence of infarct, and apoE ε4 status, df = 1,40.",2,articles/07c/pmcid_3675157/tables/table_003.csv
9720004,dad212381-tbl-0001,TABLE 1,Participant demographics,,1,articles/029/pmcid_9720004/tables/table_000.csv
9720004,dad212381-tbl-0002,TABLE 2,"Percentage of WM skeleton voxels with significant associations (positive: bold, negative: light, or none: blank) between CSF markers and diffusion parameters of WM microstructure (corrected for age, sex, and multiple comparisons across voxels, p < 0.05) in 213 participants",Note: That the associations between each DWI‐CSF marker pair were always in the same direction across WM voxels.,1,articles/029/pmcid_9720004/tables/table_001.csv
3534120,pone-0052859-t001,Table 1,Demographic and clinical characteristics of the sample groups.1,"Values are displayed as mean ± SD. M = male, F = female. CDR = Clinical Dementia Rating Scale; MMSE = Mini-mental state examination; CAMCOG = Cambridge Cognitive Examination; CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia;1Bonferroni correction;2Composite score with memory items from CAMCOG and MMSE.Post hoc analysis with Bonferroni correction:*AD vs CN, P<0.01; AD vs MCI, P<0.01; MCI vs CN, P<0.05;†AD vs CN, P<0.01; AD vs MCI, P<0.01; MCI vs CN, P>0.05;§AD vs CN, P<0.01; AD vs MCI, P<0.05; MCI vs CN, P>0.05;ΔAD vs CN, P<0.01; AD vs MCI and MCI vs CN, P>0.05.",1,articles/075/pmcid_3534120/tables/table_000.csv
3534120,pone-0052859-t002,Table 2,Brain volumetric comparisons with normalized values.,"WMH = white matter hyperintensities; CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia; volume expressed in mm3 (1) and ml (2).Post hoc analysis: *AD vs CN, P = 0.004; † AD vs CN, P = 0.013; † AD vs MCI, P = 0.009; § AD vs CN, P = 0.001; §AD vs MCI, P = 0.012; values are displayed as mean ± standard deviations;",1,articles/075/pmcid_3534120/tables/table_001.csv
3534120,pone-0052859-t003,Table 3,Correlation1 between FA values and Brain Volumetric variables from the voxelwise ROIs.,"Note - Values are Pearson Correlation coefficients; *statistical significance at level <0.05 (*) and <0.01 (**); CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia; NA = not assessed because WM tract was not statistical significant; R = right; L = left; IFOF = inferior fronto-occipito fasciculus; ILF = Inferior longitudinal fasciculus; SLF = superior longitudinal fasciculus.1FA values extracted from voxelwise region of interests (ROIs); for MCI the ROI from the contrast MCI versus controls (controlled for age and gender); for AD the ROI from the contrast AD versus control (controlled for gender, age and gray matter).2Volume in mm3.",3,articles/075/pmcid_3534120/tables/table_002.csv
9693894,table1-15500594211058263,Table 1.,Demographics and Disease-Related Variables of PD-MCI and PD-NC Groups.,"Abbreviations: PD-MCI, Parkinson's disease with mild cognitive impairment; PD-NC, Parkinson's disease with normal cognition; UPDRS, Unified Parkinson Disease Rating Scale.",2,articles/22e/pmcid_9693894/tables/table_000.csv
9693894,table2-15500594211058263,Table 2.,Cognitive Test Scores for PD-MCI and PD-NC Groups.,"Note. Block design, VF letters, D-KEFS VF categories, D-KEFS. TMT numbers, TMT switching, TMT motor, TMT scanning, and spatial span are scaled scores (M = 10, SD = 3). CVLT (single trial) and SDMT are Z-scores (M = 0, SD = 1). CVLT (total) is a T-score (M = 50, SD = 10).Abbreviations: CVLT, the California Verbal Learning Test; SDMT, the Symbol Digit Modalities Test; TMT, Trail Making Test; VF, Verbal Fluency.*p <.05.",1,articles/22e/pmcid_9693894/tables/table_001.csv
4927852,jad-48-4-jad150253-t001,Table 1,"Demographic, clinical and biomarker data of the population","Data are presented as mean (± standard deviation), except for the age range (years), HCA scores (n), and APOEɛ4 carriers (%). MMSE scores were only considered when the time lap between MMSE and the MRI scan was equal to or less than three months. An independent sample t-test was performed to compare the age, MMSE scores and CSF biomarker levels of the groups. Mann-Whitney U-tests were used to compare HCA and % APOEɛ4 carriers between the groups. AD, Alzheimer’s disease; MCI, mild cognitive impairment; CO, control; n, number; MoCA, Montreal Cognitive Assessment; APOE, apolipoprotein E; CSF, cerebrospinal fluid; HCA, hippocampal atrophy.  ***p <  0.001.",1,articles/1de/pmcid_4927852/tables/table_000.csv
4927852,jad-48-4-jad150253-t002,Table 2,Brain regions with one or more clusters reaching statistical significance (p <  0.05) after FWE correction on cluster level for multiple comparison in AD versus CO,"FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.",1,articles/1de/pmcid_4927852/tables/table_001.csv
3335803,pone-0035856-t001,Table 1,Demographic information of the sample.,"Demographic information and neuropsychological tests' scores. Chi square was used for gender comparison. One-way ANOVA test with Bonferroni correction for multiple comparisons was used for age, education-year, and MMSE score comparisons (significance level: : pcorr<0.05).a: Significant compared to aMCI and control groups;b: Significant compared to AD group.",1,articles/418/pmcid_3335803/tables/table_000.csv
3335803,pone-0035856-t002,Table 2,Results of the atlas-based analysis.,"Comparison between mean FA in the eight CC portions of the three groups of participants (groups 1–3), computed with atlas-based tractography. p-values refer to ANOVA test with correction for multiple comparisons, significance level: pcorr<0.05.",2,articles/418/pmcid_3335803/tables/table_001.csv
3335803,pone-0035856-t003,Table 3,Results of the skeleton-based analysis of the CC.,"Comparison between mean FA computed in the 8 CC skeleton portions of the three groups of participants (groups 1–3). p-values refer to ANOVA test with correction for multiple comparisons, significance level: pcorr<0.05.",2,articles/418/pmcid_3335803/tables/table_002.csv
3335803,pone-0035856-t004,Table 4,"Comparison between atlas-based tractography and TBSS in terms of overall percentage of correct pathology detection, sensitivity and specificity.","Overall percentage of correct pathology detection, sensitivity and specificity of the two experimented techniques in the detection of AD and aMCI from healthy controls and in the detection of AD from aMCI.",1,articles/418/pmcid_3335803/tables/table_003.csv
3335803,pone-0035856-t005,Table 5,80/20% Cross-validation of the logistic regression model.,"The overall percentage of correct pathology detection for the validation sample (unselected cases) was always no more than 10% lower than the accuracy rate for the training sample (selected cases), suggesting that the logistic regression model based on this analysis would be effective also applied to cases not included in the sample.",1,articles/418/pmcid_3335803/tables/table_004.csv
11063818,T1,Table 1.,Participants’ characteristics,"Data are presented as mean values followed by (standard deviations). Demographic and clinical variables were compared between groups using ANOVA or χ2 tests. CU, cognitively unimpaired; MCI, mild cognitive impairment; APOE ε4, apolipoprotein E ε4 allele; ADAS, Alzheimer's Disease Assessment Scale–Cognitive Subscale; VOSP, Visual Object and Space Perception Battery; TMT (B–A), trail making test Part B–A; SUVR, standardized uptake value ratio. Note that a higher ADAS score indicates poor memory performance.",2,articles/9ae/pmcid_11063818/tables/table_000.csv
10830492,Tab1,Table 1,Demographic of the participants.,Data is represented as mean ± SD unless otherwise indicated.SIVD = Subcortical ischemic vascular disease. AD = Alzheimer's disease. NC = normal cognition.§The Analysis of Variance (ANOVA) and Chi-square test are used wherever appropriate. Significant between-group differences are remarked as aSIVD vs. AD; bSIVD vs. NC; cAD vs. NC. Median of white matter hyperintensities (SIVD/AD/NC/overall) = (37.4/10.2/2.2/14.2) ml. Median of the lacune number (SIVD/AD/NC/overall) = (17/7/4/8).,2,articles/a54/pmcid_10830492/tables/table_000.csv
10830492,Tab2,Table 2,Diffusional kurtosis and diffusion tensor metrics from the average thalamus and the white matter measures by groups.,"Data is represented as mean ± SD unless otherwise indicated. Mean/axial/radial diffusivity is presented in units of 10−3mm2s−1. P value from the analysis of covariance (ANCOVA) with covariates including age, education, symptom duration, the volume of white matter hyperintensities, and the number of lacunes are reported. The Tukey post-hoc comparisons are remarked as a: SIVD vs. AD; b: SIVD vs. NC; c: AD vs. NC.FA = Fractional Anisotropy. KFA = Kurtosis Fractional Anisotropy. MD = Mean Diffusivity. Dradial = Radial Diffusivity. Daxial = Axial Diffusivity. MK = Mean Kurtosis. Kradial = Radial Kurtosis. Kaxial = Axial Kurtosis. SIVD = Subcortical ischemic vascular disease. AD = Alzheimer's disease. NC = normal cognition.Significant values are in bolditalics.",3,articles/a54/pmcid_10830492/tables/table_001.csv
10830492,Tab3,Table 3,"Discriminant analysis by diffusional kurtosis metrics, diffusion tensor metrics, and macroscopic imaging evaluation.","Data are reported by the value of correct classification (%). CDR = Clinical Dementia Rating. WMH = white matter hyperintensities. FA = fractional anisotropy. MD = mean diffusivity. MK = mean kurtosis. KFA = kurtosis fractional anisotropy. Daxial = axial diffusivity. Dradial = radial diffusivity. Kaxial = axial kurtosis. Kradial = radial kurtosis. SIVD = Subcortical ischemic vascular disease. AD = Alzheimer's disease. NC = normal cognition. Macroscopic imaging evaluation included the Scheltens scale and segregated WMH volume.†A total of 12 subregions averaged from bi-hemispheric ratings are used.*A total of 16 tracts including the corpus callosum (genu and body parts), and the anterior limb of internal capsule, anterior corona radiata, superior corona radiata, external capsule, cingulum (cingulate gyrus part), and superior longitudinal fasciculus of bi-hemispheres are used.§A total of 14 sub-regions of 
the thalamus including the pulvinar, anterior, mediodorsal, ventral–lateral–dorsal, central, ventral-anterior, and ventral–lateral–ventral nuclei are used. Cases number (SIVD/AD/NC): Overall = 42/50/30; CDR ≤ 0.5 = 25/22/30; WMH Volume ≤ 15 ml = 3/32/26; Lacunes ≤ 8 = 8/34/20.",2,articles/a54/pmcid_10830492/tables/table_002.csv
10830492,Tab4,Table 4,Estimated effect (β coefficients) of diffusional kurtosis and diffusion tensor metrics on global cognition (N = 122).,"Significant regions are reported by stepwise linear regression analysis, with independent variables including targeted imaging metrics showing significant correlation with the total scores of the Cognitive Abilities Screening Instrument. Metrics with a Variance inflation factor (VIF) ≥ 5 are removed. Estimated effect of all metrics is reported after controlling for age, education, symptom duration, the volume of white matter hyperintensities, and the number of lacunes.CIN = Cingulum. SCR = superior corona radiata. GCC = genu of the corpus callosum. A = anterior nuclei. C = central nuclei. P = pulvinar. VLD = ventral latero-dorsal. Medio = medio-dorsal. VA = ventral-anterior. R/L = Right/Left hemisphere. FA = fractional anisotropy. MD = mean diffusivity. MK = mean kurtosis. KFA = kurtosis fractional anisotropy. Daxial = axial diffusivity. Dradial = radial diffusivity. Kaxial = axial kurtosis. Kradial = radial kurtosis. Mean/axial/radial diffusivity variables are entered in units of 10−3mm2s−1.",2,articles/a54/pmcid_10830492/tables/table_003.csv
3760905,pone-0073280-t001,Table 1,Sociodemographic and clinical characteristics of patients and control subjects.,"HD = Huntington’s disease; Pre-HD = gene-positive, without motor symptoms; SD = standard deviation; df = degrees of freedom; CAG, trinucleotide repeat number; MMSE = Mini Mental State Evaluation; UHDRS = Unified Huntington’s Disease Rating Scale; TFC = total functional capacity; NA = not available; †† = T-student, Bonferroni correction.aPre-HD<HD (when referred to a cognitive scale comparison or CAG repetition, higher punctuations mean greater impairment).bPre-HD>HD (when referred to a cognitive scale comparison, higher punctuations mean lesser impairment).*MMSE: Missing data for 5 Pre-HD subjects & 5 HD patients.*UHDRS Motor: Missing data for 2 Pre-HD subjects & 2 HD patients.*UHDRS Cognitive: Missing data for 5 Pre-HD subjects & 2 HD patients.*UHDRS Behavioral: Missing data for 4 Pre-HD subjects & 2 HD patients.*UHDRS Functional: Missing data for 2 Pre-HD subjects & 2 HD patients.*TFC: Missing data for 2 Pre-HD subjects & 2 HD patients.",1,articles/474/pmcid_3760905/tables/table_000.csv
3760905,pone-0073280-t002,Table 2,Tractography Group Comparisons.,"HD = Huntington’s disease; Pre-HD = gene-positive, without motor symptoms.In bold: significant results after correction for multiple comparisons (FDR p<0.05).",2,articles/474/pmcid_3760905/tables/table_001.csv
8365836,T1,Table 1,Comparisons between the SCD and NC groups.,"*p < 0.05.**p < 0.01.IPAQ-SF, international physical activity questionnaire-short form; MET min/wk, metabolic equivalent task minute per week; MoCA, Montreal cognitive assessment; MMSE, mini-mental state examination; DSC, digit-symbol coding; DST, digit span test; LNS, letter-number sequencing; CF, category fluency; FMT, facial memory test.",1,articles/019/pmcid_8365836/tables/table_000.csv
8365836,T2,Table 2,"Correlations of clinical and diffusion indices in SCD (N = 31), significance at p < 0.05.","A correlation coefficient by Spearman's correlation coefficient (rs) in the 31 participants of the SCD group who agreed to undergo DTI study. This table summarized the statistically significant correlations at a confidence level of 95%.*p < 0.01.**A false discovery rate corrected p < 0.05.rs, Spearman's correlation coefficient; SCD, subjective cognitive decline; IPAQ-SF MET, metabolic equivalent (minute per week) of the international physical activity questionnaire-short form; MoCA, Montreal cognitive assessment; R, right; L, left; CST pyramids, pyramids segment of the corticospinal tract; PCR, posterior corona radiata; PTR, posterior thalamic radiation, including optic radiation; EC, external capsule; ICP, inferior cerebellar peduncle; AL-IC, anterior limb of internal capsule; SCP, superior cerebellar peduncle; Cin, cingulum; SFOF, superior fronto-occipital fasciculus; FA, fractional anisotropy; MD, mean diffusivity.",1,articles/019/pmcid_8365836/tables/table_001.csv
8365836,T3,Table 3,"Correlations of diffusion indices and actigraphy in SCD (N = 15), significance at p < 0.01.","The Spearman's correlation coefficients with p < 0.01 were considered statistically significant.*A false discovery rate corrected p < 0.05. The actigraphy was recorded by the wearing device (SOMNOwatchTM) for 72 activities in 15 SCD participants.rs, Spearman's correlation coefficient; SCD, subjective cognitive decline; FA, fractional anisotropy; PCR, posterior corona radiata; SCR, superior corona radiata.",2,articles/019/pmcid_8365836/tables/table_002.csv
8365836,T4,Table 4,Summary of the tract-specific white matter integrity related to physical activity and cognition in SCD.,"This table listed the tracts with at least one Spearman's correlation coefficient at a FDR-corrected p < 0.05.*p < 0.01.**A FDR-corrected p < 0.05.†Associations with both subjective and objective cognition.SCD, subjective cognitive decline; R, right; L, left; ICP, inferior cerebellar peduncle; CST pyramids, pyramids segment of corticospinal tract; PCR, posterior corona radiata; SCR, superior corona radiata; MoCA, Montreal cognitive assessment; IPAQ-SF MET, international physical activity questionnaire-short form, metabolic equivalent task minute per week; IV, intradaily variability; IS, interdaily stability; FA, fractional anisotropy; MD, mean diffusivity; FDR, false discovery rate.",2,articles/019/pmcid_8365836/tables/table_003.csv
8365836,T5,Table 5,Partial correlation analysis of diffusion indices and clinical scales by controlling physical-cognitive interaction in SCD.,"The partial correlation analysis tested the tracts in Table 4. This table only embraced the statistically significant partial correlations (p < 0.05, uncorrected). During partial correlation analysis, the cognitive-related diffusion indices were corrected with the diffusion indices of the physical activity-related tracts, and vice versa.*p < 0.05.**p < 0.01.***p < 0.001.†Controlled variables were the MD values of PCR (R), PCR (L), and SCR (R).¶Controlled variables were the FA values of ICP (R), ICP (L), and CST pyramids (R).rp, partial correlation coefficient; IV, intradaily variability; IS, interdaily stability; PCR, posterior corona radiata; SCR, superior corona radiata; ICP, inferior cerebellar peduncle; CST pyramids, pyramids segment of the corticospinal tract; L, left; R, right; FA, fractional anisotropy; MD, mean diffusivity.",1,articles/019/pmcid_8365836/tables/table_004.csv
11144950,hbm26704-tbl-0001,TABLE 1,Demographic table.,"Note: Patients' demographics. p‐Values are from Wilcoxon Rank Sum tests or Fisher's Exact tests where appropriate. The bold value represent a significant Wilcoxon Rank Sum tests p < .001. Data shown are median (IQR) or n (%).Abbreviations: AES, Articulatory Error Score; ASRS v3, Apraxia of Speech Rating Scale version 3; CPIB, communicative participation item bank; MDS‐UPDRS III, Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐motor subscale; MoCA, Montreal Cognitive Assessment; WAB praxis, Western Aphasia Battery‐praxis component; WAB‐AQ, Western Aphasia Battery‐Aphasia Quotient (AQ).",1,articles/c3e/pmcid_11144950/tables/table_000.csv
11144950,hbm26704-tbl-0002,TABLE 2,Comparative AUROC analysis from DTI (WM) and Tau‐PET parameters.,"Note: AUROC analysis from DTI and flortaucipir PET parameters.Abbreviations: AF, arcuatus fasciculi; AUC, area under the receiving operator curve; FA, fractional anisotropy; FAT, frontal aslant tract; IFOF, inferior frontal‐occipital fasciculi; ILF, inferior longitudinal fasciculus; L, left; LN, language network; MD, mean diffusivity; MLF, middle longitudinal fasciculi; R, right; s.e.m., standard error of the mean; SLN, speech and language network; SMA, supplementary motor area; WM, white matter.",2,articles/c3e/pmcid_11144950/tables/table_001.csv
11144950,hbm26704-tbl-0003,TABLE 3,Comparative AUROC analysis from WM META‐ROI tracts.,"Note: AUROC and p‐values (parenthesis) are included in the analysis.Abbreviations: META‐ROI, average value from DTI‐driven probabilistic ROIs along WM tracts across the entire cohort; SMA, supplementary motor area.",1,articles/c3e/pmcid_11144950/tables/table_002.csv
11077244,brb33533-tbl-0001,TABLE 1,Various clinical features of Alzheimer's patients with and without Type 2 diabetes mellitus (T2DM).,"Note: Normally distributed continuous variables were presented as mean (SD), nonnormally distributed continuous variables were presented as median (Q1–Q3), Categorical variables were presented as counts (percentages).Abbreviations: AD, Alzheimer's disease; eGFR, estimated glomerular filtration rate; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio.",1,articles/7c1/pmcid_11077244/tables/table_000.csv
11077244,brb33533-tbl-0002,TABLE 2,Linear regression analysis of variables associated with changes in extractions in the left superior longitudinal fasciculus.,"Note: Adjusted R square: Model 1 = .122, Model 2 = .100, Model 3 = .069.",2,articles/7c1/pmcid_11077244/tables/table_001.csv
6411581,t0005,Table 1,Demographics of the Wisconsin Registry for Alzheimer's Prevention (WRAP) and the Wisconsin Alzheimer's Disease Research Center (ADRC).,,1,articles/89f/pmcid_6411581/tables/table_000.csv
6411581,t0010,Table 2,"Connections identified using ptau × ∆Time as a predictor for longitudinal changes in WaCSMD (multiple comparisons corrected using Bonferroni at 0.05) sorted by corresponding p-values (column 1–3), and the correlation between simple MD changes and ptau × ∆Time on the identified connections (column 4). Two ROIs (i.e., ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.","ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal, tran/transv: transverse, frontopol: frontopolar.",1,articles/89f/pmcid_6411581/tables/table_001.csv
6411581,t0015,Table 3,"Connections identified using neurogranin × ∆Time as a predictor for longitudinal changes in WaCSMD (multiple comparisons corrected using Bonferroni at 0.05) sorted by corresponding p-values (column 1–3), and the correlation between simple MD changes and neurogranin × ∆Time on the identified connections (column 4). Two ROIs (i.e., ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.","ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal, tran/transv: transverse, frontopol: frontopolar.",1,articles/89f/pmcid_6411581/tables/table_002.csv
6411581,t0020,Table 4,"Connections identified using neurogranin × ∆Time as a predictor for longitudinal changes in WaCSFA (multiple comparisons corrected using Bonferroni at 0.05) sorted by corresponding p-values (column 1–3), and the correlation between simple FA changes and neurogranin × ∆Time on those identified connections (column 4). Two ROIs (i.e., ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.","ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal, tran/transv: transverse, frontopol: frontopolar.",1,articles/89f/pmcid_6411581/tables/table_003.csv
11782200,alz14371-tbl-0001,TABLE 1,Demographics for ADNI and NIMHANS data used in this study.,"Abbreviations: ADNI, Alzheimer's Disease Neuroimaging Initiative; CN, cognitively normal; MCI, mild cognitive impairment; NIMHANS, National Institute of Mental Health and Neurosciences.",1,articles/5c2/pmcid_11782200/tables/table_000.csv
11335656,tab1,Table 1,Complete subject characteristics.,"*One female removed due to motion (with no APO-E data). SD, standard deviation; MMSE, Mini-Mental State Examination; GDS, Geriatric Depression Scale; CDR, Clinical Dementia Rating; FAQ, Functional Activities Questionnaire; APO-E, Apolipoprotein E.",1,articles/7c8/pmcid_11335656/tables/table_000.csv
11335656,tab2,Table 2,Results for fw-DTI ((A) f index and (B) fw-FA).,"Only significant clusters with large effect size (g > 0.61) are presented. Comprehensive results, including medium and lower effect sizes, can be found in Supplementary Tables S1, S2. Vol (%): Percentage of the cluster’s volume within the respective white matter area, <t>: Mean t value within the cluster; gmax: Maximum g value within the cluster.",5,articles/7c8/pmcid_11335656/tables/table_001.csv
11335656,tab3,Table 3,Results for DKI ((A) MKT and (B) KFA).,"Only significant clusters with large effect size (g > 0.61) are presented. Comprehensive results, including medium and lower effect sizes, can be found in Supplementary Tables S3, S4. Vol (%): Percentage of the cluster’s volume within the respective white matter area, <t>: Mean t value within the cluster; gmax: Maximum g value within the cluster.",5,articles/7c8/pmcid_11335656/tables/table_002.csv
11335656,tab4,Table 4,"Results for DKI ((A) MK, (B) AK, and (C) RK).","Only significant clusters with large effect size (g > 0.61) are presented. Comprehensive results, including medium and lower effect sizes, can be found in Supplementary Tables S5–S7. Vol (%): Percentage of the cluster’s volume within the respective white matter area, <t>: Mean t value within the cluster; gmax: Maximum g value within the cluster.",5,articles/7c8/pmcid_11335656/tables/table_003.csv
11335656,tab5,Table 5,Results for MSDKI ((A) MSD and (B) MSK).,"Only significant clusters with large effect size (g > 0.61) are presented. Comprehensive results, including medium and lower effect sizes, can be found in Supplementary Tables S8, S9. Vol (%): Percentage of the cluster’s volume within the respective white matter area, <t>: Mean t value within the cluster; gmax: Maximum g value within the cluster.",5,articles/7c8/pmcid_11335656/tables/table_004.csv
11335656,tab6,Table 6,Voxel-based correlations between fw-DTI metrics (f-index and fw-FA) and MMSE scores at FDR > 0.05.,"Large significant clusters with negative correlations were found for f-index. Vol (%): Percentage of the cluster’s volume within the respective white matter area; <t>: Mean t-value within the cluster. Effect sizes were determined using Spearman’s correlation coefficient (ρ), with a large effect size defined as ρ > 0.44. <ρ>: Mean Spearman’s correlation coefficient within the significant clusters. Ρmin and ρmax: Minimum and maximum values of the Spearman’s correlation coefficient within the significant clusters, respectively.",4,articles/7c8/pmcid_11335656/tables/table_005.csv
11335656,tab7,Table 7,Voxel-based correlations between DKI metrics (MKT and KFA) and MMSE scores at FDR > 0.05.,"Vol (%): Percentage of the cluster’s volume within the respective white matter area; <t>: Mean t-value within the cluster. Effect sizes were determined using Spearman’s correlation coefficient (ρ), with a large effect size defined as ρ > 0.44. <ρ>: Mean Spearman’s correlation coefficient within the significant clusters. Ρmin and ρmax: Minimum and maximum values of the Spearman’s correlation coefficient within the significant clusters, respectively.",3,articles/7c8/pmcid_11335656/tables/table_006.csv
11335656,tab8,Table 8,"Voxel-based correlations between DKI metrics (MK, AK, and RK) and MMSE scores at FDR > 0.05.","Vol (%): Percentage of the cluster’s volume within the respective white matter area; <t>: Mean t-value within the cluster. Effect sizes were determined using Spearman’s correlation coefficient (ρ), with a large effect size defined as ρ > 0.44. <ρ>: Mean Spearman’s correlation coefficient within the significant clusters. Ρmin and ρmax: Minimum and maximum values of the Spearman’s correlation coefficient within the significant clusters, respectively.",4,articles/7c8/pmcid_11335656/tables/table_007.csv
11335656,tab9,Table 9,Voxel-based correlations between MSDKI metrics and MMSE scores at FDR > 0.05.,"Large significant clusters with negative correlations were found for MSD. Vol (%): Percentage of the cluster’s volume within the respective white matter area; <t>: Mean t-value within the cluster. Effect sizes were determined using Spearman’s correlation coefficient (ρ), with a large effect size defined as ρ > 0.44. <ρ>: Mean Spearman’s correlation coefficient within the significant clusters. Ρmin and ρmax: Minimum and maximum values of the Spearman’s correlation coefficient within the significant clusters, respectively.",5,articles/7c8/pmcid_11335656/tables/table_008.csv
10448214,t0005,Table 1,Demographic characterstics of participants in the PREDICT-HD and IMAGE-HD datasets used in this study.,"Note: UHDRS represents Unified Huntington’s Disease Rating Scale; TMS represents Total Motor Score; SDMT represents Symbol-Digit Modalities Test; BDI represents Beck Depression Inventory. *CAP scores and cut-offs for low - med - high groups as in (Zhang, 2011).",2,articles/9fc/pmcid_10448214/tables/table_000.csv
10448214,t0010,Table 2,Demographic characteristics of subjects in control and HD groups used for the comparisons between curves of DTI indices vs. age.,,1,articles/9fc/pmcid_10448214/tables/table_001.csv
10448214,t0015,Table 3,Change points of diffusivity indices in the deep gray and white matter.,Note: * indicates no significant difference between sigmoidal and linear models fitting the specific DTI index over CAP scores in the region in question. The results are still presented in this table for the sake of consistency.,2,articles/9fc/pmcid_10448214/tables/table_002.csv
10448214,t0020,Table 4,"P-value of the comparisons between curves of DTI indices vs. age, for controls and HD individuals (CAG repeat 41–42) groups, age-balanced.",Note: * indicates no significant difference between curves of controls and HD after correction for multiple comparisons.,1,articles/9fc/pmcid_10448214/tables/table_003.csv
4053649,tbl1,Table 1,"Demographics, vascular risk and cognitive function among risk groups.","Cognitive factor scores were derived from a factor analytic study of the WRAP neuropsychological battery. Individual neuropsychological tests loaded onto separate factors. Rey Auditory Verbal Learning Test (Spreen and Strauss, 1998), Trials 1 and 2 loaded onto  the Immediate Memory factor. Rey Auditory Verbal Learning Test (Spreen and Strauss, 1998), Trials 3–5 and Delayed Recall Trial loaded onto the Verbal Learning and Memory factor.  Wechsler Adult Intelligence Scale—3rd edition (Wechsler, 1997), Digit Span, Arithmetic, and Letter-Numbering Sequencing subtests loaded onto the Working Memory factor. The interference trial from the Stroop test (Trenerry, 1989), and Trail Making Test A and B (Reitan and Wolfson, 1993) loaded onto the Speed and Flexibility factor. The Speed and Flexibility factor score was unavailable for nine participants. The ANCOVA for cognitive function controlled for age, years of education, and sex. APOE4: apolipoprotein epsilon 4 allele; FH: family history of Alzheimer's disease; M: mean; SD: standard deviation; BP: blood pressure; BMI: body mass index; HDL: high density lipoprotein. Missing data: A sub-set of participants did not have vascular risk factors available; blood pressure, BMI, and cholesterol were missing for one participant, insulin was missing for 12 participants, and HDL and glucose were missing for 11 participants.",2,articles/00c/pmcid_4053649/tables/table_000.csv
5200876,t0005,Table 1,Participant demographics at baseline and year one.,⁎t-Tests used to obtain p-values.,2,articles/49c/pmcid_5200876/tables/table_000.csv
5200876,t0010,Table 2,Number and percentage of total significant voxels in regions with significantly (decreased) fractional anisotropy and/or (increased) mean diffusivity at year one compared to baseline in individuals with Alzheimer's disease and in healthy controls.,,2,articles/49c/pmcid_5200876/tables/table_001.csv
5200876,t0015,Table 3,Number and percentage of total significant voxels in regions with low fractional anisotropy and high mean diffusivity in individuals with Alzheimer's disease (AD) compared to healthy controls (HC) at baseline and at year one.,,2,articles/49c/pmcid_5200876/tables/table_002.csv
6872975,T1,TABLE 1,"Gender-related differences in demographic and clinical data, radiological parameters, and APOE status.",,2,articles/a7f/pmcid_6872975/tables/table_000.csv
3132541,tab1,Table 1,Demographic and clinical data summary.,"
							avalue for one subject is missing.
							bvalue for two subjects is missing.
							cvalue for 8 subjects is missing. WMSH = white matter signal hyperintensities.",1,articles/c19/pmcid_3132541/tables/table_000.csv
11111894,tab1,Table 1,Demographic characteristics of the control and subjective cognitive decline (SCD) groups.,"There were no between-group differences in sex, age, income, or years of education.",1,articles/068/pmcid_11111894/tables/table_000.csv
11111894,tab2,Table 2,Between-group comparison in memory performance.,"MMSE, Mini-Mental State Exam. **p < 0.01. & One control participant is missing MMSE scores. However, they scored normally on story recall and denied any memory problems. Thus, we opted to include them in the analysis.",1,articles/068/pmcid_11111894/tables/table_001.csv
11111894,tab3,Table 3,Mean cortical thickness for temporal regions of interest (in mm) for the control and subjective cognitive decline (SCD) groups.,"Between-group comparisons indicate decreased cortical thickness in SCD in left and right entorhinal cortices and the right temporal pole. *p < 0.05 and **p < 0.01. & There were 327 participants over the age of 55 with anatomical T1w images available. Two control participants and three SCD participants were excluded from the cortical thickness and brain structure volume analyses due to segmentation errors, for a total of 322 segmentations as detailed in this table.",1,articles/068/pmcid_11111894/tables/table_002.csv
11111894,tab4,Table 4,Regional diffusion metric mean values for the subjective cognitive decline (SCD) and control groups in the left and right lower cingulum.,No significant between-group differences are noted for any of the metrics. Diffusivity values are reported with units of 10−3 mm2/s.,1,articles/068/pmcid_11111894/tables/table_003.csv
9616370,utbl0001,,,,1,articles/3fd/pmcid_9616370/tables/table_000.csv
9616370,tbl0001,Table 1,Overview of data collection per visit.,,1,articles/3fd/pmcid_9616370/tables/table_001.csv
9616370,tbl0002,Table 2,"Inclusion and exclusion criteria for patients with sporadic SVDs, CADASIL and healthy controls.",,1,articles/3fd/pmcid_9616370/tables/table_002.csv
9616370,tbl0003,Table 3,"Neuropsychological tests and questionnaires in fixed order. MMSE= Mini-Mental State Examination, CES-D= Center for Epidemiological Studies Depression Scale.",,1,articles/3fd/pmcid_9616370/tables/table_003.csv
9616370,tbl0004,Table 4,3T brain MRI protocol. GE= gradient echo; TSE= turbo spin echo; FLAIR= Fluid attenuated inversion recovery; DTI= diffusion tensor imaging; BOLD= Blood oxygenation level-dependent; rs-fMRI= resting state functional magnetic resonance imaging; Qflow = quantitative flow; (pC)ASL= (pseudoContinuous) Arterial spin labeling; SWI= susceptibility weighted imaging; FOV= Field of view; TE= Echo Time; TI= Inversion Time; TR= Repetition Time.,,1,articles/3fd/pmcid_9616370/tables/table_004.csv
9616370,tbl0005,Table 5,7T brain MRI protocol in fixed order. CSO= Semioval centre; BG= Basal Ganglia; M1= first segment of the middle cerebral artery; BOLD= Blood oxygenation level-dependent; fMRI= functional magnetic resonance imaging; FOV= Field of view; TE= Echo Time; TI= Inversion Time; TR= Repetition Time. *Total scan time for a heart rate of 80 bpm.,"aA fast version of the T1-weighted sequence was added multiple times to assess potential subject motion during the scan, particularly after repositioning for attaching the mask for the hypercapnic challenge.",1,articles/3fd/pmcid_9616370/tables/table_005.csv
5349685,pone.0173982.t001,Table 1,"Summary demographics, cognitive data, and CSF measures from the included participants.",,1,articles/a77/pmcid_5349685/tables/table_000.csv
5349685,pone.0173982.t002,Table 2,Linear Pearson Correlation between biomarkers and age.,Significant correlations at P < 0.05 (*) and P < 0.001 (†) after Bonferroni correction are noted.,1,articles/a77/pmcid_5349685/tables/table_001.csv
5349685,pone.0173982.t003,Table 3,Diffusion metrics of tracts.All values are listed as mean ± standard deviation.,,2,articles/a77/pmcid_5349685/tables/table_002.csv
5349685,pone.0173982.t004,Table 4,DTI tractography results.,All results with an uncorrected P ≤ 0.05 along with the false discovery rate α value.,1,articles/a77/pmcid_5349685/tables/table_003.csv
5349685,pone.0173982.t005,Table 5,FWE-DTI tractography results.,All results with an uncorrected P ≤ 0.05 along with the false discovery rate α value.,1,articles/a77/pmcid_5349685/tables/table_004.csv
5349685,pone.0173982.t006,Table 6,Listing of all significant clusters for which the FWE-DTI f-value was correlated to one of the predictors.,"Information presented for each cluster includes diffusion metric and the related biomarker, relevant white matter region, MNI coordinates (in mm) of the peak t-value, and the cluster size (k). An explicit cluster size threshold is not needed when using TFCE as this threshold is strictly for reporting.",1,articles/a77/pmcid_5349685/tables/table_005.csv
5349685,pone.0173982.t007,Table 7,Listing of all significant clusters for which the DTI MD was correlated to one of the predictors.,"Information presented for each cluster includes diffusion metric and the related biomarker, relevant white matter region, MNI coordinates (in mm) of the peak t-value, and the cluster size (k). An explicit cluster size threshold is not needed when using TFCE as this threshold is strictly for reporting.",1,articles/a77/pmcid_5349685/tables/table_006.csv
5349685,pone.0173982.t008,Table 8,The total extent of significant voxels (mm3).,,1,articles/a77/pmcid_5349685/tables/table_007.csv
5349685,pone.0173982.t009,Table 9,The percent overlap between the significant finding maps using the FWE-DTI f-value.,"These are computed as the percent of the smaller map, which overlaps with the larger map.",1,articles/a77/pmcid_5349685/tables/table_008.csv
5349685,pone.0173982.t010,Table 10,The percent overlap between the significant finding maps using the DTI MD.,"These are computed as the percent of the smaller map, which overlaps with the larger map.",1,articles/a77/pmcid_5349685/tables/table_009.csv
7235062,Tab1,Table 1,Baseline clinical and MRI characteristics of the total cohort and comparison of subgroups according to the median split of the cavitation index,"*Sum of periventricular (0–3) and deep (0–3) WMH scores#Available in 42 patients (n = 22 with cavitation index ≤ 7%; n = 20 with cavitation index > 7%)SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; FU, follow-up; RSSI, recent small subcortical infarct; PVS, perivascular spaces; IQR, interquartile range; ACE-R, Addenbrooke’s Cognitive Examination Revised",2,articles/696/pmcid_7235062/tables/table_000.csv
7235062,Tab2,Table 2,Bivariate correlations of clinical and MRI parameters with cavitation index,"*BBB analyses were available in 59 patients (DCE data not available for 1 patient)# Available in 42 patientsNIHSS, National Institutes of Health Stroke Scale; AUC, area under the curve; RSSI, recent small subcortical infarct; DTI, diffusion tensor imaging; WMH, white matter hyperintensities; MD, mean diffusivity; FA, fractional anisotropy; ACE-R, Addenbrooke’s Cognitive Examination Revised",1,articles/696/pmcid_7235062/tables/table_001.csv
11872816,Tab1,Table 1,Characteristics of the participants,"GDS Geriatric Depression Scale, MLF middle longitudinal fasciculus, MMSE Mini Mental Status Exam, IFO inferior fronto-occipital fasciculus, SNR signal-to-noise ratioNote. Continuous variables are presented as the mean (standard deviation) and categorical variables as numbers (percentages)*Mann–Whitney U test for continuous variables and Fisher’s exact test for categorical variablesaRatio of the power of steady-state visually evoked potential at the frequency of administered flickering light",1,articles/86d/pmcid_11872816/tables/table_000.csv
11872816,Tab2,Table 2,Effects of the microstructural integrity of white matter tracts on the spectral Granger causality of gamma connectivity from visual cortex to other brain regions,"AxD axial diffusivity, ERSOz event-related synchronization of gamma rhythms at Oz, FA fractional anisotropy, IFO inferior fronto-occipital fasciculus, MD mean diffusivity, MLF middle longitudinal fasciculus, SE standard error, RD radial diffusivity, ΔR2 change in the R2 between stepsaForward stepwise multiple linear regression analyses computing the spectral Granger causality of gamma rhythm connectivity from left occipital to left temporocentral region as a dependent variable and ERSOz and one of FA, MD, RD, or AxD of left MLF as independent variablesbForward stepwise multiple linear regression analyses computing the spectral Granger causality of gamma rhythm connectivity from right occipital to right temporocentral region as a dependent variable and ERSOz and one of FA, MD, RD, or AxD of right MLF as independent variablescForward stepwise multiple linear regression analyses computing the spectral Granger causality of gamma rhythm connectivity from left occipital to left frontal region as a dependent variable and ERSOz and one of FA, MD, RD, or AxD of left IFO as independent variablesdForward stepwise multiple linear regression analyses computing the spectral Granger causality of gamma rhythm connectivity from right occipital to right frontal region as a dependent variable and ERSOz and one of FA, MD, RD, or AxD of right IFO as independent variables",2,articles/86d/pmcid_11872816/tables/table_001.csv
9693722,T1,TABLE 1,Summary of clinical and neuroimaging data.,"Kruskal Wallis and ANOVA were used to investigate differences across the three groups, as appropriate.†Six missing values.We reported the original p-values and, when significant differences were found, we ran FDR-adjusted pairwise comparisons: *FDR-adjusted p < 0.05.**FDR-adjusted p < 0.01.***FDR-adjusted p < 0.001.‡No statistical significance in pairwise comparisons, after FDR-correction.SD, standard deviation; IQR, interquartile range; MMSE, mini mental state examination; CMB, cerebral microbleeds; cSS, cortical superficial siderosis; CMI, cerebral microinfarcts; CSO-PVS, perivascular spaces in the centrum semiovale; BG-PVS, perivascular spaces in the basal ganglia; nWMHV, normalized white matter hyperintensity volume; nTBV, normalized total brain volume; CAA, cerebral amyloid angiopathy; cSVD, cerebral small vessel disease; PSMD, peak width of skeletonized mean diffusivity. Probable-CAA, patients fulfilling the modified Boston criteria for Probable CAA; cSVD, patients with neuroimaging markers of cSVD not attributable to CAA—presumed arteriolosclerosis; non-cSVD, patients without neuroimaging markers of cSVD.aNon-cSVD group; bcSVD group; CProbable CAA group.",2,articles/051/pmcid_9693722/tables/table_000.csv
6801158,acn350877-tbl-0001,Table 1,"Demographics, clinical, and imaging features of included PDD subjects.",,1,articles/dda/pmcid_6801158/tables/table_000.csv
4305215,tbl1,Table 1,Study Participants' Clinical and Imaging Characteristics,aLinear regression comparing controls with all bvFTD subjects.bFisher exact test.cWilcoxon rank sum test.BBSI = brain boundary shift integral; bvFTD = behavioral variant frontotemporal dementia; C9ORF72 = chromosome 9 open-reading frame 72; F = female; M = male; MAPT = microtubule-associated protein tau; MMSE = Mini-Mental State Examination; SD = standard deviation; TIV = total intracranial volume.,2,articles/3ed/pmcid_4305215/tables/table_000.csv
4305215,tbl2,Table 2,Study Participants' Neuropsychological Performance at Baseline and Follow-up,"Scores shown are raw scores for each test with maximum scores shown in parentheses. Probability values denote significance level comparing behavioral scores (raw score at baseline and change from baseline over time) of all bvFTD participants with control participants after adjustment for age, gender, and disease duration.aTotal scores on the TASIT are scaled scores.vFTD = behavioral variant frontotemporal dementia; CI = confidence interval; DKEFS = Delis–Kaplan Executive Frontal System; PIQ = performance intelligence quotient; SD = standard deviation; TASIT = Awareness of Social Inference Test; VIQ = verbal intelligence quotient; WASI = Wechsler Abbreviated Scale of Intelligence.",3,articles/3ed/pmcid_4305215/tables/table_001.csv
4305215,tbl3,Table 3,Baseline Diffusion Tensor Imaging Metric Data for Individual White Matter Regions of Interest for Control Participants and Patients,"aLinear regression comparing bvFTD with controls after adjusting for age, gender, and disease duration.vFTD = behavioral variant frontotemporal dementia; FA = fractional anisotropy; L = left; MD = mean diffusivity; R = right; SCP = superior cerebellar peduncle; SD = standard deviation.",2,articles/3ed/pmcid_4305215/tables/table_002.csv
4305215,tbl4,Table 4,"Estimated Percentage per Year Difference in the Rate of Change of FA and MD for bvFTD Patients and bvFTD Subgroups, by Region, Compared with Controls",bvFTD = behavioral variant frontotemporal dementia; C9ORF72 = chromosome 9 open-reading frame 72; CC = corpus callosum; CI = confidence interval; FA = fractional anisotropy; L = left; MAPT = microtubule-associated protein tau; MD = mean diffusivity; R = right; SCP = superior cerebellar peduncle.,2,articles/3ed/pmcid_4305215/tables/table_003.csv
4305215,tbl5,Table 5,Sample Size Estimatesa per Treatment Arm of a Clinical Trial Comparing 3 Different Outcome Measures to Detect a 20 to 50% Reduction in Rates of Change,"Sample size estimates have been adjusted for control rates of change.aβ = 80%, α = 0.05.AX = axial diffusivity; BBSI = brain boundary shift integral (a measure of whole brain atrophy); DTI = diffusion tensor imaging; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity.",3,articles/3ed/pmcid_4305215/tables/table_004.csv
9292816,gps5540-tbl-0001,TABLE 1,Demographic characteristics and cognitive test scores across groups,"Abbreviations: AD, AD‐dementia; ADNI_EF, executive functioning composite score; ADNI_MEM, memory composite score; M, mean; MBI, mild behavioral impairment; MCI, mild cognitive impairment; NC, normal cognition; SD, standard deviation.",1,articles/094/pmcid_9292816/tables/table_000.csv
9292816,gps5540-tbl-0002,TABLE 2,"Simple effect of MBI on regions of interest for DTI parameters from linear mixed‐effects regression analysis controlling for age, sex, education, psychotropic medication use, and disease diagnosis (MCI, AD, or NC)","Abbreviations: AD, AD‐dementia; AxD, axial diffusivity; CGC, cingulum; CGH, cingulum (hippocampus); F, female; FA, fractional anisotropy; FX, fornix; IFO, inferior fronto‐occipital fasciculus; M, male; MCI, mild cognitive impairment; MD, mean diffusivity; MBI+, presence of impulse dyscontrol symptoms; NC, normal cognition; RD, radial diffusivity; SFO, superior fronto‐occipital fasciculus; SE, standard error; UNC, uncinate fasciculus.",2,articles/094/pmcid_9292816/tables/table_001.csv
9292816,gps5540-tbl-0003,TABLE 3,"Simple effect of MBI on regions of interest for cortical thickness, surface area, and volume from linear mixed‐effects regression analysis controlling for age, sex, education, psychotropic medication use, and disease diagnosis (MCI, AD, or NC)","Abbreviations: MBI+, presence of MBI impulse dyscontrol symptoms; SE, standard error.",2,articles/094/pmcid_9292816/tables/table_002.csv
10638840,j_biol-2022-0714_tab_001,Table 1,Demographically based clinical and neuropsychological discovery data,"a – Significant in comparison to NCs. b – Notable dissimilarity in comparison to those with a typical MCI. c – The average of the best three recalls scores. d – The results of a five-minute delayed recall test. e – Nineteen people with AD, two with aMCI, and one without dementia did not or would not finish the test.",1,articles/cc8/pmcid_10638840/tables/table_000.csv
10638840,j_biol-2022-0714_tab_002,Table 2,Demographically based clinical and neuropsychological replicated data,"a – Significant in comparison to NCs. b – Notable dissimilarity in comparison to those with a typical MCI. c – The average of the best three recalls scores. d – The results of a five-minute delayed recall test. e – Nineteen people with AD, two with aMCI, and one without dementia did not or would not finish the test.",1,articles/cc8/pmcid_10638840/tables/table_001.csv
10638840,j_biol-2022-0714_tab_003,Table 3,Performance analysis of the accuracy,,2,articles/cc8/pmcid_10638840/tables/table_002.csv
10638840,j_biol-2022-0714_tab_004,Table 4,Performance analysis of the specificity,,2,articles/cc8/pmcid_10638840/tables/table_003.csv
10638840,j_biol-2022-0714_tab_005,Table 5,Performance analysis of the specificity,,2,articles/cc8/pmcid_10638840/tables/table_004.csv
5167220,Tab1,Table 1,"Demographic information for the 33 healthy controls, 20 bvFTD and 23 EOAD patients studied here. The mean age, breakdown by sex and Mini Mental State Examination (MMSE) scores are listed for each diagnostic group",,1,articles/f6e/pmcid_5167220/tables/table_000.csv
5167220,Tab2,Table 2,Representative fiber bundles,"The corpus callosum tracts are divided into 6 distinct segments: frontal, temporal, parietal, occipital, precentral gyrus and postcentral gyrus. The SLF tract was only traced in the left hemisphere as it tends to be highly asymmetrical in population studies (Catani et al. 2007). For each fiber tract, we indicate the total number of fibers included in the atlas template that we used for our population studies",1,articles/f6e/pmcid_5167220/tables/table_001.csv
5167220,Tab3,Table 3,Comparisons between dementia groups and healthy controls,"bvFTD participants showed severe deficits, most frequently detected as decreases in FA (↓) (FDR critical P = 0.024), increases in MD (↑) (FDR critical P = 0.035), RD (FDR critical P = 0.034) and AX (FDR critical P = 0.019). Most affected tracts in bvFTD were the L-UNC, R-UNC, CC-FNR, L-ATR, R-ATR, L-CGC, R-CGC and L-SLF (Fig. 2). EOAD participants showed significant decreases in FA (FDR critical P = 1.5 × 10−3), increases in MD (FDR critical P = 0.01), RD (FDR critical P = 9.2 × 10−3) and AX (FDR critical P = 5.2 × 10−3). The L-PHC, R-PHC and CC-PAR stood out as most affected (Fig. 3). The percentage of tracts that passed FDR threshold is listed and total effect size (r) computed across each fiber",2,articles/f6e/pmcid_5167220/tables/table_002.csv
11345637,hbm26805-tbl-0001,TABLE 1,Demographics and clinical characteristics of the study population.,"Note: Data are presented as median (Q1, Q3). N represents the number of patients. p values reported in bold denote statistical significance at p < .05 (Kruskal‐Wallis test, FDR corrected).Abbreviations: Aβ42, amyloid β 42; AD, Alzheimer's disease patients; CU, cognitively unimpaired subjects; GMVF, gray matter volume fraction; MCI, mild cognitive impairment patients; MMSE, Mini‐Mental State Examination; nAD, non Alzheimer's disease degenerative patients; P‐tau, phosphorylated tau; T‐tau, total tau; WMLVF, white matter lesion volume fraction.",2,articles/743/pmcid_11345637/tables/table_000.csv
6390411,T1,Table 1,"Demographic and clinical measures for participants in Alzheimer’s Disease Neuroimaging Initiative (ADNI3), subdivided by diffusion-weighted MRI (dMRI) protocol.","We report the average age, Mini-Mental State Examination (MMSE), Clinical Dementia Rating scale sum-of-boxes (CDR-sob), and AD Assessment scale 13 (ADAS-cog) measures, and their standard deviations. *Data not available for all participants: MMSE N = 315; CDR-sob N = 316 and ADAS-cog N = 278. +We recognize the limitations of these assessments as proxy measures of specific cognitive abilities (Balsis et al., 2015).",3,articles/d04/pmcid_6390411/tables/table_000.csv
6390411,T2,Table 2,ADNI diffusion MRI acquisition protocols.,"*Reflects the time to acquire the full multi-shell protocol (127 volumes), not the single-shell subset.",1,articles/d04/pmcid_6390411/tables/table_001.csv
6390411,T3,Table 3,"The following 24 regions of interest (ROIs) from the Johns Hopkins University (JHU) atlas (Mori et al., 2008) were analyzed.",,1,articles/d04/pmcid_6390411/tables/table_002.csv
11497707,alz14158-tbl-0001,TABLE 1,Demographic and clinical data for patients with FTD and healthy controls,"Abbreviations: bvFTD, behavioral variant frontotemporal dementia; CDR, Clinical Dementia Rating; FTD, frontotemporal dementia; MMSE, Mini‐Mental State Examination; nfvPPA, nonfluent variant primary progressive aphasia; svPPA, semantic variant primary progressive aphasia.",1,articles/311/pmcid_11497707/tables/table_000.csv
11497707,alz14158-tbl-0002,TABLE 2,WMH volumes in patients with FTD compared with healthy controls,"Abbreviations: bvFTD: behavioral variant frontotemporal dementia; FTD, frontotemporal dementia; L, left; nfvPPA, nonfluent variant primary progressive aphasia; R, right; svPPA, semantic variant primary progressive aphasia; WM, white matter; WMH, white matter hyperintensity.aIndicates that there was a significant difference in the corresponding metric between the patient group and its matched healthy controls (p < 0.05); data represent median (25% fraction, 75% fraction).",1,articles/311/pmcid_11497707/tables/table_001.csv
9194644,t0005,Table 1,"Participants baseline characteristics. Mean (SD) and Count (%) for continuous and categorical variables, respectively.",The final samples shown in the table are the total samples utilized. Abbreviations: APOE e4: Apolipoprotein E epsilon 4; BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycated hemoglobin.,1,articles/d03/pmcid_9194644/tables/table_000.csv
9194644,t0010,Table 2,"Results from two regression (baseline) and two mixed models (progression) on WMH and WM health, Genu-FA.","WMH measurements are log-transformed. Higher WMH and lower Genu-FA represent poor brain health. HTN: Hypertension. Other potential variables were dropped out from the stepwise regression. 1564 participants are included in baseline analysis where 1396 are cognitively normal; 740 participants are included in the progression analysis, where 632 are cognitively normal.",1,articles/d03/pmcid_9194644/tables/table_001.csv
9194644,t0015,Table 3,"Results from two standardized regression models on WMH with and without controlling for WM health, Genu-FA.",WMH measurements are log transformed before the standardized regression models.,1,articles/d03/pmcid_9194644/tables/table_002.csv
9935650,Tab1,Table 1,Baseline characteristics,"Outcome is based on 6-month follow-up. Data are presented as n (%) for dichotomous variables, mean ± sd for normally distributed continuous variables, and median [IQR] otherwise. CPC, cerebral performance category; OHCA, out-of-hospital cardiac arrest",1,articles/184/pmcid_9935650/tables/table_000.csv
9935650,Tab2,Table 2,"Whole-brain mean diffusivity, fractional anisotropy, and percentage of brain volume with mean diffusivity below the threshold of 450*10-6 mm2/s","Data are represented as n (%) for dichotomous variables, mean ± sd for normally distributed continuous variables and median [IQR] otherwise. Effect size is depicted as Cohen’s d (95% CI). MD, mean diffusivity; %MD450, brain volume with mean diffusivity below the threshold of 450 × 10-6 mm2/s; *MD × 10-6 mm2/s",1,articles/184/pmcid_9935650/tables/table_001.csv
3305887,T1,Table 1,Subject demographic information.,"aDiffers from all groups, p < 0.0001;bHigh WMH marginally differ from Low WMH, p = 0.09;cDiffers from young, p < 0.008;dAll groups differ, p < 0.04.",1,articles/58e/pmcid_3305887/tables/table_000.csv
3305887,T2,Table 2,Tract-based multiple regression model p-values for WMH and FA covariates for 10 separate models.,"Model covariates include subject age, sex, and education, and tract WMH and FA as predictors of memory performance.Abbreviations: UNC, uncinate fasciculus; SLF-FP, frontal-parietal portion of the superior longitudinal fasciculus; TH-SFG, projections between thalamus and superior frontal gyrus; TH-MFG, projections between thalamus and middle frontal gyrus; CST, corticospinal tract; CGH, ventral cingulum bundle; CGC, dorsal cingulum bundle; ILF, inferior longitudinal fasciculus; SAF-IOG-MOG, short association fibers between inferior occipital and middle occipital gyrus; SAF-Cu-SOG, short association fibers between cuneus and superior occipital gyrus.*p < 0.05 (uncorrected);**p < 0.0051 (α = 0.05 corrected for 10 comparisons).",1,articles/58e/pmcid_3305887/tables/table_001.csv
3305887,T3,Table 3,Tract-based multiple regression model p-values for WMH and FA covariates as predictors of control cognitive measures.,"Model covariates include subject age, sex, and education, and tract WMH and FA. All values not significant at p < 0.05.Abbreviations: UNC, uncinate fasciculus; ILF, inferior longitudinal fasciculus.",1,articles/58e/pmcid_3305887/tables/table_002.csv
6978216,tbl0001,Table 1,Characteristics of the study population.,Data represent mean ± SD or number of participants (%). WMH volume was expressed as median (IQR). MMSE: Mini-Mental State Examination; WMH: white matter hyperintensities; NAWM: normal appearing white matter; MD: mean diffusivity; FA: fractional anisotropy.,1,articles/d3b/pmcid_6978216/tables/table_000.csv
6978216,tbl0002,Table 2,Associations between SVD markers and rich club organization.,"Associations of the conventional SVD markers WMH, lacunes and microbleeds with structural network measures. WMH volumes were log-transformed because of skewedness. Data are displayed as standardized betas [95% confidence intervals], analyzed using linear regression analyses. *p<0.05; **p<0.01; ***p<0.001.",1,articles/d3b/pmcid_6978216/tables/table_001.csv
6978216,tbl0003,Table 3,Rich club organization and cognitive decline.,"Longitudinal associations between network measures and cognitive decline. Data are displayed as standardized betas [95% confidence intervals]. Statistical differences were analyzed using linear regression analyses, adjusted for age, sex and education. *p<0.05; **p<0.01; ***p<0.001.",1,articles/d3b/pmcid_6978216/tables/table_002.csv
11335690,tab1,Table 1,"Socio-demographic, symptoms, and imaging measures for the two control groups (orthopedic control, OC, and healthy controls, HC).","Values shown are Mean ± SD, with ranges or percentage in (). Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p < 0.05) were shown in bold with *. MVC, Motor Vehicle Collision.",1,articles/4ae/pmcid_11335690/tables/table_000.csv
11335690,tab2,Table 2,"Socio-demographic, symptoms, and imaging measures for control and mTBI patients at two visits (14Day and 6–12Mon).","Values shown are Mean ± SD, with ranges or percentage in (). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p < 0.05) were shown in bold with*. MVC, Motor Vehicle Collision.",1,articles/4ae/pmcid_11335690/tables/table_001.csv
11335690,tab3,Table 3,"Sicio-demographic, symptoms, and imaging measures for mTBI patients with and without memory problems at two visits (14Day and 6–12Mon).","The existence of memory problems was defined as RPQ ratings ≥ 2 at the 14Day visit. Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Same mTBI patients were included for both visits, therefore demographic information stays the same. Significant p-values (p < 0.05) were shown in bold with *. BMI, Body Mass Index. MVC, Motor Vehicle Collision.",1,articles/4ae/pmcid_11335690/tables/table_002.csv
11335690,tab4,Table 4,Logistic regression model coefficients for Model 2 (Figure 7).,"Among all socio-demographic and clinical information, Education and CT or MRI findings were selected to compose the best logistic model for prediction of 6–12Mon memory problem. 14Day WM-ePVS and ALPS were also significant factors (bolded with *).",1,articles/4ae/pmcid_11335690/tables/table_003.csv
11019668,T1,Table 1,Participant’s demographics and disease characteristics.,"Data shown are n (%) or median (first and third quartiles). For continuous variables, p-values are from Mann-Whitney test. For categorical variables, p-values are from Pearson’s Chi-squared test. Key; MoCA, Montreal Cognitive Assessment; CDR, Clinical Dementia Rating Scale; AVLT-RPC, Rey Auditory Verbal Learning Test – Recognition Percent Correct; RBD, Rapid eye movement sleep behavior disorder.",1,articles/974/pmcid_11019668/tables/table_000.csv
5624890,Tab1,Table 1,Demographic and clinical characteristics.,"Note: all analyses were one-way ANOVA, except †using χ² or Fisher’s Exact test and ‡using independent-samples t test. *Post-hoc analysis indicated significant differences between HC and hypos-PD groups and between norms-PD and hypos-PD groups, but no difference between HC and norms-PD groups. §Post-hoc analysis indicated significant differences between HC and hypos-PD groups; GDS = Geriatric Depression Scale; Handedness: R = right, L = left, M = Mixed; HVLT = Hopkins Verbal Learning Test; H&Y = Hoehn & Yahr staging; JOL = Judgment of Line Test; LNS = Letter-Number Sequencing Test; MOCA = Montreal Cognitive Assessment; SDMT = Symbol-Digit Modalities Test; SF = Semantic Fluency Test; UPDRS-III = MDS-Unified Parkinson’s Disease Rating Scale-Motor Subscale; UPSIT = University of Pennsylvania Smell Identification Test.",2,articles/980/pmcid_5624890/tables/table_000.csv
11755477,neurosci-06-00008-t001,Table 1,Complete subject characteristics: N: total number; F: females; CN: cognitively normal; EMCI: early MCI; LMCI: late MCI SD: standard deviation; MMSE: Mini–Mental State Examination; GDS: Geriatric Depression Scale; CDR: Clinical Dementia Rating; FAQ: Functional Activities Questionnaire; APOE: Apolipoprotein E. All the data represent mean ± standard deviation unless otherwise indicated. * with Bonferroni correction. ** from multi-shell.,,3,articles/387/pmcid_11755477/tables/table_000.csv
11755477,neurosci-06-00008-t002,Table 2,Complete MRI scanners and dMRI acquisition information: ms: milliseconds. TR: repetition time—measured in milliseconds (ms). TE: echo time—measured in milliseconds (ms). mm3: cubic millimeters. mm2: Square Millimeters. N: number of images without diffusion. s: seconds. dir: number of diffusion directions. * from multi-shell—only used b = 1000 with 48 directions. ** Data from multi-shell dMRI.,,1,articles/387/pmcid_11755477/tables/table_001.csv
11755477,neurosci-06-00008-t003,Table 3,"The outcomes of the analysis of covariance (ANCOVA) (at a False Discovery Rate (FDR) < 0.05), along with post hoc comparisons, for the f-index (corresponding to Figure 2). % Vol: the volume of the significant cluster within the relative white matter region. <t> the mean of the t-value inside the significant clusters. η2 and g are the effect sizes for the ANCOVA model and the post hoc comparisons, respectively. JHU: Johns Hopkins University white matter atlas. WM: white matter. max: maximum. CN: cognitively normal. EMCI: Early Mild Cognitive Impairment. LMCI: Late Mild Cognitive Impairment. L: left. R: right. ICBM: International Consortium for Brain Mapping, the standardized brain templates and atlases used in neuroimaging. DTI: diffusion tensor imaging. Fornix (cres): crescent-shaped part of the fornix.",,3,articles/387/pmcid_11755477/tables/table_002.csv
11755477,neurosci-06-00008-t004,Table 4,"The outcomes of the analysis of covariance (ANCOVA) (at a False Discovery Rate (FDR) < 0.05), along with post hoc comparisons, for free-water fractional anisotropy (corresponding to Figure 3). % Vol: the volume of the significant cluster within the relative white matter region. <t> the mean of the t-value inside the significant clusters. η2 and g are the effect sizes for the ANCOVA model and the post hoc comparisons, respectively. JHU: Johns Hopkins University white matter atlas. WM: white matter. max: maximum. CN: cognitively normal. EMCI: Early Mild Cognitive Impairment. LMCI: Late Mild Cognitive Impairment. L: left. R: right. ICBM: International Consortium for Brain Mapping, the standardized brain templates and atlases used in neuroimaging. DTI: diffusion tensor imaging. Fornix (cres): crescent-shaped part of the Fornix.",,3,articles/387/pmcid_11755477/tables/table_003.csv
11755477,neurosci-06-00008-t005,Table 5,"The outcomes of the correlations between the f-index and Mini–Mental State Examination for different effect size thresholds. % Vol: the volume of the significant cluster within the relative white matter region. <ρ>: the mean of the effect size value inside the significant clusters. JHU: Johns Hopkins University white matter atlas. WM: white matter. max: maximum. CN: cognitively normal. EMCI: Early Mild Cognitive Impairment. LMCI: Late Mild Cognitive Impairment. L: left. R: right. ICBM: International Consortium for Brain Mapping, the standardized brain templates and atlases used in neuroimaging. DTI: diffusion tensor imaging. Fornix (cres): the crescent-shaped part of the fornix.",,3,articles/387/pmcid_11755477/tables/table_004.csv
11755477,neurosci-06-00008-t006,Table 6,"The outcomes of the correlations between free-water-fractional anisotropy and Mini–Mental State Examination for different effect size thresholds. % Vol: the volume of the significant cluster within the relative white matter region. <ρ>: the mean of the effect size value inside the significant clusters. JHU: Johns Hopkins University white matter atlas. WM: white matter. max: maximum. CN: cognitively normal. EMCI: Early Mild Cognitive Impairment. LMCI: Late Mild Cognitive Impairment. L: left. R: right. ICBM: International Consortium for Brain Mapping, the standardized brain templates and atlases used in neuroimaging. DTI: diffusion tensor imaging. Fornix (cres): the crescent-shaped part of the fornix.",,3,articles/387/pmcid_11755477/tables/table_005.csv
11755477,neurosci-06-00008-t007,Table 7,Region of interest analysis was conducted for all free-water (fw) DTI metrics within the entire white matter. Significant group differences were identified in the f-index metric. All the data represent the mean ± standard deviation unless otherwise indicated. CN: cognitively normal. EMCI: Early Mild Cognitive Impairment. LMCI: Late Mild Cognitive Impairment. F: F-test. t: t-test. FA: fractional anisotropy. AX: axial diffusivity. RAD: radial diffusivity. *** p < 0.001.,,1,articles/387/pmcid_11755477/tables/table_006.csv
11755477,neurosci-06-00008-t008,Table 8,"Volumetric analysis of white matter (WM), gray matter (GM), and cerebrospinal fluid (CSF) volumes across groups. The data are presented as the means (standard deviation). Shapiro–Wilk tests indicate non-normal distributions, and Kruskal–Wallis tests reveal significant differences across groups for all brain compartments. * Three CN individuals and one EMCI individual were excluded from this analysis due to the unavailability of structural images. ** p < 0.001.",,1,articles/387/pmcid_11755477/tables/table_007.csv
8689627,table1-20584601211066467,Table 1.,Results of cognitive testing for the two groups. These are the average results from the tests; the two groups must be as close as possible for MMS and CDT in order to be comparable groups and differ as much as possible for NPI and FLI in order to confirm our hypothesis. Abbreviations: MMSE: Mini-Mental Status Examination; CDT: clock-drawing test; NPI: Neuropsychiatric Inventory; FLI: Frontal Lobe Inventory.,,1,articles/4bd/pmcid_8689627/tables/table_000.csv
8689627,table2-20584601211066467,Table 2.,"A presentation of fractional anisotropy (FA) values in patients with and without behavioral problems. The values presented are averages of FA in right frontal lobe (RF), left frontal lobe (LF), right temporal lobe (RT), left frontal lobe (LT), right occipital lobe (RO), and left occipital lobe (LO). A chi-square test was done to look for differences between the measurements and * denotes p < 0.05. We did only find differences between the measurements of the frontal lobes.",,1,articles/4bd/pmcid_8689627/tables/table_001.csv
8689627,table3-20584601211066467,Table 3.,Logistic regression parameters for each covariate used for predicting behavioral problem status. The lasso-regularized maximum likelihood estimates for the parameters of the logistic linear regression were used to predict the presence or absence of behavioral problems in the patients.,,1,articles/4bd/pmcid_8689627/tables/table_002.csv
4207674,pone-0109676-t001,Table 1,Sociodemographic and clinical characteristics of patients and control subjects.,"Legend. HD = Huntington's disease; Pre-HD = gene-positive, without motor symptoms; SD = standard deviation; df = degrees of freedom; CAG, trinucleotide repeat number; MMSE = Mini Mental State Examination; UHDRS = Unified Huntington's Disease Rating Scale; TFC = Total Functional Capacity; NA = Not Available;††T-student, Bonferroni correction.aPre-HD<HD (when referred to a cognitive scale comparison or CAG repetition, higher punctuations mean greater impairment).bPre-HD>HD (when referred to a cognitive scale comparison, higher punctuations mean lesser impairment).*MMSE: Missing data for 5 Pre-HD & 5 HD subjects.*UHDRS Motor: Missing data for 2 Pre-HD & 2 HD subjects.*UHDRS Cognitive: Missing data for 5 Pre-HD & 2 HD subjects.*UHDRS Behavioral: Missing data for 4 Pre-HD & 2 HD subjects.*UHDRS Functional: Missing data for 2 Pre-HD & 2 HD subjects.*TFC: Missing data for 2 Pre-HD & 2 HD subjects.",1,articles/31a/pmcid_4207674/tables/table_000.csv
4207674,pone-0109676-t002,Table 2,Total Deep White Matter Tractography Group Comparisons.,"Legend. FA = Fractional Anisotropy; AD = Axial Diffusivity; RD = Radial Diffusivity. (AD/RD Mean units: 10−3 mm2/s, R2* (10−3 mm1/s).*Significant FDR corrected results are in BOLD.",2,articles/31a/pmcid_4207674/tables/table_001.csv
4207674,pone-0109676-t003,Table 3,Individual Deep White Matter Tractography Group Comparisons.,"Legend. AF = Arcuate Fasciculus, SLF = Superior Longitudinal Fasciculus, Cing = Cingulate, ILF = Inferior Longitudinal Fasciculus, IFO = Inferior Frontal Occipital fasciculus, ATR = Anterior Thalamic Radiation, UF = Uncinate Fasciculus; Hemi DWM = total left and right Deep White Matter, it is the result of the individual white matter tracts combined for each hemisphere; FA = Fractional Anisotropy; AD = Axial Diffusivity; RD = Radial Diffusivity; R = Right; L = Left.*Significant FDR corrected results are in BOLD.",2,articles/31a/pmcid_4207674/tables/table_002.csv
5534111,Tab1,Table 1,Basic information,"Abbreviation: SIVD subcortical ischemic vascular disease, AD Alzheimer’s disease, CDR Clinical Dementia Rating, SD Standard deviation**p < 0.01***p < 0.001 on comparisons between SIVD and AD",2,articles/f3f/pmcid_5534111/tables/table_000.csv
5534111,Tab2,Table 2,Cognitive status and Neuropsychiatric Inventory among dementia patients,"(1) Mean ± SD were shown. (2) Abbreviation: SIVD subcortical ischemic vascular disease, AD Alzheimer’s disease, CDR Clinical Dementia Rating, MMSE Mini-Mental State Examination, CASI Cognitive Abilities Screening Instrument, Sig. Significance.(3) T-test was used to evaluate the group difference and significant difference was defined as p value <0.05. (4) *p < 0.05 on the comparisons between all SIVD patients and all AD patients;#p < 0.05 on the comparisons between SIVD patients with CDR score = 0.5 and AD patients with CDR score = 0.5; §p < 0.05, §§p < 0.01 on the comparisons between SIVD patients with CDR score = 1 ~ 2 and AD patients with CDR score = 1 ~ 2. (5) £p < 0.05, ££p < 0.01, and £££p < 0.001 on the comparisons between patient with CDR score = 0.5 and with CDR score = 1 ~ 2 among all patients respectively. (6) ǂp < 0.05 and ǂǂp < 0.01 on the comparisons between patient with CDR score = 0.5 and with CDR score = 1 ~ 2 in SIVD group respectively. (7) $$$p < .001 on the comparisons between patient with CDR score = 0.5 and with CDR score = 1 ~ 2 in AD group",2,articles/f3f/pmcid_5534111/tables/table_001.csv
5534111,Tab3,Table 3,Correlation between Neuropsychiatric Inventory and diffusion tensor imaging parameters within corpus callosum across patient groups,"(1) Pearson’s correlation coefficient was used. (2) *p < 0.05, **p < 0.01 on the correlation between NPI and DTI parameters. (3) ǂp < 0.05, ǂǂp < 0.01 on the correlation between NPI and DTI parameters on controlling of age, the total score of CASI, and the CDR score",2,articles/f3f/pmcid_5534111/tables/table_002.csv
5534111,Tab4,Table 4,Regression models for Neuropsychiatric Inventory domains among patient groups,"(1) The beta coefficients were noted. (2) The p value of all noted beta coefficients were less than 0.05, while the bold-faced italic values were less than 0.01. (3) Abbreviation: NA not available. CASI Cognitive Abilities Screening Instrument, CDR Clinical Dementia Rating, HIS Hachinski Ischemic Scale. GCC genu of the corpus callosum, BCC body of the corpus callosum, SCC splenium of the corpus callosum, RSLF right superior longitudinal fasciculus, LSLF left superior longitudinal fasciculus, Rfminor right forceps minor, Lfminor left forceps minor, Rfmajor right forceps major, Lfmajor left forceps major, Ratr right anterior thalamic radiation, Latr left anterior thalamic radiation, Runc right uncinate fasciculus, Lunc left uncinate fasciculus, RILF right inferior longitudinal fasciculus, and LILF left inferior longitudinal fasciculus",2,articles/f3f/pmcid_5534111/tables/table_003.csv
5331035,T1,Table 1,Participant demographics.,"CDDAT, clinically diagnosed dementia of the Alzheimer type; NT, neurotypical; F, female; M, male; R, right-handed; nR, non-right-handed; CA, Caucasian.",1,articles/f53/pmcid_5331035/tables/table_000.csv
5331035,T2,Table 2,Summary of functional magnetic resonance imaging (fMRI) contrasts.,"A total of five subject-level contrast maps were created for all subjects. EVDT, emotional valence determination test.",1,articles/f53/pmcid_5331035/tables/table_001.csv
7998032,Tab1,Table 1,Group demographics with MMSE and CDR scores.,*Student t-test demonstrated differences in MMSE and CDR between AD and HC cohorts.,1,articles/b3a/pmcid_7998032/tables/table_000.csv
7998032,Tab2,Table 2,Brain locations where clusters of significant differences between groups were found for both standard and FW-DTI analyses.,"All results are shown for p < 0.01 (FWE corrected), except for the last column, indicated by *, where RD (HC) < RD (AD) is reported at p < 0.05 (FWE corrected). % columns indicate the percent volume of the cluster inside the corresponding brain area.For JHU white-matter tractography atlas: ATR anterior thalamic radiation, CST cortical spinal tract, CGC cingulum (cingulate gyrus part), CGH cingulum (hippocampal part), IFOF inferior fronto-occipital fasciculus, ILF inferior longitudinal fasciculus, UF uncinate fasciculus. For ICBM-DTI-81 white-matter atlas: CC corpus callosum, LIC limb of internal capsule, IC internal capsule, CR corona radiate, SS sagittal stratum, SFOF superior fronto-occipital fasciculus.",3,articles/b3a/pmcid_7998032/tables/table_001.csv
7998032,Tab3,Table 3,Brain locations where clusters of significant differences between groups were found for FW maps analysis at p < 0.01 (FWE corrected).,"% columns indicate the percent volume of the cluster inside the corresponding brain area. Only clusters with higher FW values in AD than HC were observed.For JHU white-matter tractography atlas: ATR anterior thalamic radiation, CST cortical spinal tract, CGC cingulum (cingulate gyrus part), CGH cingulum (hippocampal part), IFOF inferior fronto-occipital fasciculus, ILF inferior longitudinal fasciculus, SLF superior longitudinal fasciculus, UF uncinate fasciculus. For ICBM-DTI-81 white-matter atlas: CC corpus callosum, CP cerebral peduncle, LIC limb of internal capsule, IC internal capsule, CR corona radiata, SS sagittal stratum, EC external capsule.",1,articles/b3a/pmcid_7998032/tables/table_002.csv
7998032,Tab4,Table 4,Brain locations where clusters of significant differences between groups were found for MA index analysis at p < 0.01 (FWE corrected).,"% columns indicate the percent volume of the cluster inside the corresponding brain area.For JHU white-matter tractography atlas: ATR anterior thalamic radiation, CST cortical spinal tract, IFOF inferior fronto-occipital fasciculus, ILF inferior longitudinal fasciculus, UF uncinate fasciculus. For ICBM-DTI-81 white-matter atlas: CC corpus callosum, LIC limb of internal capsule, CR corona radiata, EC external capsule, SFOF superior fronto-occipital fasciculus.",3,articles/b3a/pmcid_7998032/tables/table_003.csv
10642051,Tab1,Table 1,Demographics of participants,"aMCI Amnestic mild cognitive impairment, naMCI Non-amnestic mild cognitive impairment, MMSE Mini Mental Status Examination, AVLT Auditory Verbal Learning Test, R-O Rey-Osterrieth Complex Figure, CDT Clock Drawing Test; CVFT, Category Verbal Fluency Test, BNT Boston Naming Test, SDMT Symbol Digit Modalities Test, TMT Trail Making Test, StroopCtime Time of Stroop Word Color Test CaStatistically significant difference between controls and aMCI at p < 0.05bStatistically significant difference between controls and naMCI at p < 0.05cStatistically significant difference between aMCI and naMCI at p < 0.05",1,articles/921/pmcid_10642051/tables/table_000.csv
10642051,Tab2,Table 2,"Correlations between gray matter volume, fiber bundle number, and cognitive tests","MMSE Mini Mental Status Examination, AVLT Auditory Verbal Learning Test, R-O Rey-Osterrieth Complex Figure; CDT, Clock Drawing Test, CVFT Category Verbal Fluency Test, BNT Boston Naming Test, SDMT Symbol Digit Modalities Test, TMT Trail Making Test, StroopCtime, Time of Stroop Word Color Test C*p < 0.05; **p < 0.001. Analyses were controlled for gender, education and age",2,articles/921/pmcid_10642051/tables/table_001.csv
10925090,T1,Table 1.,"Study demographics and image acquisition parameters of each dataset. In multi-shell acquisitions, the shells used for DTI processing are indicated in bold.","*Original acquisition dimensions. GE automatically zero-pads in k-space by default, so processing was performed on resampled data.☨QTIM participants were scanned twice, once with each protocol.☨☨Non-zero b-value shells were processed separately, for comparison.",1,articles/f01/pmcid_10925090/tables/table_000.csv
10925090,T3,Table 3.,Demographics and ApoE4 information for the datasets included in the regression models. The included subjects are healthy controls filtered for European ancestry.,1n (%),1,articles/f01/pmcid_10925090/tables/table_002.csv
7005463,tbl0001,Table 1,Clinical characteristics of study sample.,"Abbreviations: M/F = Male/Female, MMSE = Mini-Mental State Examination, ACER = Addenbrooke's Cognitive Evaluation Revised, * = t-test, # = Mann-Whitney, $ = Chi-Square test.",1,articles/cc9/pmcid_7005463/tables/table_000.csv
6221120,ana25309-tbl-0001,Table 1,Demographic and Clinical Information,CAG = cytosine–adenine–guanine; CPO = cumulative probability to onset; F = female; M = male; n.s. = not significant; N/A = not applicable; Pre‐HD = premanifest Huntington's disease; SD = standard deviation; TMS = total motor score.,1,articles/d34/pmcid_6221120/tables/table_000.csv
6221120,ana25309-tbl-0002,Table 2,Neurite Orientation Dispersion and Density Imaging Metrics for the ROI Analysis ‐ NDI and ODI,"False discovery rate (FDR)–corrected, p < 0.05.NDI = neurite density index; ODI = orientation dispersion index; Pre‐HD = premanifest Huntington's disease; ROI = region of interest; SD = standard deviation; WM = white matter.",2,articles/d34/pmcid_6221120/tables/table_001.csv
11813630,jcsm13719-tbl-0001,TABLE 1,Characteristics of included studies.,"Abbreviations: CDR, Clinical Dementia Rating scale; CHS, Cardiovascular Health Study frailty score; CN, cognitively normal; DSM‐III‐R, Diagnostic and Statistical Manual, third edition revised; DTI, diffusion tensor imaging; EFS, Edmonton frailty scale; fMRI, functional magnetic resonance imaging; IST, Isaacs Set Test; MCI, mildly cognitively impaired; MEG, magnetoencephalography; MMSE, Mini‐Mental State Examination; MRI, magnetic resonance imaging; NINCDS‐ADRDA, National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association; PET, positron emission tomography.aMedian, IQR.",1,articles/51b/pmcid_11813630/tables/table_000.csv
11813630,jcsm13719-tbl-0002,TABLE 2,A summary of findings of studies on MRI.,"Abbreviations: AF, atrial fibrillation; AG, angular gyrus; BG, basal ganglia; BMI, body mass index; BNP, B‐type natriuretic peptide; BPV, brain parenchymal volume; CF, cognitive frailty; CKD, chronic kidney disease; CMB, cerebral microbleeds; CN, cognitively normal; COPD, chronic obstructive pulmonary disease; CRP, C‐reactive protein; CSF, cerebrospinal fluid; CSFV, cerebral spinal fluid volume; CSVD, cerebral small vessel disease; DAN, dorsal attention network; DM, diabetes mellitus; DWI, diffusion weighted imaging; EFS, Edmonton frailty scale; eGFR, estimated glomerular filtration rate; EPVS, enlarged perivascular spaces; FLAIR, fluid‐attenuated inversion recovery; FPN, frontoparietal network; GMF, grey matter fraction (GMV/BPV); GMV, grey matter volume; GRE, gradient echo sequences; hs‐CRP, high sensitivity C‐reactive protein; ICV, intracranial volume; IFG, inferior frontal gyrus; IHD, ischemic heart disease; MCI, mildly cognitively impaired; MEG, magnetoencephalography; MFG, middle frontal gyrus; MYF, myelin fraction (MYV/BPV); MYV, myelin volume; PAR, parenchyma; PD, proton density; pDMN, posterior default mode network; PF, physical frailty; RH, right hemisphere; SI, subcortical infarct; SMA, sensory motor area; SMG, supramarginal gyrus; SMR, sensorimotor rhythm; SPL, superior parietal lobule; SVD, small vessel disease; SWI, susceptibility weighted imaging; T, tesla; TBV, total brain volume; TIV, total intracranial volume; VAN, ventral attention network; WHV, white matter hyperintensity volume; WM, white matter; WMF, white matter fraction (WMV/BPV); WMH, white matter hyperintensity; WMV, white matter volume.",1,articles/51b/pmcid_11813630/tables/table_001.csv
11813630,jcsm13719-tbl-0003,TABLE 3,A summary of findings of studies on DTI.,"Abbreviations: AD, axial diffusivity; APOE e4, apolipoprotein e4; BMI, body mass index; DTI, diffusion tensor imaging; FA, fractional anisotropy; gFA, general factors for FA; gMD, general factors for MD; MD, mean diffusivity; RD, radial diffusivity; ROI, region of interest; WM, white matter; WMH, white matter hyperintensities.",1,articles/51b/pmcid_11813630/tables/table_002.csv
11813630,jcsm13719-tbl-0004,TABLE 4,A summary of findings of studies on fMRI.,"Abbreviations: ASA, American Society of Anaesthesiologists; BMI, body mass index; Cad, coronary artery disease; CCI, Charlson comorbidity index; CHF, congestive heart failure; FC, functional connectivity; fMRI, functional magnetic resonance imaging; GPT, Grooved Pegboard Test; N/A, not applicable; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; Rs, resting state; SMA, supplementary motor area; TMT‐A, Trail‐Making‐Test Part A.",1,articles/51b/pmcid_11813630/tables/table_003.csv
11813630,jcsm13719-tbl-0005,TABLE 5,A summary of findings of the study on PET scan.,"Abbreviations: ApoE e4, apolipoprotein E e4; FI, frailty index; MAPT, Multidomain Alzheimer's Preventive Trial; PET, positron emission tomography; SUVR, standard uptake value ratios.",1,articles/51b/pmcid_11813630/tables/table_004.csv
8959640,dad212261-tbl-0001,TABLE 1,"Intra‐class coefficients of FW, PSMD, and WMH measures between sites (inter‐rater reliability study), sessions (test–retest repeatability study) and scanners (inter‐scanner reproducibility study)","Abbreviations: FW, free water; GE, General Electric; JHU, Johns Hopkins University School of Medicine; PMSD, peak width skeletonized mean diffusivity; RUSH, Rush University Medical Center/Illinois Institute of Technology; UCD, University of California Davis; UKY, University of Kentucky; UNM, University of New Mexico Health Sciences Center; USC, University of Southern California; UTHSCSA, University of Texas Health Science Center at San Antonio; WMH, white matter hyperintensity.",1,articles/f39/pmcid_8959640/tables/table_000.csv
11484424,Tab1,Table 1,Demographic information of participants,,1,articles/149/pmcid_11484424/tables/table_000.csv
11484424,Tab2,Table 2,"Repeated measure ANOVA test results were conducted on normal, early and late MCI groups with two and four years follow-ups",*significance with p-value < 0.05,3,articles/149/pmcid_11484424/tables/table_001.csv
11160843,T1,Table 1.,"Socio-demographic, symptoms, and imaging measures for the two control groups (orthopedic control, OC, and healthy controls, HC). Values shown are Mean ± SD, with ranges or percentage in ( ). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden.",Significant p-values (p < 0.05) were shown in bold with *.,1,articles/b9a/pmcid_11160843/tables/table_000.csv
11160843,T2,Table 2.,"Socio-demographic, symptoms, and imaging measures for control and mTBI patients at two visits (14Day and 6–12Mon). Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden.",Significant p-values (p < 0.05) were shown in bold with *.,1,articles/b9a/pmcid_11160843/tables/table_001.csv
11160843,T3,Table 3.,"Sicio-demographic, symptoms, and imaging measures for mTBI patients with and without memory problems at two visits (14Day and 6–12Mon). The existence of memory problems were defined as RPQ ratings ≥ 2 at the 14Day visit. Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Same mTBI patients were included for both visits, therefore demographic information stays the same.",Significant p-values (p < 0.05) were shown in bold with *.,1,articles/b9a/pmcid_11160843/tables/table_002.csv
11160843,T4,Table 4.,"Logistic regression model coefficients for Model 2 (Figure 7). Among all socio-demographic and clinical information, Education and CT or MRI findings were selected to compose the best logistic model for prediction of 6–12Mon memory problem.",14Day WM-ePVS and ALPS were also significant factors (bolded with *).,1,articles/b9a/pmcid_11160843/tables/table_003.csv
3902504,BMJOPEN2013003976TB1,Table 1,Demographics and clinical characteristics,"The three groups did not differ regarding age, sex, years of education, cerebrovascular burden and Fazekas score.Numbers represent means±SD (range) unless otherwise indicated.*Significant at the p<0.05 level.†Alzheimer's disease—mild cognitive impairment.‡Parkinson's disease.§Mini-Mental State Examination.¶Global Deterioration Scale, category 1=normal, category 2=subjective cognitive impairment, category 3=mild cognitive impairment.**Composite score from 0 to 6 were 0 indicates no cerebrovascular burden, 6 indicates a maximum disease burden.",1,articles/4ad/pmcid_3902504/tables/table_000.csv
